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Introduction and aim of the thesis 
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The rhythmic contraction of the heart pumps blood to the peripheral organs and tissues of 
the body and provides them with oxygen and nutrients. The energy that is required by the 
heart for basal metabolism (20%), electromechanical coupling (5%) and contraction (75%) is 
derived from energy rich phosphate bonds as in adenosine triphosphate (ATP). Since the heart 
has limited stores of ATP, its constant regeneration from adenosine diphosphate (ADP) is 
required. ATP can be generated either aerobically (oxidative phosphorylation via the 
tricarboxylic acid cycle, high yield) or anaerobically (via glycolysis, low yield). Anaerobic 
glycolysis can at best provide 5-10% ofUle ATP requirements under basal conditions, so that 
the heart must rely principally on oxidative phosphorylation for ATP generation. Under basal 
conditions the heart already extracts 70-80% of the coronary arterial oxygen content. 
Consequently, reductions in coronary blood supply will result in airoost equivalent reductions 
in oxygen supply. Clinically a decrease in oxygen supply can result from narrowing of a 
proximal coronary artery segment, vasospasm, thrombus formation, or a combination of these 
factors. The consequences of an acute decrease in oxygen supply include 1) diroinished 
contractile function, 2) cardiac arrhythmias, and 3) myocardial cell death (infarct). Onset and 
occurrence of myocardial cell death depends on factors such as species, residual flow via 
collateral vessels and oxygen demand at the onset of occlusion. Myocardium can, therefore, 
be salvaged anywhere between one hour (swine, rabbit) and three hours (dogs, humans) after 
the onset of occlusion. To salvage jeopardized myocardium it is mandatory to reinstate blood 
flow to the heart (reperfusion), but understanding and subsequent manipulation of factors that 
affect the progression of myocardial cell death could delay infarction so that more myocardium 
is salvaged when reperfusion is achieved. 
The concept of infarct size linlitation l .' has its basis in early human autopsy studies which 
reported that myocardial infarcts were significantly smaller than the myocardial region 
supplied by the occluded coronary artery ,'.5 and in experiroental studies reporting that brief 
(up to 20 min) periods of ischemia are tolerated without development of necrosis. 6 Fuelled by 
emerging concepts of the determinants of infarct size, of which collateral blood flow and 
energy utilization of the ischemic myocardial segment were the most iroportant, many 
pharmacological studies were undel1aken in an attempt to limit infarct size. Early experimental 
studies were often able to show an infarct size limiting effect of a drug, but later studies could 
not reproduce these results when more rigorous investigative methods were used. 
Consequently, myocardial reperfusion is clinically Ule only infarct-size reduction therapy 
currently in use. 
Experiroental interest in the concept of infarct size limitation was revived in 1986 when 
Murry et al
' 
fIrst described the phenomenon "Ischemic Preconditioning" when they observed 
that multiple brief ischemic episodes separated by brief periods of reperfusion reduced infarct 
size produced by a sustained period of myocardial ischemia, despite an increase in total 
ischemia tiroe. More specifIcally they found that in dog hearts infarct size (defmed as the ratio 
of infarcted area and the anatomical area at risk) was reduced frolll 29 % to 7 %, when a 40 min 
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total coronary al1ery occlusion was preceded by four sequences of 5 min occlusion and 5 min 
of reperfusion. These findings could not be explained by enhanced recruitment of coronary 
collateral blood flow. However, during the 40 min total coronary artery occlusion depletion 
of high energy phosphates in the preconditioned animals was slower than in the control 
animals. Interestingly, infarct size limitation was lost when the duration of the coronary 
occlusion Was extended to three hours, indicating that preconditioning only delayed myocardial 
necrosis' and therefore could only enhance myocardial salvage when reperfusion was 
reinstated. 
Since the classical study of Murry et al a vast number of studies exploring the phenomenon 
of ischemic preconditioning has been published. These studies can be divided into two groups: 
I) Descriptive studies (e.g. what stimuli produce preconditioning?, how long does the 
protective effect last? and 2) Mechanistic studies (mediators and cellular mechanisms of 
preconditioning). For example, it is now clear that the duration of the protective effect of 
ischemic preconditioning is limited in time,8 but can be reinstated after an ischemia-free 
period.'·lo A classical preconditioning stimulus-can be described as a single brief coronary 
artery occlusion. This approach necessitates an intervening reperfusion before the sustained 
occlusion for the preconditioning stimulus to be effective (as it would otherwise be a sustained 
occlusion period). Ovize et al" showed that a partial coronary artery occlusion could be 
equally effective in producing a protective effect although intermittent reperfusion was still 
necessary. Until now most studies have focused on manipulating the supply side of the 
myocardial oxygen balance to obtain preconditioning. However, evidence is emerging that an 
increase in oxygen demand can also produce preconditioning. Thus, a short period of 
ventricular pacing protected the heart against the arrhythmogenic effect of a longer coronary 
artery occlusion. 12 Also, an acute increase in left ventricular f!l1ing pressure by volume loading 
was shown to decrease infarct size." Early mechanistic studies showed that myocardial 
stu1ll1ing was not the mechanism underlying preconditioning as the protective effect of a brief 
coronary artery occlusion had dissipated at a time when impaired contractile function was still 
present. 8 Downey and co-workers made the first important step toward revealing the 
mechanisms of ischemic preconditioning, when they described the role of adenosine in 
mediating the phenomenon. 13 Other mediators/mechanisms of preconditioning that are 
currently under investigation are K+ ATP channels, adrenergic receptors, muscarinic receptors 
and protein kinase C. Despite the tremendous wealth of information on preconditioning that 
has emerged in the last decade, the exact mechanism of preconditioning and particularly its 
clinical relevance are still incompletely understood. 
Experimental animal 
All experiments in tllis dissertation have been performed in domestic pigs (25-35 kg), which 
were anesthetized throughout the experimental protocol. Several reviews have emphasized the 
value of the pig in cardiovascular research." For studies on myocardial preconditioning the pig 
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model poses several advantages over other, particularly smaller, animal models. First, the size 
of the heart is large enough to monitor regional contractile function and to allow myocardial 
tissue sampling to monitor oxidative metabolism during the experimental protocol and to 
accurately detenuine infarct size in two layers of the left ventricle. Thus, the protective effect of 
a preconditioning stimulus can be related to reduction in myocardial contractile function and to 
the metabolic state ofthe myocardium. Second, the anatomy of porcine coronary circulation is 
quite similar to that of man in that there are no collaterals between Ole perfusion areas of the three 
main coronary arteries. Consequently, infarct size variability due to variable collateral blood 
flow, which is common in species like the dog, is likely to be minimal in pigs. Furthermore, the 
absence of a significant collateral circulation allows the study of ischemic preconditioning by 
partial flow reductions in the pig. Partial flow reductions are easy to monitor and to adjust on line 
with Doppler flow measurements on the supplying coronary artery. The presence ofa coronary 
collateral circulation can perturb the results of such studies as flow measurements on the 
supplying coronary artery do not correctly represent myocardial flow. 
AIM OF THE THESIS 
In this thesis, the results of our studies on ischemic preconditioning in domestic pigs are 
presented. The rationale for these studies stems from several earlier observations. 
First, it has been well established that in dogs the relation between infarct size (IS) and the 
anatomical area at risk (AR) is linear but not proportional, i.e. the regression line describing the 
relation between IS and AR is linear but has a positive intercept on the AR-axis." Such a relation 
implies that the IS/AR ratio, which is the index commonly used to express infarct size, is not a 
constant but depends on AR. In the dog, this intercept can be explained, at least in part, by 
collateral blood flow. If a positive intercept would also be present in a collateral deficient species 
like the pig, this could severely limit the use ofIS/AR in assessing infarct size and myocardial 
protection. Consequently, we determined the relationship between O,e anatomical area at risk and 
the infarcted area in the pig. 
Second, it is well established that most of the protective effect of a brief period of ischemia 
is lost when the reperfusion period separating the brief and sustained coronary artery occlusion 
exceeds two hours.' The relation between the extent of protection by ischemic preconditioning 
and the duration of the intervening reperfusion period is not well established, although some data 
suggest that the protective effect disappears gradually and quite early in the intervening 
reperfusion period." We studied the time course of the protective effect of a brief period of 
ischemia to detelmine the time window of protection and whether protection wears off gradually 
or disappears abruptly. 
Third, the necessity of a period of reperfusion between the brief and sustained total coronary 
artery occlusions to elicit ischemic preconditioning is self-evident; otherwise the duration of the 
sustained coronary artery occlusion will be merely increased. It is less obvious, however, whether 
a partial coronary artery occlusion can lead to ischemic preconditioning without the need for an 
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intervening reperfusion period. If myocardium can be preconditioned with a partial coronary 
artery ocelusion, the question naturally arises whether this protection is equal for the inner and 
outer halves of the myocardium as it is well established that a coronary flow reduction affects 
perfusion ofthe epicardial layers less dramatically than perfusion of the endocardial layers with 
consequently more severe ischemia in the latter. 111US we assessed the transmural distribution of 
infarct size after a coronary artery was occluded for 60 min immediately following a period in 
which coronary blood flow was reduced to a fixed percentage of baseline. 
Fourth, Ovize et al" have shown that stretch produced by acute volume loading precondition 
the myocardium without the need for ischemia suggesting that ischemia is not obligatory for the 
induction of preconditioning. We have extended these observations and investigated whether 
other non-ischemic stimuli are also capable to precondition the myocardium. 
Finally, although there is much experimental evidence for the existence of ischemic 
myocardial preconditioning, there is still no direct proof that ischemic preconditioning exists in 
man, when infarct size is taken as endpoint. The reason that the clinical relevance of ischemic 
preconditioning remains incompletely understood is several-fold. First, in man infarct size is 
usually assessed from enzyme leakage. Although enzymes such as creatine phosphorase-MB 
are relatively cardiac specific, estimates are rather inaccurate compared to the measurements 
in the animal laboratory. Second, it is next to impossible to determine the duration of a 
coronary artery occlusion as neither the onset of occlusion nor tile time that reperfusion starts 
can be determined accurately. Multiple episodes of reversible ischemia are not uncommon in 
man, however, and those induced by repeated stress tests, and balloon inflations during 
angioplasty are even fairly reproducible. These interventions could be tools to investigate 
whether the human myocardium can adapt to ischemic stress. We h.ve reviewed the literature 
in order to find evidence for the occurrence of ischemic preconditioning in humans. 
Brief description of the content of the thesis 
In chapter two the effects of multiple intermittent episodes of brief coronary ocelusions on 
region.1 myocardial function were studied. The multiple ocelusion-reperfusion sequences do not 
lead to myocardial necrosis, but reversible ahnomlalities in myocardial contractile performance 
were observed. In this model the effects of the anti-anginal drug trimetazidine were studied to 
determine ifthis compound alters the time course ofthe regional myocardial function responses 
to the brief occlusion-reperfusion sequences. 
In chapter three the teclmiques used to identify and quantify the area at risk and delineate 
viable from necrotic myocardium are presented. In addition the methodological and physiological 
determinants of infarct size are discussed. Infarct size is usually expressed as the ratio of the 
infarcted area and the area at risk. Such an index is only valid if this ratio is independent ofthe 
area at risk, i.e. infarcted area and area at risk are proportional. To assess if the relationship is 
indeed proportional, data are presented for both control and preconditioned animals in which the 
site of occlusion was varied to produce variable areas at risk. 
10 Chapter 1 
In chapter four the time course of the protective effect of a single 10 min total coronary artery 
occlusion was studied to detennine the duration of preconditioning and to determine whether the 
protective effect dissappears gradually or abruptly. For this purpose the duration of the 
intervening reperfusion period that separated the 10 min preconditioning period and the ischemic 
period was varied between 15 and 240 min. 
In view of the clinical relevance of preconditioning the question arose if it was possible to 
trigger preconditioning with a partial coronary artery occlusion without intermittent reperfusion 
before the onset of the sustained occlusion, as in many patients thrombus development may give 
rise to severe ischemia before the artery is totally occluded. This was studied in chapter five in 
which a 30 min 70% flow reduction preconditioning stimulus immediately preceded the 
sustained ischemia episode. 
In chapter six we further explored the myocardial preconditioning afforded by a partial 
occlusion immediately preceding the sustained ischemic period without an interveniug period 
ofreperfusion. Specifically, we determined wheUler the protection afforded by a partial occlusion 
depended on the severity and the duration of the flow reduction and whether the magnitude of 
the protection was inhomogeneously distributed across the left ventricular wall. The latter is not 
unlikely, as a partial coronary artery occlusion compromises perfusion of the endocardial layers 
more severely than perfusion of the epicardial layers, causing different degrees in the severity 
of ischemia. It could thus be that a partial occlusion would result in protection in Ule inner but 
not in the outer layers of the myocardium. 
In chapters four, five and six brief periods of ischemia were applied to study myocardial 
protection. In chapter seven we employed rapid ventricular pacing as a preconditioning stimulus 
and studied its effects on myocardial infarct size. Specifically, periods of ventricular pacing with 
and without an intervening period of spontaneous sinus rhytlun prior to the sustained ischemic 
period were studied. In addition, the role of myocardial ATP·sensitive K'-channel activation and 
induction of myocardial ischemia in the protection afforded by ventricular pacing were 
detennined. 
In chapter 8, we will review the literature for evidence that adaptation to ischemic stress and 
ischemic preconditioning occurs in man. Chapters nine (English) and ten (Dutch) contain a 
general discussion and sunilllary of this thesis. 
REFERENCES 
I Braunwald E. The pathogenesis and treatment of shock in myocardial infarction. Topics 
in clinical medicine. Johns Hopkins J Med 1967;121 :421-429. 
2 Maroko PR, Kjekbus JK, Sobel BE, Watanabe T, Covell JW, Ross J, Braunwald E. Factors 
influencing infarct size following experimental coronary artery occlusions. Circulation 
1971;43:67-82. 
Introduction 11 
3 Wartman WB, Souders JC. Localization of myocardial infarcts with respect to the muscle 
bundles of the heart. Arch PathoI1950;50:329-346. 
4 Wilkinson RS, Schaefer JA, Abildskov JA. Electrocardiographic and pathologic features 
of myocardial infarction in man. Am J Cardio11963;11 :24-35. 
5 Lee JT, Ideker RE, Reimer KA. Myocardial infarct size and location in relation to the 
coronary vascular bed at risk in man. Circulation 1981 ;64:526-534. 
6 Jennings RB, Sommers HM, Smyth GA, Flack HH, Linn H. Myocardial necrosis induced 
by temporaty occlusion of a coronary artery in the dog. Arch Pathol 1960;70:68-78. 
7 Muny CE, Jennings RB, Rein!er KA. Preconditioning with ischemia: a delay of lethal cell 
injury in ischemic myocardium. Circulation 1986;74: 1124-1136. 
8 Murry CE, Richard VJ, Jennings RB, Reimer KA. Myocardial protection is lost before 
contractile function recovers from ischemic preconditioning. Am J Physiol 1991 (Heart 
Circ Physiol 29);260:H796-H804. 
9 Sack S, Mohri M, Arras M, Schwarz ER, Schaper W. Ischaemic preconditioning - time 
course of renewal in the pig. Cardiovasc Res 1993;27:551-555. 
10 Xi-Ming Y, Amoult S, Tsuchida A, Cope D, Thornton JD, Daly JF, Cohen MY, Downey 
JM. The protection of ischaemic preconditioning can be reinstated in the rabbit heart after 
the initial protection has waned. Cardiovasc Res 1993;27:556-558. 
II Ovize M, Przyklenk K, Kloner RA. Partial coronary stenosis is sufficient and complete 
reperfusion is mandatory for preconditioning the canine heart. Circ Res 1992;71: 1165-
1173. 
12 Vegh A, Szekeres L, Parratt JR. Transient ischemia induced by rapid cardiac pacing results 
in myocardial preconditioning. Cardiovasc Res 1991 ;25: I 051-1 053. 
13 Liu GS, ThorntonJ, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM. Protection 
against infarction afforded by preconditioning is mediated by A, adenosine receptors in 
rabbit heart. Circulation 1991 ;84:350-356. 
14 Swine in Biomedical Research, 1986. Ed: M.E. Tumbleson, Plenum Press, New York. 
15 Jugdutt BI. Different relations between infarct size and occluded bed size in barbiturate-
anesthetized versus conscious dogs. J Am Coli Cardiol 1985;6: I 035-1 046. 
16 Miura T, Ogawa T, Iwamoto T, Tsuchida A, limura O. Infarct size limiting effect of 
preconditioning: It's duration and "dose-response" relationship. Circulation (SuppI.III) 
1990;82:271. 
17 Ovize M, Kloner RA, Przyklenk K. Stretch preconditions canine myocardium. Am J 
Physiol (Heart Circ Physiol. 35) 1994;266:HI37-Hl46. 

Chapter 2 
Intracoronary trimetazidine does not improve recovery of 
regional function in a porcine model of repeated ischemia 
M.M.G. Koning, R. Krams, C.s. Xiao, lR. van Meegen, K. BezstarostP, J.M.J. Lamers' 
and P.D. Verdouw 
Experimental Cardiology (Thoraxcentre) and 'Department of Biochemistry 
Cardiovascular Research Institute (COEUR) 
Erasmus University Rotterdam, Rotterdam, The Netherlands 
Cardiovasc Drugs Ther 7(5):801-807,1993 
14 Chapter 2 
SUMMARY 
We evaluated the effect oftrimetazidine (TMZ) on recovery of regional cardiac function in 
anesthetized open-chest pigs, sUbjected to fifteen two-minutes occlusions of the left anterior 
descending coronary artery, separated by two minutes of reperfusion and a 120 min recovery 
period. Regional myocardial function was evaluated by sonomicrometry-derived segment 
lengthening and the area enclosed by the left ventricular pressure-segment length loop (external 
work EW) in animals, which received either an intracoronary infusion ofTMZ (33 flg.kg·l.min· l, 
n = 6) or saline (I ml.min· l, n = 7), starting 15min before the first occlusion and ending 2min 
after the fifteenth occlusion. In addition, myocardialmalondialdehyde production to evaluate 
oxygen free radical production, oxygen consumption and the ATP, ADP and AMP content as 
well as the energy charge were determined at regular time intervals. 
In control pigs the sequences of occlusion-reperfhsion did not affect systemic hemodynamics, 
except for the LVdP/dt""." which decreased by II % during the interventions and did not recover 
during the following reperfusion period of2 hours (78% of baseline, p < 0.05). Systolic segment 
length shortening and EW were increased at the end of the first occlusion-reperfusion cycle, 
decreased gradually during the remainder of the occlusion-reperfusion periods and did not 
improve during the recovery period. Energy charge and myocardial blood flow were not 
impaired, but oxygen consumption was decreased during the recovery period. The 
malondialdeyde data did not provide evidence for production of oxygen free radicals. TMZ 
decreased LVdP/dt""., by 6% (p < 0.05) and caused a twofold increase in post-systolic segment 
shortening (p < 0.05) before the first occlusion, but did not influence the hemodynamic 
responses, the changes in regional cardiac function and the metabolic events produced by 
repetitive regional ischemia. 
Key words. trimetazidine, myocardial ischemia, reperfusion, regional myocardial perfusion 
and nmction, external work, oxygen free radicals, high energy phosphates 
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INTRODUCTION 
The effectiveness of the 1-(2,3,4-trimethoxybenzyl)-piperazine dihydrochloride, trimetazidine 
in increasing the ischemic threshold during exercise tolerance testing without obvious changes 
in hemodynamic parameters has led to further investigations concerning the mechanisms by 
which the drug exerts its action [1-3]. A number of properties, mainly demonstrated in isolated 
organs and tissues, have been identified that could explain the cardioprotective activity of 
trimetazidine: I) reduced intracellular acidosis during ischemia [4,5], 2) accelerated adenine 
nucleotide rephosphorylation [4,6], 3) decreased membrane content ofperoxidized lipids [7], 4) 
diminished cellular oedema and preservation of oxydative phosphorylation during reperfusion. 
The latter two arguments indicate a reduction in oxygen free radical production [8]. 
Kober et al [9] demonstrated recently that intracoronary administration of trimetazidine 
delayed the development and reduced the magnitude of ECG-changes in patients undergoing 
percutaneous translmninal coronary angioplasty (PTCA) during balloon inflation. In this study 
it was not investigated whether this was also accompanied by an improved recovery of regional 
cardiac fimction after reperfusion was "reinstated. Several studies suggest that in particular the 
diastolic function shows an impaired recovery after repeated brief (2-4 min) coronary artery 
occlusions [10,11]. 
In the present study, we, therefore, investigated the effects of trimetazidine on the recovery 
of regional cardiac function after multiple two-minutes-occlusions separated by two minutes of 
. reperfusion, mimicking a clinical PTCA protocol. Since other studies [7,8] have indicated that 
trimetazidine or its metabolite(s) may reduce the formation of oxygen free radicals, a potential 
mechanism for myocardial stmming [12], we also determined myocardial malondialdehyde 
(MDA) production to investigate whether formation of oxygen free radicals plays a role in this 
model. 
METHODS 
Surgical procedure 
After an overnight fast, cross-bred Landrace x Yorkshire pigs of either sex (25-32 kg) were 
sedated with 25 mg.kg·' ketarnine (A.U.V., Cuijck, The Netherlands) Lm., anesthetized with 18 
mg.kg·' pentobarbital (Sanofi, Paris, France) Lv., intubated and connected to a respirator for 
intermittent positive pressure ventilation with a mixture of oxygen and nitrogen. By adjusting 
respiratory rate, tidal volume and the fraction of oxygen in the inspired mixture, arterial blood 
gases and pH were kept within the normal limits. The temperature of the animal was kept arOlmd 
37'C by using an electrical blanket. Anesthesia was maintained with a continuous inftlSion of 
pentobarbital (10-15 mg.kg·'.h·', Lv.). Saline and haemaccel (Behringwerke A.G., Marburg, 
Germany) were infused to maintain the fluid balance via catheters, inserted into the external 
jugular vein. Catheters were also positioned via both femoral arteries into the descending aorta 
for measurement of central aortic blood pressure and withdrawal of blood samples for 
determination of blood gases and malondialdehyde concentrations. A 7F Sensodyn 
microtransducer catheter (B. Braun Medical B.V., Uden, The Netherlands) was advanced into 
the left ventricle (LV) via the carotid artery to monitor left ventricular pressure and its first 
derivative (L VdP/dt). Following administration of 4 mg pancuronium bromide (Organon Teknika 
B.V., Boxtel, The Netherlands) Lv., a midline thoracotomy was performed, the left mammary 
vessels were ligated and the second and third left ribs were partly removed to facilitate additional 
instrumentation. An electromagnetic flow probe (Skalar, Delft, The Netherlands) was placed 
around the ascending aorta and the left atrial appendage was cannulated for injection of 1-2.10' 
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microspheres, 15 ± I (SD) J-lm in diameter (NEN Company, Dreieich, Germany), labelled with 
either 9'sNB, 103Ru, II3Sn, 468c or 141CC, to detennine regional myocardial blood flow using the 
reference blood sanlple teclmique. For the measurement of regional segment shortening by 
sonomicrometry (Triton Teclmology Inc., San Diego, CA, USA) ultrasonic crystals (Sonotek 
Corporation, Del Mar, CA, USA) were positioned in the layers of the left ventricle 
subendocardium, covering the interventional area as well as a control area. The proximal left 
anterior descending coronary artery (LADCA) was dissected free to apply intermittent occlusions 
with an atraumatic clanlp and a proximally placed electromagnetic flow probe. Distal to this site 
a small calUlUla (O.S mm outer diameter) was inserted into the LADCA for the administration of 
either trimetazidine or saline. The vein accompanying the LADCA was carmulated for the 
determination of coronary venous blood gases, malondialdehyde and hemoglobin concentrations. 
At the end of the experiment the interventional area was identified by an intra-atrial injection of 
methylene blue after the LADCA had been occluded again. The pigs were then sacrificed with 
an overdose of pentobarbital, the heart was excised and processed to determine regional 
myocardial blood flow. 
Experimental procedure and data analysis 
After surgical preparation the pigs were allowed to stabilize for 45 minutes. Prior to the 
intervention protocol, which consisted of 15 sequences of2 min occlusion and 2 min reperfusion, 
pigs either received an intracoronary infusion of saline or trimetazidine (33 J-lg.kg-'.min·') at a 
rate of I ml.min·', which started 15 min before the first occlusion and continued until the end of 
reperfusion 15 (at 2 min of the final reperfusion period), which was then followed by two hours 
of recovery. At scheduled intervals recordings were made of systemic hemodynamic variables 
and regional myocardial function, arterial and coronary venous blood samples were drawn to 
quantify oxygen consumption and malondialdehyde production, biopsies were taken for the 
determination of high energy phosphates and microspheres were injected to obtain regional blood 
flow data. 
From the segment length tracings were calculated (Fig. I) (i) regional systolic segment 
shortening as SS(%)=IOO x (EDL - ESL)IEDL, in which EDL and ESL are the segment length 
at end-diastole and end-systole respectively, (ii) regional post-systolic segment shortening (PSS) 
as PSS(%)=IOO(%) x (ESL - minL)IEDL, in which minL is the segment length at maximal 
contraction, (iii) normalized regional velocity of contraction (VC) as VC(mm.s·') = 10(mm) 
(EDL-ESLIEDL)/t~""" in which t~'tol' equals the duration of left ventricular ejection and (iv) the 
relaxation time (t,,) as the duration of O,e period (ms) in which 50% of total segment lengthening 
was achieved. Left ventricular pressure and myocardial segmenth length were digitized (sample 
rate 250 Hz) using an S bits AD-converter (Tiepie Engineering, Leeuwarden, The Netherlands) 
on an IBM PC-computer to calculate the area enclosed by the pressure-segment length loop over 
a full cardiac cycle [13], which is an index of regional myocardial work [14]. 
High energy phosphates were measured in transmural myocardial biopsies, taken with a Tru-
Cut needle (Travenol Laboratories Inc., Deerfield, Illinois, USA) from the intermittent ischemic 
area and the adjacent control area. Biopsies were immediately dipped into 0.9% NaCI at O'C to 
remove adherent blood, frozen in liquid nitrogen (wifuin 10 s) and stored until analysis at -SO'C 
[15]. 
MDA formation was measured in blood samples which were placed on ice directly after 
sampling, centrifuged at O'C to obtain plasma and stored at -SO'C until analysis. The 
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Figure 1 Calculation of regional segment function data from the segment length tracings. AoP:::: aortic 
pressure; L~:::: left ventricular pressure; LVdPdt = first derivative of LVP; SL = segment length; EDL 
:::: end-diastolic length; ESL:::: end-systolic length; minL = minimum length (at maximal contraction); 
SO%L = length at 50% relaxation; tsystole :::: duration of left ventricular ejection; t50 :::::: time-period in 
which 50% of the relaxation is achieved, 
MDA content of the plasma samples was measured as previously described [16]. 
Oxygen consumption (MVO,) and MDA production were calculated as the product of regional 
transmural myocardial blood flow and the difference in the arterial and coronary venous contents. 
Energy charge was calculated as (ATP + 0.5 ADP)f[ATP + ADP + AMP] as defined by Atkinson 
[17]. 
Stat/st/cal analysis 
All data are presented as mean ± SEM. Statistical analysis was performed by use of a 
parametric two-way analysis of variance (randomized block design), followed by the Duncan 
new multiple range test. Statistical significance was accepted at p< 0.05 (two-tailed). 
Drugs 
Except for the anesthetic drugs, only trimetazidine (courtesy of Dr C. Harpey, I.R.I.S., 
Courbevoie, France) dissolved in isotonic saline was used. 
RESULTS 
Systemic hemodynamics 
Two min after the last occlusion, LVdPfdt",., had decreased to 85-90% of the preocclusion 
18 Chapter 2 
value, but none ofthe other cardiovascular variables were significantly affected (Table I). During 
the following 15 min, there was an additional decrease in LVdP/dt",~ to 80% of its preocclusion 
value (p<0.05), not followed by any sign of recovery. Hence, at the end of the recovery period, 
the values of all variables except for tlmt ofLVdP/dt",~ were similar to those observed before the 
first occlusion. 
Infusion oftrimetazidine did not alter heart rate, mean arterial blood pressure, cardiac output 
and left ventricular end-diastolic pressure, but decreased LVdP/dtm~ by 6% (p< 0.05). The drug 
did not modify the changes in the hemodynamic variables during the occlusion-reperfusion 
protocol. During the recovery period, in constrast with the untreated animals, there was a 
complete recovery ofLVdP/dt",,, in the trimetazidine-treated animals (Table I). 
Regional myocardial wall jimcfion 
In the untreated animals, the first occlusion caused a complete loss of systolic segment 
shortening (SS) of the myocardium perfused by the LADCA, but there was a complete recovery 
during reperfusion (Fig. 2). As a matter of fact SS was even slightly increased to above baseline. 
During the subsequent occlusion-reperfusion cycles there was again a complete loss of function 
during occlusion, while recovery became only partial during reperfusion. Consequently, two 
minutes after the fifteenth occlusion SS had decreased from 18 ± 2% at baseline to 13 ± 2% (p 
< 0.05) and further declined to 9 ± 1% (p<0.05) during the following 15 min. There were no 
further changes in SS during the remainder of the reperfusion period. Post-systolic shortening 
(PSS) was absent at baseline and also after the first occlusion-reperfusion sequence, but gradually 
increased during the following occlusion-reperfusion sequences (4 ± I % after the fifteenth 
sequence). There were no further changes in PSS during the recovery period. TIle changes in the 
velocity of systolic shortening were parallel to those in SS, because heart rate and the duration 
of systole did not change. The relaxation time was not affected by the first occlusion-reperfusion 
sequence, but gradually shortened during the following sequences, to be prolonged again during 
the 120 min recovery period. In the adjacent control region SS decreased from 17 ± 1% at 
baseline to 13 ± I % two min after the last occlusion period and did not change during the ensuing 
recovery period of 120 min. PSS never became significantly different from zero and the changes 
in the velocity of shortening again paralleled those in SS, while relaxation time was not affected. 
Intracoronary infusion of trimetazidine had no significant effect on SS, neither before and 
during the occlusion-reperfusion periods, nor during the 120 min recovery period (Fig. 2). The 
same was true for velocity of shortening and the relaxation time. PSS, however, increased from 
I ± 0.3% to 4 ± 0.4% (p < 0.05), which was neither enhanced by the repetitive occlusions, nor 
attenuated during the recovery period. 
External work 
In the untreated animals, the index reflecting the external work performed by the myocardililll 
perfused by the LADCA (231 ± 31 nmaHg.mm at baseline) decreased to virtually zero during the 
occlusions, but was unchanged at the end ofthe first, fifth, tenth and fifteenth reperfusion. During 
the following 120 min recovery period there was a decline to 151 ± 18 nmaHg.mm (p<0.05) after 
15 min, which did not improve during the remainder of the observation period (140 ± 16 
mmHg.mm after 120 min). 
Trimetazidine administration tended to decrease external work in the intervention region (231 
± 33 mmHg.mm at baseline and 217 ± 8 mmHg.mm after 10 min intracoronary infusion, p = 
0.16). During the following occlusion-reperfusion sequences, the changes in the trimetazidine 
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animals resembled closely those in the untreated animals (199 ± 38 mmHg.mm after the last 
occlusion-reperfusion cycle and 178 ± 36 mmHg.mm after 120 min of recovery). 
Myocardial hloodj/ow 
Baseline values of the untreated animals and the trimetazidine-treated animals of the 
myocardium pemlsed by the LADCA were very similar (158 ± 13 ml.min·'.IOOg·' and 160 ± 18 
ml.min·'.IOOg·', respectively). In either group of animals, transmural blood flow and its 
distribution over the subendocardial and subepicardial layers were not different from baseline, 
both at 15 min and 60 min, of the recovery period (not shown). There were also no changes in 
the perfusion of the myocardium outside the distribution area of the LADCA (not shown). 
Oxygen consumption oJthe myocardium perji/Sed by the lej/ anterior descending coronary artery 
Fifteen minutes after the last of 15 sequences of occlusion and reperfusion, myocardial oxygen 
consumption (MVO,) of the LADCA-perfused myocardium was reduced from 486 ± 31 
flmol.min·'.g·' to 326 ± 44 flmol.min·'.g·' (p< 0.05) and did not fully recover during the following 
60 min of reperfusion (394 ± 20 flmol.min·'.g·', p< 0.05). Trimetazidine did not modifY this 
pattern, as MVO, had decreased from 467 ± 48 flmol.min·'.g·' to 362 ± 86 l,mol.min·'.g·' (p< 
0.05) at 15 min ofreperfusion in the treated animals and was only 372 ± 27 l,mol.min·'.g·' after 
60 min of reperfusion. 
Myocardial high energy phosphate levels 
In the untreated animals, myocardial ATP content after the first five occlusion-reperfusion 
sequences (28 ± 2 flmol/g protein) was not different from the values measured at baseline (28 ± 
3 flgmol/g protein), but during the following ten occlusion-reperfusion sequences there was a 
gradual decrease to 23 ± 2 flmol/g protein (p<0.05). There was no recovery during the first 15 
min of reperfusion (20 ± 2 flmol/g protein). 
In the trimetazidine-treated animals (32 ± 2 flmol/g protein at baseline) a similar pattern in the 
changes in ATP content was observed (29 ± 3, 26 ± 3 and 27 ± 3 flgmol/g protein, at the end of 
the fifth and fifteenth occlusion·reperfusion sequence and after 15 minutes of recovery, 
respectively). 
For both groups of animals, the total adenine nucleotide levels followed the same pattern as 
the ATP levels. CP levels had increased significantly (p<0.05) from 37 ± 7 flmol/g protein at 
baseline to 63 ± 14 flmol/g protein after the fifth occlusion·reperfusion cycle in the untreated 
animals and from 37 ± 4 llmol/g protein at baseline to 62 ± 9 flmol/g protein in the treated 
animals (p<0.05). In both groups there was a slight decline during the recovery period (to 54 ± 
9 flmol/g protein and 57 ± 10 flmol/g protein in the untreated and treated animals at 15 min of 
reperfusion, respectively). The energy charge (0.91 ± 0.09 at baseline for both groups) was not 
significantly affected during the reperfusion periods. 
Myocardial malondlaldehyde production 
In neither the untreated animals (0.02 ± 0.09 mnol.ml·', 0.02 ± 0.12 nrnol.ml·' and 0.04 ± 0.08 
nrnol.ml·' at baseline, 2 min and 10 min after the last occlusion respectively) nor in the 
trimetazidine treated animals (·0.02 ± 0.07 mnol.ml·', ·0.08 ± 0.02 nmol.ml·' and -0.05 ± 0.08 
mnol.ml·
' 
at baseline, 2 min and 10 rnin after the last occlusion, respectively) did we observe any 
significant production of MDA. 
Table 1 Systemic hemodynamic effects induced by 15 ccnsecutive cycles of2 min occlusion and 2 min reperfusion in untreated (C, n ~ 7) and with 
trimetazidine-treated (n ~ 6) open-chest anesthetized pigs. Trimetazidine infusion (33 I-'g.kg-1.min.1) started 15 minutes prior to the first occlusion 
and lasted until 2 min after the last occlusion. 
reccvery after last occlusion (min) 
Pre-trimetazidine Pre-occlusion 2 15 60 120 
HR C III ± 7 112 ± 7 109 ± 5 108 ± 6 108 ± 7 111 ± 8 
105 ± 7 104 ± 8 106 ± 6 106 ± 5 108 ± 5 104 ± 6 
MAP C 97 ± 4 98 ± 3 94 ± 5 93 ± 6 91 ± 2 98 ± 6 
91 ± 3 92 ± 3 85 ± 2 84 ± 2' 82 ± 2*0 83 ± 5 
LVdP/d""" C 2180 ± 190 2360 ± 160 2070 ± 110 1850 ± 170' 1840 ± 180' 1890 ± 210' 
2250 ± 250 2090 ± 210' 1950 ± 210 1880 ± 230' 2000 ± 310 2480 ± 300 
LVEDP C 14 ± 1 14 ± I 14 ± I 14 ± I 13 ± I 13 ± 1 
12 ± 2 13 ± 2 14 ± 2 14 ± 2 14 ± 2 12 ± 2 
CO C 2.6 ± 0.3 2.6 ± 02 25 ± 02 2.5 ± 02 2.4 ± 0.3 2.3 ± 02 
2.3 ± 0.2 25 ± 0.3 25 ± 02 2.5 ± 02 2.4 ± 02 22 ± 0.3 
SVR C 40 ± 3 40 ± 4 39 ± 3 38 ± 3 44 ± 5 46 ± 6 
40 ± 3 38 ± 4 35 ± 2 34 ± 2 36 ± 3 39 ± 4 
Trimetazidine infusion (33 I-'glkglmin) started 15 minutes prior to the first occlusion and lasted until 2 minutes after the last occlusion. 
HR ~ heart rate (beats.rnin.'); MAP; mean arterial blood pressure (mmHg); LVdP/d"",,; maxima\ rate of rise ofleft ventricular pressure (mmHg.s·1); 
L VEDP; left ventricular end-diastolic pressure (mmHg); CO ; cardiac output (I.min.'); SVR; systemic vascular resistance (mmHg.minl·'). Data 
have been expressed as mean ± SEM • P<O.05 versus baseline; 'P<0.05 versus trimetazidine 
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Figure 2 Effect of 15 consecutive occlusion-reperfusion periods of2 minutes each in untreated (open 
columns, 0=7) and trimetazidine-treated (hatched columns, 0=6) animals on segment length changes 
(SS), posl-systolic segment leng1h changes (PSS), velocity of contraction (V c) and relaxation time (t,,). 
Data are shown from 15 minutes and 0 minutes before the first occlusion and from the end of the first 
(I), fifth (5), tenth (10) and fifteenth (15) occlusion-reperfusion period and from 15 minutes (15), 60 
minutes (60) and 120 minutes of reperfusion during the recovery period. Trimetazidine was 
administrated before and during the occlusion-reperfusion periods. + p < 0.05 versus minus 15 minutes 
(-15) before the first occl\lsion. Data are presented as mean ± s.e. mean. 
DISCUSSION 
The model used in the present study mimicks the clinical PTCA in so far that multiple short 
lasting coronary artery occlusions separated by 2 min ofreperfusions were used. In the clinical 
setting the effects ofPTCA on myocardial wall motion are not well defined as the duration and 
number of occlusions may vary considerably. A further complicating factor may be that in 
experimental animals, hearts are used which have not been submitted to myocardial ischemia 
before, while in the clinical setting the myocardinm has usually experienced several episodes of 
myocardial ischemia and may already have an abnormal wall motion, and possibly, metabolism 
because of the presence of an existing chronic obstruction. Hence) phenomena such as ischemic 
preconditioning and hibernation may be confounding factors in clinical investigations. It is 
therefore not surprising that Jasld et al. [10] reported that after 4-6 balloon inflations each lasting 
less than I min, both systolic and diastolic wall motion returned to normal within 5 min, while 
Wijns et al. [II], reported an impaired diastolic function in the presence of a normal systolic 
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fllnction following a similar study protocol involving a larger nwnber of ocelusions. It Ulerefore 
appears that diastolic function may be more sensitive to multiple shortlasting ocelusions than 
systolic function. 
In the present study, systolic segment shortening completely recovered during the first 
reperfusion period. As a matter of fact there was even a slight increase in regional myocardial 
function and external work, which is consistent with earlier observations [18]. This may be, but 
is not necessarily [19] related to the hyperemic response. The aforementioned study [18] also 
showed that after such a shortlasting occlusion, stunning does not develop when perfusion is 
maintained. In the present study, myocardial stunning gradually developed during the following 
ocelllsion-reperfusion sequences and was most pronounced after reperfusion was established for 
15 min. Our observation that regional wall function completely recovered after the first 
ocelusion, but became impaired during the following episodes of ischemia·reperfusion appears 
to contradict clinical studies, which suggest, using electrocardiographic and metabolic 
abnormalities, that the first ocelusion is the most damaging [20]. 
Kober et a!. [9] ignoring the first occlusion, observed that electrocardiographic abnormalities 
were similar during the second and third occlusion in patients undergoing PTCA. When 
trimetazidine (6 mg) was administered intravenously before the third occlusion, the signs of 
ischemia were less during balloon inflation. Using a study protocol in which demand ischemia 
developed rather than supply ischemia as in the study of Kober et a!. [9], Sellier et a!. [I] and 
Dalla-Volta et a!. [2] also showed less evidence of ischemia based on electrocardiographic 
abnormalities. The present study failed to demonstrate an effect of trimetazidine on recovery of 
function during reperfusion following repeated brief coronary artery occlusions. This does not 
necessarily contradict the observation by Kober et a!. [9], considering the poor relation between 
functional and electrocardiographic changes [21]. 
Myocardial oxygen consumption (the product of coronary blood flow and difference in arterial 
and coronary venous oxygen contents) was not affected by trimetazidine, which is in accordance 
with the concept that trimetazidine does not influence the hemodynamic variables determining 
myocardial oxygen demand, but it contrasts the suggestion that trimetazidine enhances the 
utilization of the available oxygen [4]. In this in vivo model, also at variance with the results 
found in isolated rat heart [4] and in isolated myocardial mitochondria [8], high energy 
phosphates were not better preserved or restored in the presence oftrimetazidine. Previously, it 
was shown that trimetazidine can reduce ischemia·induced acidosis in myocardium [4]. 
Development of acidosis is believed to contribute to the deregulation of myocardial Ca'+ 
homeostasis via a coupled operation of the Na+JH+ and the Na+/Ca'+ exchangers [4,5]. In the 
present investigation, we did not study any variable reflecting tissue acidosis or Ca2+ overload 
and a possible occurrence of a beneficial effect of trimetazidine on tissue acidosis or Ca'+ 
overload can therefore not be excluded. 
MDA is one ofthe endproducts of the reaction of endogenously generated free radicals with 
membrane polyunsaturated fatty acids, but its formation in the myocardium could not be 
consistently demonstrated in the coronary effluent during the repetitive occlusion·reperfusion 
periods in the present study. This could be due to the short duration of the occlusions (2 min) as 
we have demonstrated previously U,at MDA production occurred in anesthetized pigs which were 
subjected to 5 min coronary artery occlusions [16]. On the other hand, there are two studies 
which showed that trimetazidine attenuated oxygen free radical generation during ischemia-
reperfusion [22,23]. It should be noted that in these studies, the most convincing evidence for 
free radical generation and an inhibitory effect of trimetazidine on this harmful process was 
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obtained using spintrapping agents such as N-tert-butyl alpha phenylnitrone and electron 
paramagnetic resonance spectroscopy (ESR) in liquid nitrogen frozen myocardial biopsies. In 
one study, the changes in the myocardial homogenate MDA content corresponded with the 
changes in ESR spectra [23]. In the present study, we determined MDA concentrations only in 
arterial and coronary venous blood, and no spintrapping agents for detecting the earliest products 
during oxygen free radical generation were used. We can therefore not make a definite statement, 
conceming the generation of oxygen free radicals in our study. Nevertheless, the impairment of 
regional wall timction during reperfusion, which may be a result of oxygen-free radical induced 
damage [12], was not affected by trimetazidine in this particular model of ischemia and 
reperfilsion. 
The question may arise whether the lack of effect oftrimetazidine is due to the experimental 
design, the choice ofthe experimental animal, the dose or route of the drug or a combination of 
these factors. The lack of any significant effect of trimetazidine on systemic hemodynamic 
variables is consistent with earlier observations using intravenous doses. It is uniikely that the 
intracoronary dose used in tllis study, was too low considering the intravenous dose used in the 
study by Kober et al. [9]. It is also unlikely that the duration of the administration of 
trimetazidine was the cause for the lack of effect on regional wall function, as no improved 
recovery was seen when the duration of trinletazidine adnlinistration was extended until the end 
of the 120 min recovery period (unpublished observations in 5 animals). 
In conclusion trimetazidine, in this in vivo model, did not affect hemodynamic, metabolic and 
functional responses to fifteen repetitive short-lasting occlusions. 
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Chapter 3 
Determination and Determinants of the 
Area at Risk and Infarct Area 
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A prerequisite for the assessment of the protective effect of myocardial preconditioning on 
infarct size is accurate identification of the area of myocardial necrosis and the anatomical area 
at risk. In patients infarct size is estimated indirectly from the kinetics of the CPK plasma 
concentrations, electrocardiograms and radionuclide imaging teclmiques. In contrast, in 
experimental animals myocardial infarct size can be detennined microscopically by quantitative 
histology. This technique is time consuruing and a sharp delineation between viable and necrotic 
tissue can be made only 12 hours after the onset of ischemia. An alternative method is the use 
of a histochemical staining technique to visualize early myocardial infarcts macroscopically. 
Identification a/myocardial necrosis 
Early studies reported that within hours after the onset of myocardial infarction plasma levels 
of several myocardial enzymes increase, which is associated with a decrease in enzyme levels 
in the infarcted area of the heart, as these enzymes leak out of dead myocytes. These 
observations led to the development of histochemical staining techniques to delineate between 
viable and necrotic myocardial tissue in the gross identification of early myocardial infarcts.'" 
Using triphenyltetrazoliuru chloride (TIC), an oxidation-reduction indicator, it was possible to 
recognize infarcts 4 to 24 hours after the onset of coronary artery occlusion. Nonnal myocardiuru 
reduced TIC to a brick red fonnazan stain, whereas the infarcted tissue remained unstained.' 
Nachlas and Shnitka' used another tetrazolium salt nitroblue tetrazolium (NBT) to identify 
myocardial necrosis, which reportedly provided a better contrast between nonnal (dark blue) and 
necrotic (pale) myocardium than TIC staining. Moreover, myocardial infarction could be 
identified as early as 2 to 8 hours after the onset of coronary artery occlusion. Both, TIC and 
NBT have gained wide acceptance for infarct size determinations, each of which offers distinct 
advantages and disadvantages. For example, with NBT the demarcation between infarct and 
viable tissue appears more distinct than with TIC. On the other hand, TIC gains easy tissue 
access as it is able to penneate through the cell membrane and can thus be injected intravenously 
reduced 
substrate 
oxidized 
substrate 
NAD+~~ 
----- NADH 
formazan 
tetrazollumsalt 
Figure 1 An enzymatic cycle as the basis of the NET stain for identifying myocardial infarction 
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or into the coronary arteries. With NBT infusion is not possible because the compound cannot 
cross the cell membrane. It therefore has the disadvantage that it can only be applied to cut 
surfaces of cells. 
The histochemical staining technique is based on an enzymatic cycling of oxidation-reduction 
reactions (Fig. I). Tetrazolium salts are converted to the colored forrnazan by the uptake of2 
electrons and I proton with the help of membrane-bound diaphorases (enzymes of the respiratory 
chain) and NADH. The resultant NAD is reduced back to NADH by a dehydrogenase. Nachlas 
and Shnitka' explained the basic mechanism of the NBT staining by alterations in dehydrogenase 
activity. However, they also considered that loss of coenzymes and substrates may be of 
importance in early infarcts. Klein et ai' showed that loss of the coenzyme NAD played a key 
role in identifying early myocardial infarction with NBT. In contrast to a 66% reduction in 
concentration of total NAD (smn ofNAD and NADH) the activities of the tissue dehydrogenases 
had not changed after 4 hour of ischemia, while NBT staining revealed an infarction which could 
be made "viable" again (false-positive staining) by the addition of coenzymes. In older infarcts 
(more than 12 hours) loss of coenzymes is joined by marked decreased activities of 
dehydrogenases and diaphorases. Schaper et ai' demonstrated that infarct size measured with 
para-NBT correlated very well with the size determined by histological examination. In another 
study Schaper et al" showed that no significant differences were found between infarcts which 
were reperliIsed for 48 hours and those reperfused for only 90 minutes. Schaper et al concluded 
that the short period ofreperfusion produced washout of the necessary enzymes, subsequently 
shown to be the coenzymes by Klein et al". Fujiwara et al' confinned these findings as they 
observed that in pigs myocardial necrosis could be demarcated with NBT as early as I hour after 
the onset ofreperfusion following a one hour coronary artery occlusion. If reperfusion was not 
allowed NBT staining needed 4-8 hours to obtain a clear demarcation between necrotic and 
viable tissue, which agrees well with the time reported by NacWas and Shnitka'. These findings 
are also in accordance with the suggestion that reperfusion accelerates the washout of enzymes 
and coenzymes needed in the histochemical staining of viable myocardium. 
Quantitative determination of the area at risk and infarct size 
In this thesis hearts of open-chest pigs were subjected to a one hour total coronary artery 
occlusion to produce myocardial infarction of reproducible size (control animals). Two hours 
ofreperfusion were allowed to enable reliable determination ofinfarct size with the NBT staining 
method. Preconditioning stimuli were given prior to the one hour occlusion and 2 hours of 
reperfusion. 
To demarcate the area at risk perfused by the occluded artery from the control area the 
coronary artery was reoccluded at the former site of the coronary artery occlusion at the end of 
each protocol and 15 ml of 10 % (w/w) solution Mfluorescein sodimn (Sigma Chemical Co, St. 
Louis, USA) were injected into the left atrimn to demarcate the area at risk by negative staining 
from fluorescein. After induction of ventricular fibrillation with a 9V battery the heart was 
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Figure 2 Segmental subdivision of the left ventricle, assessment of the risk area and the infarct area by 
fluorescein and NBT staining respectively and division of the left ventricular wall into endocardial and 
epicardial layers of equal thickness. 
excised and both atria, Ole right ventricular free wall and the left ventricular epicardial fat were 
removed. The remaining left ventricle was filled wiOI alginate impression material (BayerDental, 
Leverkusen, Germany) to preserve the shape of the left ventricle, cooled in crushed ice and sliced 
parallel to the atrioventricular groove into 5 segments (Fig. 2). The cut surface(s) of each 
segment and the demarcated areas at risk (AR) was (were) then traced on an acetate sheet nnder 
a black light. The 5 ventricular segments were subsequently incubated for 30 min in 0.125 g 
para·nitrobluetetrazoliwn (Sigma Chemicals Co., St. Louis, USA) per liter of phosphate buffer 
(PH 7.1) at 37'C, while the slices were tumed upside down after 15 minutes of incubation for 
equal treatment oftop and bottom side. As a result viable tissue was stained deeply blue and the 
non-stained pale infarcted tissue was traced on the acetate sheet. The tracings of the ring, risk 
area and infarct area were computed by planimetry. With the obtained data the risk area fraction 
(area at risk/area of ring) and the infarcted area fraction (infarcted areafarea of ring) were 
calculated for the top and bottom of each ring and the mean value for each ring was multiplied 
by the weight. The weight of the risk area and infarcted area was summed and divided by the 
weight of the left ventricle to yield the fraction of 010 left ventricle at risk and the fraction ofthe 
left ventricle infarcted. In subsequent studies this method was extended to a further subdivision, 
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every traced segmental surface was subsequently subdivided into an endocardial and epicardial 
layer by adding a line that divided the myocardial wall into two layers of equal thickness. The 
endocardial, epicardial and total area were determined for the top and bottom of each segment. 
The endocardial and epicardial fraction of each segment were computed as the average of top and 
bottom. TIle endocardial fraction and the epicardial fraction of each segment were multiplied by 
the total weight of that slice to yield the endocardial and epicardial weight of the slice, 
respectively. The area at risk (fraction of ring area) and the infarcted area (fraction of ring area) 
were calculated separately for the endocardial, epicardial and total area for the top and bottom 
of each segment and averaged. TIlese fractions were multiplied by the endocardial, epicardial and 
total weight ofthe segment to yield the weight of the endocardial, epicardial and total area at risk 
or infarcted. The endocardial, epicardial and total weights of the area at risk and the infarcted 
area of the 5 segments were sunlllled separately and divided by the weight of the left ventricle 
to yield the endocardial, epicardial and total fraction of the left ventricle at risk and infarcted, 
respectively. 
Determinants of infarct size 
Duration of Occ/usion. A major detenninant of infarct size is the time during which the 
myocardiwn is deprived of blood flow. Thus, in dogs myocardium was salvageable up to three 
hours after the onset of coronary artery occlusion.s,1O In swine this time window is much 
narrower as within 75 min most ofthe myocardium was irreversibly damaged. IO." This difference 
in time course between species is, at least in part, related to the amount of collateral blood flow 
available to the myocardium distal to the occlusion site. Thus, in dogs collateral blood flow can 
be as high as 0.4 ml/minlg,I4 whereas in pigs collateral blood flow is usually less than 0.07 
m1iminlg. IO•Il 
Area at Risk Early canine studies of the effects of coronary artery occlusion on myocardial 
infarction used occlusions at an anatomically identical site, expressing infarct size as a percent 
of the left ventricle. However, variability in the pattern of distribution of terminal arterial 
branches can result in substantial variability of the myocardial mass perfused by the occluded 
arterial segment. IS To take into account this anatomic variability in coronary vascular 
distribution, infarct size is generally expressed as a percent of the area at risk. However, several 
investigators l&-20 have shown that in both anesthetized and conscious dogs infarct area as percent 
of left ventricular mass (lA/L V) and area at risk as percentage of left ventricular mass (ARlL V) 
are highly linearly related, but that the regression has a positive intercept on the area at risk axis. 
Hence, the ratio between the infarct area and the area at risk is not a constant, but is dependent 
on the area at risk. Comparing the results of studies in which different areas at risk have been 
used may therefore lead to misinterpretation ofthe quantitative data. 
To illustrate this problem the relationships between IA and AR of two groups of pigs 
presented in chapter 5 have been depicted in figure 3. One group of animals had a 60 min 
occlusion of the left anterior descending coronary artery at varying sites and 2 hours of 
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Figure 3 The linear regression lines (solid lines) for the control group (Yt - O.94x - 4.0) and a 
preconditioned group (Y2 = O.68x - 4.8), The vertical dashed lines indicate that for the specified area at 
risk (AR, x) the effect of preconditioning can be calculated by substracting Y2 (infarct area (IA) of the 
preconditioned group) from y, (IA of the control group) to yield the infarct size limitation (ISL). 
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Figure 4 Relation between infarct size limitation (ISL) beea\lse of preconditioning and the area at risk 
(AR). For each AR infarct size limitation is calculated as (Yt - Y2)/YI X 100% in which y, and Y2 are the 
infarct area for the control and the preconditioned animals as predicted from the respective regression 
equations y, and y, (Fig 3). 
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reperfusion. The relationship between IA (y-axis) and AR (x-axis) can be described by the 
equation y = 0.94x - 4.0. The other animals had an intervention which preceded the 60 min 
coronary artery occlusion and which had a protective effect on the myocardium resulting in a 
smaller infarct area than could be predicted from the equation from the first group. The 
relationship for the intervention group could be described by the equation y = 0.68x - 4.8. 
To determine the infarct size limitation (ISL) for the varying areas at risk within the 
intervention group its observed linear regression equation should be substracted from the linear 
regression equation for the control group and than divided by the linear regression equation for 
the control group to yield the salvaged myocardium for varying areas at risk as a fraction ofthe 
predicted dead myocardium if no protection had been applied. A new equation is generated 
which has been plotted as a funtion ofthe area at risk in figure 4. From this graph it can easily 
be seen that small variations in the low range of areas at risk can give rise to huge differences in 
infarct size limiting effects and thus may give rise to confusing results when comparing ratios 
between IA and AR only. When larger areas at risk are taken into account the infarct size 
limitation varies only slightly with an increase or decrease of the area at risk. 
The reason for the positive intercept is wlClear, but it is of interest that the value found in this 
thesis in control pig studies is very similar to the value for the intercept in the anesthetized 
dogs." The possibility that infarct size development in small areas at risk progresses less rapidly 
than in larger areas at risk can therefore not be excluded. TIlls has been suggested for the dog and 
been explained by its collateral flow. The latter is, however, absent in the pig. In conclusion the 
non-zero intercept of the regression equations requires a careful use of the infarct size-area at risk 
ratio because this ratio depends on the area at risk itself. 
Collateral Blood Flow to the Area at Risk. In species with substantial and variable degrees 
of native collateral circulation such as the dog, the magnitude of collateral blood flow to the 
ischemic region exerts a potent effect on infarct size.8•IO,IJ,'7.'8,21,22,23 In species like rabbit and 
particularly pigs the collateral blood flow to the area at risk is negligible, which results in less 
infarct size variability. 
Myocardial Oxygen Demand. The role of myocardial oxygen demand at the onset of 
occlusion as a dctcnninant of infarct size is controversial. Both a positive correlatlon IO,24,25 and 
no significant relationship"·")4)' between myocardial oxygen demand, estimated by the product 
of heart rate and LV systolic pressure, and infarct size as a percent of the area at risk have been 
reported in dogs. Studies ofthe influence of myocardial oxygen demand on infarct size in dogs 
are complicated by the effects of heart rate and blood pressure on collateral flow. Thus, an 
increase in heart rate can decrease collateral blood flow and redistribute collateral flow away 
from the subendocardiwn, while an increase in blood pressure can increase collateral blood flow 
by increasing the collateral driving pressure." However, even when multiple stepwise linear 
regression was perfonned to assess the contribution of the rate-pressure product to infarct size, 
independent of its effects on collateral flow, the results were variable with both positive" and 
negative results." In species with minimal collateral blood flow such as rabbit, infarct size 
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expressed as a percent of the area at risk was not significantly correlated with the rate-pressure 
product." Garcia-Dorado et al" studied the effects of an increase in myocardial oxygen demand 
on infarct size expressed as a percent of the area at risk produced by a 60 min occlusion of the 
left anterior descending coronary artery in open-chest swine. Increasing the rate-pressure product 
by atrial pacing had no effect on infarct size, while increasing the arterial blood pressure caused 
a small increase in iufarct size from 61% in the control group to 74% in the hypertensive group 
(P<0.05). The increase in arterial pressure was produced by intravenous infusion of the a,-
adrenergic receptor agonist methoxamine; this was associated with significantly elevated left 
venb'icular end-diastolic pressure which might also have influenced infarct size. The myocardilUn 
ceases to contract early after onset of occlusion so that energy utilization is confined mainly to 
maintenance of ionic homeostasis and basal metabolism. Under these conditions the rate-pressure 
product may no longer reflect the energy demands of the ischemic myocardium. 
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SUMMARY 
The protective effect of a short lasting coronary artery occlusion on the development of 
myocardial necrosis during a subsequent longer lasting occlusion has only a limited duration 
("ischemic preconditioning")'). It has not been established, however, how the magnitude ofthis 
protective effect changes Witll time during tl,e reperfusion period following the preconditioning 
stimulus. Because this knowledge may help elucidating the mechanism underlying ischemic 
preconditioning we varied the duration of the reperfusion period following the preconditioning 
stimulus. Experiments were performed in pigs, a species in which the infarct size limiting effect 
of ischemic preconditioning has been demonstmted"', while interpretation of the results will not 
be complicated by a variable residual myocardial blood flow after a coronary artery has been 
occluded, as functional coronary collaterals are absent. 
MATERlALS AND METHODS 
Fasted open-chest pentobarbital anesthetized pigs (28-32 kg) were randomly assigned to 
different experimental groups and instmmented as described earlier'. The control group (A) 
involved a 60 min coronary artery occlusion (CAO) followed by 120 min ofreperfusion. In all 
other animals the 60 min CAO was preceded by a single 10 min CAO. In these animals the 
reper/hsion period (R) between the 10 min and the 60 min CAO's was 15 min (B), 60 min (C), 
120 min (D), 180 min (E), or 240 min (F). In each group the area at risk (AR) of the individual 
animals was varied by occluding the left anterior descending coronary artery or its branches at 
different sites. During the experimental protocol, continuous recordings were made of the ECG, 
systemic hemodynamic variables and systolic segment length shortening (SS), while needle 
biopsies for determination of ATP, ADP, creatine, creatine phosphate and energy charge were 
collected at intervals. At the end ofthe experimental protocol AR was identified and the infarcted 
area (JA) was determined'. 
RESULTS AND DISCUSSION 
In the control group (A) SS decreased from 16 ± I % to 2 ± I % during the 60 min CAO. This 
loss in ftmction was independent of AR. During the subsequent 120 min R tl,ere was no recovery 
of function (3 ± 1%). In these animals, IA was linearly related to AR (Figure I). In the other 
groups the 10 min CAO also resulted in a loss ofSS (from 19 ± 2% to 4 ± 2%) and a partial 
recovery (to 12 ± 1%) independent of the duration of R. In B and C the slope of the line 
describing the relation between IA and AR, was significantly reduced compared to the slope 
found for A, indicating infarct size limitation (Figure I). In D and E the protective effect of 
preconditioning was lost in several animals, while still conspicuously present in others (Figure 
I). Preconditioning was completely lost in all but one of the animals ofF. INAR proved not to 
be related to any of the metabolic variables prior to 60 min CAO (or the change from baseline). 
In Figure 2 the lack of relation between ATP/ADP and INAR has been depicted (Figure 2). 
Our working hypothesis was that the protective effect of preconditioning would decrease 
gradually as the duration ofthe reperfusion period between 10 min CAO and 60 min CAO was 
extended. Such an observation would be consistent with a decrease in the concentration of a 
substance (circulating or present in tissue) responsible for the infarct size limitation. Our data, 
however, did not reveal such a gradual decrease when the reperfusion period was extended to 120 
min or longer. Our data may therefore point towards an tlall or nothing tl phenomenon, which 
suggest a different type of mechanism. 
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Figure 1 Top: The relationships between the infarcted area (lA and the area at risk (AR), both 
presented as percentage of the left ventricular mass, of the control animals (Group A), which had a 60 
min coronary artery occlusion (CAO), and the preconditioned animals of Groups Band C, which had a 
preceding 10 min CAD followed by 15 min and 60 min reperfusion, respectively, have been depicted. 
Bottom: The regression lines for Group A and Groups Band C are shown, together with the individual 
data of the animals, which had a preconditioning stimulus followed by 120 min (D), 180 min (E), or 240 
min (F) reperfusion. 
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Figure 2 The relation between the infarcted area (IA) as percentage of the area at risk 
(AR) and ATP/ADP prior to the 60 min coronary artery occlusion (CAO). Data are from 
the control animals (A; 60 min CAO) and the animals in which the 60 min CAO was 
preceded by a 10 min CAO preconditioning stimulus followed by reperfilsion periods of 
15 min (B), 60 min (C), 120 min (D), 180 min (E) or 240 min (F). 
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SUMMARY 
Objective: To investigate whether ischaemic preconditioning can be obtained by a partial 
coronary artery occlusion without intermittent reperfusion. Methods: In 7 anaesthetized open-
chest pigs, the flow in the proximal left anterior descending coronary artery (LADCA) was 
reduced to 30% of baseline during 30 min before tile vessel Was occluded completely for 60 min 
(60 min TCO). After two hours ofreperfusion (REP), the area at risk (AR) and infarct size (IS) 
were determined using standard procedures. Infarct sizes were compared to those observed in 
control animals (n = 12), which were subjected to 60 min TCO and two hours of REP, and to IS 
detennined in animals preconditioned by 10 min TCO with either 15 min (n = 10) or 60 min (n 
= 5) of REP before the 60 min TCO and IWo hours REP. In tile last 3 groups of animals, AR was 
varied by occluding tile LADCA or its branches at different sites. Results: In the control animals 
IS was linearly related (r = 0.99, p<O.OOI) to AR with a positive intercept on the AR-axis: 
ISILV =, (x 100%) = 0.88 ARlL V mu, (x 100%) - 3.6. At comparable AR, the IS of the animals 
preconditioned with a 10 min TCO was less than for the control animals. For the animals 
preconditioned with 10 min TCO and 15 min REP, the relationship between IS and AR was 
again linear (r = 0.88) and had also a positive intercept on the AR-axis: ISILV mu, (x 100%) = 
0.68 ARlLVmu, (x 100%) - 4.8. All animals with the flow reduction to 30% of baseline 
immediately preceding the 60 min TCO had infarct sizes smaller (p<0.05) than predicted from 
the regression equation for tile control animals, but the infarct size limitation could not be simply 
related to variables such as changes in regional systolic and post-systolic segment length 
shol1ening, ATP or ADP during the partial occlusion period. Conclusion: Myocardium can be 
preconditioned with a flow reduction to 30% of baseline for 30 min without intermittent 
reperfusion (two-stage Harris model). The positive intercept on the AR-axis ofthe IS-AR relation 
warrants caution ofthe use ofiS/AR as an index for infarct size limitation. 
INTRODUCTION 
The standard protocol to induce ischaemic preconditioning involves one or more brief 
coronary artery occlusions before that artery is occluded for a prolonged period of time. This 
method has been shown to be effective in reducing infarct size in dogs l,2, pigs3.4, rabbitss and 
rat86, and in several of these species also in reducing the incidence of ventricular arrhythmias and 
ventricular fibrillation during the longlasting coronary artery occlusion and subsequent 
myocardial reperfusion.'·' In a recent study, Ovize et a[lo showed that moderate ischaemia 
induced by a 50% reduction in myocardial blood flow lasting 15 min also reduced infarct size 
during a subsequent 60 min total coronary artery occlusion when myocardial reperfusion was 
restored completely between the ischaemic preconditioning stimulus and the subsequent 60 min 
total occlusion. In that study the partial flow reduction did not lead to infarct size limitation 
during the subsequent 60 min total coronary artery occlusion, when myocardial reperfusion was 
not restored between the partial and total coronary artery occlusion periods. The reason for this 
last prerequisite remains llllClear and, because only one degree of flow reduction for one period 
oftime was used, cannot he generalized to partial occlusions which differ in duration and degree 
of flow reduction. In tiris respect it is of interest that over 40 years ago, Harris used a two-slage 
coronary ru1ery occlusion to prevent the large incidence of death because of ventricular 
fibrillation during the first 30 nUn after an abrupt coronary artery occlusion." His first step was 
to occlude a coronary artery partially for 30 min, thereby allowing a (not measured) reduced 
perfusion, before the ru1ery was occluded completely for a prolonged period of time. It was 
reasoned that during these 30 min the hypoperfusion reduced the severity of ischaemia and 
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thereby prevented the conduction disturbances (because of reentry and enhanced automaticity), 
that give rise to the high incidence of ventricular fibrillation when the artery is occluded 
completely. It was never considered why these lethal arrhythmias should not occur when the 
artery was occluded completely after the 30 min of partial occlusion. 
The current insight in the effects of ischaemic preconditioning invites an alternative 
hypothesis: the myocardium becomes preconditioned during the 30 min partial coronary artery 
occlusion, and the high incidence of ventricular fibrillation usually observed during an acute total 
occlusion is decreased when the artery is totally occluded after 30 min. If this would be true, it 
is also possible that myocardial infarct size is reduced when a complete occlusion is preceded by 
a partial occlusion. Considering the above, the failure of Ovize el altO to observe an infarct size 
limiting effect using a two-stage coronary artery occlusion could be due to the short duration of 
the partial occlusion in their study. In the present series of experiments in pigs, a species with 
only a minimal collateral circulation, we have evaluated tlus hypothesis by using a 30 min partial 
occlusion of the proximal left anterior descending coronary artery before occluding the artery 
completely without intermittent reper/\!sion (two-stage coronary artery occlusion). We used a 
flow reduction (to 30% of baseline), which reduces the incidence of ventricular fibrillation during 
the first 30 min by more than 70%." 
The infarct sizes of the animals with the two~stage coronary artery occlusion were compared 
to those of a control group (60 min total coronary artery occlusion) and to those of two groups 
of animals which were preconditioned with a single 10 min total coronary altery occlusion and 
either 15 min or 60 min of myocardial reperfusion before the 60 min total coronalY "'tery 
occlusion. Several groups of investigators have shown that after an acute coronary artery 
occlusion, the relationship between infarct size (IS) and area at risk (AR) is linear but has a 
positive intercept on the AR-axis."·Il This implies that the use ofiS/AR may lead to erroneous 
conclusions when studies with different area at risks are compared. In the last three groups of 
animals we therefore varied the size of the area at risk to determine whether the infarct size 
limitation by ischaemic preconditioning also depends on the area at risk. 
METHODS 
Experimental groups 
The control group consisted of 12 animals which were subjected to a 60 min total coronary 
artery occlusion (60 min TCO) using an atraumatic clamp. Fifteen animals were preconditioned 
with a single 10 min total coronary artery occlusion (l0 min TCO) before the vessel was 
occluded for 60 min. The reperf\!sion period between the 10 min TCO and the 60 min TCO was 
15 min (15 min REP) in 10 and 60 min (60 min REP) in 5 animals. In these animals the site of 
occlusion (left anterior descending coronary artery or its branches) were varied to create areas 
at risk (AR) which were different for each animal. The last group consisted of 7 animals, in 
which the flow in the proximal left anterior descending coronary artery was reduced to 
approximately 30% of baseline during 30 min by using a balloon occluder driven by a 
micrometer (Hamilton Co., Reno, Nevada, U.S.A.), before the vessel was occluded for 60 min 
without intermittent reperfusion (two-stage coronary artery occlusion). In this last group of 
animals the area at risk could not be varied because of the length of the vessel segment needed 
for the placement ofthe flow probe and the balloon occluder (see below). 
Surgical procedure 
All experiments were performed in accordance with the "Guiding principles in the care and 
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use of animals" as approved by the Council of the American Physiological Society and under Ule 
regulations of the Animal Care Committee of the Erasmus University Rotterdam. 
Domestic Yorkshire-Landrace pigs (25-35 kg, HVC, Hedel) were anaesthetized with 
pentobarbital and instrumented for measurement of arterial and left ventricular pressure and 
control of arterial blood gases as described elsewhere." Following administration of 
pancuronium bromide (4 mg Lv., Organon Teknika B.V., Boxtel, The Netherlands), a midline 
thoracotomy was performed, the left manunary vessels were ligated and parts of the second and 
third left rib were removed to facilitate further instrumentation. An electromagnetic flow probe 
(Skalar, Delft, The Netherlands) was placed around the ascending aorta to measure cardiac 
output. In 27 animals, the left anterior descending coronary artery (LADCA) or its side branches 
were dissected free from the surrounding tissue to induce ischaemia with different areas at risk. 
In 7 animals a proximal segment of the LADCA was dissected free to accommodate a probe for 
pulsed Doppler flow velocimetry (Crystal Biotech Inc., Hopkinton, Md, U.S.A.) and an inflatable 
balloon (R.E. Jones, Silver Spring, Md Maryland, U.S.A.) to occlude the vessel in two stages. 
One pair of ultrasonic crystals (Sonotek Corporation, Del Mar, Ca, USA) was positioned into the 
layers of the left ventricular mesocardium in the distribution area of the LADCA, while a 
separate pair was placed into the myocardium remote from the ischaemic segment for the 
measurement of regional segment length shortening by sonomicrometry (Triton Teclmology Inc., 
San Diego, Ca, USA)." 
Experimental procedures 
After completion of the instrumentation, a stabilization period of at least 30 min was allowed 
before the animals were subjected to the experimental protocols (see experimental groups). When 
necessary, small adjustments were made in the volume of the balloon to keep the flow at its 
reduced value during the 30 min partial coronary artery occlusion in the 7 animals in which the 
LADCA flow was reduced to 30% of baseline. In all animals, the ischaemic myocardium was 
reperfused for two hours at the end of the 60 min TCO. 
In the animals with the partial occlusion, ATP and ADP were determined in biopsies taken 
prior and at the end of the 30 min partial occlusion period." Systemic haemodynamic variables 
and regional segment length changes were recorded throughout the experimental protocols. In 
case of ventricular fibrillation, the animals were promptly (within 30 s) defibrillated using DC 
countershock (15-30 Watt) and the animals were allowed to complete the experimental protocol. 
This procedure does not cause irreversible damage". 
Area al risk and Infarci size 
Validation of the methods to determine the area at risk and infarct size has been described 
extensively"''', while details have been reported by Rohmarm el 01." Briefly the area at risk was 
identified by an intra-arterial injection of IS ml of a 10 % (w/w) solution of fluorescein sodium 
(Sigma Chemical Co, St. Louis, USA) after the LADCA had been reoccluded. After induction 
of ventricular fibrillation with a 9V battery the heart was excised and both atria, the right 
ventricular free wall and the left ventricular epicardial fat were removed. The remaining left 
ventricle was filled with alginate impression material (BayerDentaI, Leverkusen, Germany), 
cooled in crushed ice and sliced parallel to the atrioventricular groove into 5 segments. The cut 
surface(s) of each segment and Ule demarcated areas at risk (AR) were then traced on an acetate 
sheet. The viable myocardium was then stained deeply blue by incubating the segments for 30 
min in 0.125 g para-nitrobluetetrazolium (Sigma Chemicals Co., St. Louis, USA) per liter of 
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phosphate buffer (PH 7.1) at 37'C. The non-stained pale infarcted tissue was traced onto the 
acetate sheet and the area at risk (percentage of area of ring) and the infarcted tissue (percentage 
of area of ring) were calculated for tl,e top and bottom of each ring and the mean value for each 
ring was multiplied by the weight. The weights of the regions were summed and divided by the 
weight of the left ventricle to yield the percentage of the left ventricle at risk (ARIL V m~')' the 
percentage of the left ventricle that had become infarcted (lSIL V m~') and the percentage of the 
area at risk that had become infarcted (lS/AR). 
Data analysis and presentation 
The relationship between ISIL V~, and ARIL V~, was detennined for the control animals and 
the animals preconditioned with 10 min TCO and 15 min REP in order to detemline whether the 
size of the area at risk is important for the protective effect of ischaemic preconditioning. For 
each of the animals, which undelwent the two-stage coronary artery occlusion, infarct size 
limitation was calculated as (IS"", - IS",JIISp,'" (x I 00%) in which IS"", and IS,b, are the infarct 
sizes predicted from the regression equation of tlle control group on the basis of the weight of the 
area at risk and the actually observed infarct size, respectively. 
From the segment length tracings were calculated (i) regional systolic segment shortening as 
SS(%) = 100 x (EDL - ESL)IEDL, in which EDL and ESL are tl,e segment length at end-diastole 
and end-systole, respectively, and (ii) post-systolic segment length shortening as PSS(%) = 100 
x (ESL - minimal segment length)IEDL. Haemodynamic and regional myocardial function data 
have been presented as mean (SEM). Statistical significance for the changes in the cardiovascular 
variables were detemlined by the paired Student t-test. 
RESULTS 
Ventricular fibrillation 
Table I shows that ventricular fibrillation did not occur more frequently in the control group 
than in the 10 min TCO preconditioning groups. Because the occurrence of ventricular 
fibrillation depends strongly on variables such as the size of the area at risk, which was varied 
intentionally in these series of experiments, we also analysed the relation between the incidence 
of ventricular fibrillation and the area at risk independent of preconditioning. Ventricular 
fibrillation occurred in 7 oftlle 9 (78%) animals in which ARIL V m~' was more than 30%, while 
it occurred in I of the 13 (7%) animals in which ARlLVmti, was less than 20% (p<0.05). 
Ventricular fibrillation did not occur during the partial flow reduction, but was still observed in 
3 of the 7 animals (ARlLV_ between 20% and 30%) during the 60 min TCO. All aninlaiS were 
defibrillated successfully within 30 seconds and kept in the study. 
Infarct size area at risk reiationships in the controi animals and the animals preconditioned with 
a single 10 min TeO 
In the control group, there was a highly linear relationship (r = 0.99, p<O.OO I) between 
ISILVm~ and ARlLVmti" which could be described with ISILVm~. (x 100%) = 0.88 ARlLVm~ 
(x 100%) - 3.6. The same figure also shows the individual data for the animals which were 
preconditioned with 10 min TCO and 15 min REP. In these animals the relationship (lSIL V~, 
(x 100%) = 0.68 ARIL V mti' (x 100%) - 4.8, not shown in figure) proved again to be linear (r = 
0.88,p<0.05) with a less steeper slope (p<0.05), but with a similar positive intercept on the AR-
axis as found for the control animals. The protective effect of the 10 min TCO was still present 
when the duration of REP was extended to 60 min (fig I). 
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Table 1 Ventricular fibrillation in all pigs 
Preconditioning 
Groups (n) occlusion reperfusion 60 min 120 min 
TCO REP 
Control 12 3 2 
10 min TCO + 15 min REP 10 0 2 4 3 
10 min TCO + 60 min REP 5 0 4 
30 min 30% Flow 7 0 3 0 
Teo = Total coronary artery occlusion, REP = Reperfusion, 30 min 30% Flow = 30 min 70% flow 
reduction without reperfusion before the 60 min TeO 
40 
o 
o 
o 
AR/LV mass (x 100%) 
y = 0.88x - 3.6 
r=0.99 
p < 0.001 
... = Control 
o = 10mlnTCO + 
15 min REP 
O=10mlnTCO+ 
60 min REP 
o = 30 min 30% Row 
50 
Figure 1 Individual data points detenninil1g the relation between the infarct size (IS), expressed as 
percentage of left ventricular mass (LV !MIl) and the area at risk (AR). also expressed as percentage of 
LV mill are shown for the four groups of animals which underwent a 60 min total coronary artery 
occlusion without (Control or after a preconditioning stimulus). TeO = total coronary artery occlusion; 
REP = reperfusiollj 30 min 30% Flow = 30 min reduction of flow to 30% of baseline. The solid line is 
the linear regression line for the control group, while the dashed lines indicate the 95% confidence 
interval. 
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Infarct size aj/er a two-stage coronmy arMy occ/usion 
The individual infarct size data of the animals with the 30 min reduction in flow to 30% of 
baseline (30 min 30% Flow) preceding the 60 min total coronary artery occlusion (two-stage 
coronmy artery occlusion) have also been depicted in fig I. The most striking feature is that the 
infarct sizes of these animals were smaller than predicted from the regression line and the 9S% 
confidence interval of the control animals. 
Factors possibly related to the preconditioning effect of the partial occ/usion 
Baseline values of heart rate (HR), mean arterial blood pressure (MAP), LVdP/dt",u, left 
ventricular end-diastolic pressure (L VEDP) and cm·diac output (CO) were I 05(4) bpm, 90(1) 
nmlHg, 2270(130)nmlHg.s·', 12(1) nmlHg and 3.0(0.1) l.min·', respectively. TIle haemodynarnic 
responses to the 60 min TCO of the individual animals in the control group and the groups 
conditioned with the single 10 min TCO varied considerably depending on the size of the area 
at risk. The major differences were in the LVdP/dt",~, which decreased up to 40% in the animals 
in which ARIL V_exceeded 30%, but was less than IS% when ARIL V m~' was less than 10%. 
MAP, LVdP/dt",u and CO had decreased to 86(3) nunHg, 1400(SO) mmHg.s·' and 2.3(0.2) 
l.min·' (allp<O.OS vs baseline) at the end ofthe 30 min 30% Flow, while LVEDP had increased 
(p<O.OS) to 23(3) mmHg (p<O.OS) and heart rate did not change. The subsequent 60 min TCO 
. did not lead to further changes (90(3)nunHg, 1320(SO)mmHg.s·', 2.2(0.1 )l.min·' and 97(7)bpm, 
respectively). During the two hour repemlsion period only tlle LVEDP (IS(2) mmHg) recovered, 
as MAP (82(3)mmHg), LVdP/dt",u (1330(170)nunHg.s·') and CO (1.8(0.1)l.min·') remained 
depressed (allp<O.OS), while HR had increased to 12S(S) bpm (p<O.OS). 
Analysis ofthe pooled (global haemodynarnic) data of all groups of animals did not reveal a 
significant relationship betweenlS/AR mId variables such the heart rate-pressure product at the 
beginning of the 60 min TCO (r ~ 0.22). This proved also to be tnte for the data of the separate 
groups (values for the control group and the two-stage coronary artery groups were r ~ 0.36 and 
r ~ 0.22, respectively). 
Baseline values for the SS of the myocardium perfused by the LADCA were 19(1)%. In the 
control group SS decreased to 2(1)% during the 60 min TCO and did not recover during the 2 
hours REP (3(1)%). During the 10 min TCO preconditioning stimulus, SS was also abolished 
but had recovered to 11(2)% and 13(1)% (bothp<O.OS vs baseline) after the IS min REP and 60 
min REP, respectively. At the end of the subsequent 60 min TCO, SS was 2(1)% and 3(1)% for 
the IS min REP and 60 min REP, respectively and did not recover during the 2 hours REP 
(2(1)% and 3(1)%, respectively). In the animals with the two-stage coronary artery occlusion SS 
had decreased to 2(2)% (p<O.OS) after 30 min 30% Flow. During the subsequent 60 min TCO 
there was a fhrther decrease to -1(1)% (p<O.OS), while there was no sign of recovery during the 
2 hours REP (-2(1)%,p<0.OS vs baseline). During the 70% flow reduction the loss in systolic 
segment length shortening was accompanied by the appearance of the post-systolic segment 
length shortening PSS (from 3(1)% to 11(2)%,p<0.OS). There were no further changes in PSS 
during the filfther course of the experiment. 
Because pm1ial flow reductions of the animals in the two-stage coronary artery group was in 
the range between 61% and 78% of baseline (68 ± 3%), we investigated whether there was a 
relation between the flow reduction and IS/AR. This proved not to be the case (r ~ 0.02). Figure 
2 shows that there were also no significant correlations between lSI AR and the 
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Figure 2 Relation between infarct size/area at risk (IS/AR) and the changes in systolic segment length 
shortening (SS). post-systolic segment length shortening (PSS) and ATP during the 30 min 30% Flow 
preceding the 60 min total coronary artery occlusion. 
changes in SS, PSS and ATP, observed during the 30 min 30% Flow. There were also only weak 
correlations between infarct size limitation (see data analysis) and Ihe changes from baseline 
prior to the 60 min total coronary artery occlusion in SS (r ~ 0.71), PSS (r ~ -0.32), ATP (r ~ 
0.44), ADP (r ~ 0.42) and ATP/ADP (r ~ -0.08). 
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DISCUSSION 
Relationships between infarct size and area at risk/or control pigs and pigs preconditioned with 
a single 10 min TCO 
In both anaesthetized and conscious dogs, IS and AR (both expressed as percentage of left 
ventricular mass) are highly liuearly related with a positive intercept on the AR-axis."·14 Because 
of this non-zero iutercept, the ratio between IS and the AR is not a constant, but depends on the 
AR. In the present study we found a highly liuear relationship with similar positive iutercepts on 
the AR-axis for our control pigs, as well as for the pigs preconditioned with a single 10 min 
TCO. The slope for the preconditioned aniu18ls was significantly less than for the control animals 
iudicatiug that infarct size development was less. The reason for the positive iutercept is nnclear. 
It is unlikely tllat in the present study insertion ofthe crystals contributed significantly to tile non-
zero intercept as nOllRzero intercepts have also been found in studies in which no crystals were 
implanted." The possibility that infarct size development in small areas at risk progresses less 
rapidly than in larger areas at risk can therefore not be excluded. This has indeed been suggested 
for the dog and been explained by its collateral flow. This now appears to be an unlikely 
explanation as not only in the pig, but also in the rabbit"''', an other species with a lack of 
coronary collaterals, tlle IS-AR relationship is liuear with a positive intercept on the AR-axis. In 
this respect it is of interest that in the rat, a species with a much smaller heart, the relation 
between IS and AR appears to have a zero intercept (unpublished observations from our 
laboratory). 
Irrespective of its cause, the non-zero iutercept makes IS/AR highly dependent on AR. Using 
the liuear regression equations of the control group and the group preconditioned with a 10 min 
TCO + IS min REP, it can be easily calculated that infarct size limitation by preconditioning 
(IS","o' - ISp"",d)IIS","O' x (100%) is 62% when AR is 10% of the LV m~" but only 28% if AR 
is 25% ofthe LVm=. This large variability may easily lead to erroneous conclusions when studies 
are compared in which different sizes of the area at risk have been used. 
Preconditioning with a partial occlusion without intermillent reperjilsion 
Up till now complete restoration of myocardial reperfusion was necessary to obtaiu ischaemic 
preconditioning (see ref. 23). This requirement appears to be further supported by the study of 
Ovize et al lO, who showed that moderate ischaemia caused by a 50% reduction in myocardial 
blood flow lasting for 15 min failed to reduce infarct size during a subsequent 60 min TCO 
unless iutermittent reperfusion was allowed. In the present study we now show that infarct size 
can be limited by a partial occlusion without intermittent reperfusion. The two-stage occlusion 
model proved to be as effective as the standard model in which preconditioning is elicited by 
brief total occlusion separated from the longlasting occlusion by a period of complete reperfusion 
(fig I). Similar to other investigators", we found a very poor correlation between IS/AR and 
global haemodynamic variables such as the heart rate-pressure product just prior to the 60 min 
TCO. There were also only weak correlations with the loss in function and some metabolic 
measures such as changes in ATP and ATP/ADP. It must be remarked, however, that we 
measured total ADP content, which is almost entirely bonnd or compartmented in the myocyte. 
From thermodynamic point of view, the free cytosolic ADP concentration is a more valid of 
measure of myocardial energetics, but its calculation using the creatine kinase mass action ratio 
would have required the measurement of creatine and creatinephosphate. 
The need for reperfusion in the earlier studies has remained unclear as some phenomena 
directly related to reperfusion such as hyperaemia (accompanied by washout of metabolites 
50 Chapter 5 
accumulated during ischaemia), free radical generation and myocardial stunning have been 
discarded.23-2S However, several groups of investigators have shown that the tolerance of normal 
healthy myocardium can also increase by preceding transient ischaemic periods in adjacent 
myocardium26 or kidneys.27 Tills may point towards a role for circulating substances, not 
necessarily released by the transient ischaemic tissue. 
It has been well established that metabolism of the ischaemic segment changes continuously 
during a fixed reduction in coronary blood flow, while the function remains depressed at the 
same level. Studies from several laboratories, including our own, have shown that ATP 
breakdown, myocardial lactate production and eillux ofpotassiwn ions increase gradually during 
the early period of a fixed flow reduction, but that there is a normalization of ischaemia-induced 
metabolic changes as the hypoperfusion is prolonged."·"·)1 If the metabolic state of the 
myocardium is important for preconditioning, the duration and severity of the flow reduction 
may be critical in obtaining this protective action. In the study of Ovize et al. lO, the combination 
of the duration and the degree of flow reduction may have not been suillcient. Several other 
mechanisms (adenosine hypothesis, opening of ATP sensitive potassium channels, preservation 
of high energy phosphates, etc. for an extensive review see ref. 22) have been proposed to explain 
myocardial preconditioning. The design of the present study does not provide any evidence in 
favour of against any of these hypothesis. 
Limitations 
During the 30 min 30% Flow, the volume of the inflated balloon had to be adjusted 
occasionally to keep the flow at its reduced value. Although this was not a frequent phenomenon, 
we can not exclude entirely that the small flow oscillations have contributed to the 
preconditioning effect. In this respect, it is worth mentioning that Ovize ef af" have reported that 
cyclic flow variations could lead to preconditioning. In their study" the flow oscillations were 
very large, however, and reperfusion was restored between the flow reductions. The model in that 
study therefore resembles more closely that of the multiple complete occlusion-reperfusion 
sequences. Furthermore, we have tested only one flow reduction (68 ± 3%) for a fixed period of 
time (30 min) and have therefore no infoffilation about infarct size limitation when other 
combinations of duration and degree of flow reductions are used. 1o 
Cone/us ion 
Infarct size can be limited with a two-stage coronary artery occlusion without intermittent 
reperfusion. This last observation brings the phenomenon of ischaemic preconditioning closer 
to the clinical setting as in many patients thrombus development may give rise to severe 
ischaemia before the artery is totally occluded. The model also suggests that complete washout 
of metabolites, accumulated during ischaemia, is not required to obtain preconditioning. 
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ABSTRACT 
Background One or more brief total coronary artery occlusions can limit myocardial infarct 
size produced by a subsequent sustained occlusion. Recently, we reported that a partial coronary 
artery occlusion inunediately preceding a sustained coronary at1ery occlusion could also limit 
infarct size. In the present study we investigated (i) whether the protection against infarction 
exerted by partial coronary artery occlusions depends on the severity and(or) duration of the flow 
reduction and (If) whether the protection afforded by tile partial coronary artery occlusions varies 
in the different myocardial layers. 
Methods and Results. Studies were perfonned in 63 open-chest pigs. Using standard staining 
techniques, the left ventricular area at risk (AR) and infarct area (IA) expressed as a percentage 
of the left ventricular (LV) mass were determined for the endocardial half (IAeo,jL Veod, and 
AR,...,jL V,,,,,,) and epicardial half of the left ventricle (IJ\,/LV,pl en AR,p/L V,p')' The results of 
eight groups of animals are presented. In control animals that underwent 60 min oftotal coronary 
artery occlusion (TCO) followed by 120 min or reperfusion (Rep) there were a highly linear 
relations in the endocardium (t=0.98, P<O.OOI) and epicardium (FO.97, P<O_OOI) between 
IAlLV and ARlLV which could be described by the equations IA",jLV"di'IOO%) = 
1.01·AR,,,,jLV,,,,,,(· I 00%) - 4.6 and by IA,/LV,pl (·100%) = 0.9 l'AR,,;ILV,pl (. 100%) - 4.1. A 
second group of animals underwent a single 10 min TCO and 15 min of Rep prior to the 60 min 
TCO and 120 min Rep. Infarct area in both the endocardium and epicardium were again linearly 
related with the area at risk, with a positive intercept on the ARIL V axis that was similar to that 
of the control group. Preconditioning with 10 min TCO and 15 min Rep decreased infarct size, 
so that the slopes of the linear relations in both the endocardium (0.63) and epicardium (0.57) 
were less steep compared to the control group (both P<0.05). The magnitude of protection was 
not different between the inner and outer half. Two groups of pigs were subjected to either 30 
or 90 min of70% reduction of coronary blood flow (FR) inunediately preceding the 60 min TCO 
and 120 min Rep, without intennittent reperfusion. Thirty min of70% FR decreased infarct size 
in both the endo- and epicardial half, so that the degree of protection was not different between 
the inner and outer half. Ninety min of 70% FR also resulted in infarct size limitation in both 
layers (P<0.05), but the protection was greatest in the epicardium (P<O.OI vs endocardium). 
Ninety min of70% FR alone, without the 60 min TCO, resulted in infarction in both endo- and 
epicardium with the greatest infarct size in the endocardium (P<O.O I endocardium vs 
epicardium). Thus, the observation that 90 min of70% FR resulted in less infarct size reduction 
(compared to the control group) in the endocardial than in the epicardial half was likely due to 
a greater degree of irreversible damage in tile endocardium already produced by this duration of 
severe flow reduction. Endocardial and epicardial infarct size in animals SUbjected to either 30 
or 90 min of30% FR prior to the 60 min TCO was not different from that in the control group, 
indicating that exposure to such mild flow reductions fails to limit irreversible ischemic damage 
during a subsequent 60 min TCO and 120 min Rep. Ninety min of30% FR without the 60 min 
TCO did not produce myocardial necrosis in either the outer or hmer half of the left ventricle. 
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COllclusions. Thirty or ninety min of severe (70%) but not mild (30%) coronary flow 
reductions protected against myocardial infarction produced by a subsequent total coronary ruiery 
occlusion, suggesting the presence of an ischemic threshold for myocardial preconditioning. 
Infarct size limitation afforded by a single 10 min TCO and 15 min Rep was distributed 
homogeneously across the left ventricular wall. In contrast, the transmural distribution of 
infarct size limitation by a 70% coronary flow reduction was influenced by the duration of 
flow reduction. Thus, whereas 30 min of 70% flow reduction produced similar decreases in 
infarct size in the ilmer- and outer half of the left ventricle, 90 min of 70% flow reduction 
preferentially limited epicardial infarct size. These fmdings suggest that perfusion abnormalities 
immediately preceding a coronary artery occlusion in patients may be an important source of 
infarct size variability. 
INTRODUCTION 
In a large number of species, including dogsl,2, pigs)'s rabbits6.7 and rats,8,9 one or more brief 
total coronary ruiery occlusions CaIl limit the irreversible damage produced by a subsequent 
sustained occlusion. Recently, it was reported that partial coronary artery occlusions can also 
precondition the myocardimn. IO•11 Thus, Ovize et al.lO observed in dogs that the development of 
myocardial necrosis during 60 min total coronary ruiery occlusion was attenuated, when coronary 
blood flow was reduced by 50% for 15 min preceding the sustained coronary artery occlusion. 
In that study 15 min of complete reperfusion bel"ween the graded coronary artery stenosis and the 
sustained total coronary occlusion was necessary to obtain the reduction in infarct size. In 
contrast, we observed in pigs that a 70% coronary flow reduction that lasted 30 min protected the 
myocardium during a subsequent 60 min total coronary artery occlusion withoul the need of 
intermittent reperfusion. 1I These findings suggest that the severity andlor duration of the flow 
reduction plays a critical role in eliciting the protective effect. 
Although ischemic preconditioning has been the topic of many studies, none of them 
investigated the transmural distribution of infarct size limitation afforded by the ischemic 
stimulus. It is well established that a partial coronary artery occlusion affects perfusion of 
subendocardial and subepicardial layers differently, with the largest decreases occurring in the 
subendocardiallayers,12.17 TIlUs, differences in severity of ischemia across the left ventricular wall 
could produce different degrees of protection for different myocardial layers. To address these 
questions we investigated (i) whether the protection exerted by pruiial coronary ruiery occlusions 
depends on the severity and( or) duration of the flow reduction and (ii) whether the protection 
afforded by the pruiial coronary ruiery occlusions varies in the different myocardial layers. These 
issues are of particular clinical interest, since preconditioning with partial occlusions mimics 
more closely the condition of patients suffering from coronary ruiery disease than the abrupt brief 
total occlusion and reperfusion sequences. To compare the protective effects of the flow 
reduction models with a classical model of myocardial preconditioning we also aIlalyzed the 
subendocaI'dial and subepicardial distribution of previously published transmural infarct size data 
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of eleven pigs that had been preconditioned with a single 10 min coronary artery occlusion." 
METHODS 
All experiments were performed in accordance with the "Guiding principles in the care and 
use of animals" as approved by the Council of the American Physiological Society and under the 
regulations of the Animal Care Committee of the Erasmus University Rotterdam. 
Surgical Procedures 
Domestic Yorkshire-Landrace pigs (25-35 kg, HVC, Hedel, The Netherlands) were 
anesthetized with pentobarbital and instnunented for measurement of arterial and left ventricular 
pressure and control of arterial blood gases." After administration of pan cur onium bromide (4 
mg Lv., Organon Teknika B.V., Boxtel, The Netherlands), a lnidline thoracotomy was performed 
and an electromagnetic flow probe (Skalar, Delft, The Netherlands) was placed around the 
ascending aorta to measure cardiac output. In the control animals the left anterior descending 
Control 
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10 min TeO + 16 mIn Rap 
30 min 70% FR 
90 min 70% FR 
90 min 70% FR 
30 mIn 30% FR 
90 min 30% FR 
90 min 30% FR 
EXPERIMENTAL GROUPS 
60 mIn TCO 
120 mIn Rep 
Vi/ 
W/Z?VVA 
fu 
,0 n?;;??, ( 
HU????22?! 
I I , 
·90 -30 0 60 180 
time (mIn) 
group 1 n=17 
group 2 0",10 
group 3 n=9 
group 4 n 0 7 
group 6 n=7 
group 6 n c 3 
group 7 n=7 
group 8 "=3 
Figure 1 Experimental protocol of the 8 groups of animals in which the distribution of infarction size 
was determined. The 60 min total coronary artery ocdusion (60 min TeO) has been indicated in black. 
Flow reductions have been indicated with a cross-hatch pattem. Teo = total coronary artery occlusion, 
Rep = reperfusion, FR = flow reduction. ' 
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coronary artery (LADCA) or its diagonal branches supplying the left ventricular anterior wall 
were dissected free from the surrounding tissue to allow placement of a microvascular clamp. 
The anatomic location of the occlusion site was varied to create areas at risk of different sizes," 
In Ole animals which underwent a partial occlusion preceding Ole total coronary artery occlusion, 
a proximal segment of the LADCA was dissected free for the placement of a probe for pulsed 
Doppler flow velocimetry (Crystal Biotech, Hopkinton, MD, U.S.A.) and an inflatable balloon 
(R.E. Jones, Silver Spring, MD, USA) to occlude the vessel in two stages. 
Regional Myocardial Contractile Function 
One pair of ultrasonic crystals (Sonotek Corporation, Del Mar, CA, USA) was positioned into 
the subendocardial layers of the left ventricular myocardium in the distribution region of the 
LADCA for the measurement of segment shortening by sonomicrometry (Triton Technology, 
San Diego, CA, USA). Another pair of crystals was placed into the myocardilUll perfused by the 
left circumflex coronary artery, remote from the ischemic region. From the segment length 
tracings the segment lengOI at the end of diastole (EDL, Oll5et of positive ascending aortic flow) 
and the length at the end of systole (ESL, positive aortic flow crossing the zero flow line) were 
detennined and regional systolic segment shortening was computed as: 
SS(%) ~ 100 x (EDL - ESL)IEDL, 
while post-systolic segment length shortening was computed as: 
PSS(%) ~ 100 x (ESL - minimal segment length)IEDL. 
Experimental Protocols 
After completion oflhe instrumentation, a stabilization period of at least 30 min was allowed 
before the animals were subjected to the experimental protocols. Systemic hemodynamic 
variables and regional segment length changes were recorded throughout the experimental 
protocols. In case of ventricular fibrillation defibrillation was started within 30 s, using DC 
countershocks (15-30 Watt). If defibrillation was succesful within 2 min animals were allowed 
to complete the experimental protocol, since this procedure does not produce irreversible 
damage." Animals in which defibrillation could not be accomplished within 2 min were 
excluded from further study. 
The results of eight groups of animals are presented (Fig I). Eighteen animals underwent a 
single 60 min total coronary artery occlusion (TCO), followed by 120 min ofreperfusion (Rep). 
Eleven animals underwent a 60 min TCO preceded by a single 10 min TCO and 15 min Rep. 
Four groups underwent a partial coronary artery occlusion of either 30 min or 90 min, before the 
artery was occluded completely for 60 mi~ without intermittent reperfusion. The partial 
occlusions were chosen such that coronary blood flow was reduced by either 30% or 70% of 
baseline. When necessary, small adjustments were made in the volume oflhe balloon to keep the 
flow at its reduced value during the partial coronary artery occlusion period. In all animals the 
ischemic myocardium was reperfused for 120 min following the 60 min total coronary artery 
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occlusion. Because it is conceivable that the preconditioning stimulus of either 90 min of70% 
coronary flow reduction (FR) or 90 min of 30% FR could already lead to necrosis, we also 
analyzed two groups of animals that underwent 90 min of either 70% FR (n=7) or 30% FR (n=3), 
followed by 120 min Rep without the 60 min of total coronary artery occlusion (Fig I). 
Transmural infarct size data of 12 animals of the control group and lO animals that were 
preconditioned with a single 10 min total coronary artery occlusion, as well as 7 animals with 
30 min of 70% FR have been presented in an earlier study. II 
Area at Risk and Infarct Area 
Validation of the methods to deterutine the area at risk and infarct area has been described 
extensively.'·20)' Briefly, following reocclusion of the LADCA the area at risk was identified by 
an intra-atrial injection of 15 ml of a 10 % (w/w) solution of fluorescein sodium (Sigma 
Chemical Co, St. Louis, USA). Ventricular fibrillation was produced with a 9V battery and the 
heart was excised. Both atria, the right ventricular free wall and the left ventricular epicardial fat 
were removed. The left ventricle (LV) was filled with alginate impression material (BayerDental, 
Leverkussen, Germany), cooled in crushed ice and sliced parallel to the atrioventricular groove 
into 5 segments. The cut surface(s) of each segment and the demarcated areas at risk (AR) were 
then traced on a transparent acetate sheet under a black light. The viable myocardium was then 
stained deeply blue by incubating the segments for 30 min in 0.125 g para-nitrobluetetrazolium 
(Sigma Chemicals Co., st. Louis, USA) per liter of phosphate buffer (PH 7.1) at 37'C and the 
non-stained pale infarcted tissue was traced onto the acetate sheet. The surface of each ring of 
was subsequently subdivided into a subendocardial (ilmer) half and subepicardial (outer) half by 
drawing a line which divided the myocardial wall into two layers of equal thickness. Division 
into two layers was done as it provides information on the transmural distribution of infarct 
size, yet preserving sufficient accuracy of infarct size detennination in the two halves. Surface 
areas of the subendocardial and subepicardial halves, and of the subendocardial and 
subepicardial areas at risk and infarct areas (lA) were determined and averaged for the top and 
bottom of each individual ring. Then the fraction of the ring that was infarcted and at risk was 
multiplied by the weight of the ring to yield the weight of the infarct area and area at risk for 
that ring. The weights of the subendocardial and subepicardial halves and the total weight of 
each ring were then summed to yield the LV,",,, LV"I and total LV masses. The weights of 
the endocardial, epicardial and total areas at risk of each ring were sununed to yield the total 
AR,,,,,, ARq,1 and total AR masses; the weights of the endocardial, epicardial and total infarct 
areas of each ring were sutmned to yield lAo'd" IA",I and total IA masses. Endocardial, 
epicardial and total IA and AR data were expressed as a percentage of LV,,,,,, LV"I and total 
LV masses, respectively. 
Data Analysis and Presentation 
Infarct size data have been presented by plotting the IAiL V against the ARlL V for the inner 
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and outer half and for the whole left ventricular wall. Linear regression analysis was 
performed to determine the relation between endocardial and epicardial IAiLVand ARlLV in 
the control group and the animals preconditioned with 10 min TCO and IS min of Rep. For 
the animals that underwent the two-stage coronary artery occlusion the individual data are 
presented. Intergroup differences in IA,""/LV,",,, IA,p,lLV,ph or total IAlLV were analyzed 
by analysis of covariance (ANCOV A), with AR",.,ILV,",,, AR,p/LV,pi or total ARlLV as a 
covariate. Intragroup differences between IA"d,lLV,",o and IA,pI/LV,pl were analyzed using 
ANCOVA for repeated measures, with AR,,,,.,ILV,",, and AR,p/LV,pl as covariates. The 
incidence of ventricular fibrillation was analyzed by Fisher's exact test (two-tailed). 
Hemodynamic data were analyzed with ANOVA followed by unpaired t-test. Values are 
expressed as mean ± SEM. 
RESULTS 
Mortality and Exclusions 
In the control group (60 min TCO) one animal was excluded because defibrillation during 
the 60 min TCO was unsuccessful within Imin after onset of ventricular fibrillation. Two 
animals which underwent a 30% FR (one pig for 30 min and the other for 90 min) could also 
not be defibrillated during the 60 min TCO period. Two animals died after unsuccesful 
defibrillation, during 70% FR (after IS min and 20 min of flow reduction, respectively), while 
one animal was excluded from further study because of technical failure of the balloon 
occluder. One animal was excluded from the 90 min 70% FR group because ofunsuccesful 
reperfusion after 60 min TCO. 
Ventricular Fibrillation 
Table I shows that during the 60 min TCO ventricular fibrillation occurred in 7 of the 18 
control animals, and in 5 of Ole II animals that had been subjected to 10 min TCO and IS Rep 
(P=NS). Animals Omt fibrillated in these two groups during 60 min TCO had larger areas at 
risk than animals that did not fibrillate (34 ±3 % and 18 ±2 % of the left ventricle, respectively, 
P<O.OI). Thirty min of 70% FR also failed to exert a protective effect on the incidence of 
ventricular fibrillation during the subsequent 60 min TCO (area at risk 27±2% of the left 
ventricle), but ventricular fibrillation during the 60 min TCO in the animals that were 
precondtioned with 90 min 70% FR was absent (0 of 8, P<0.05 vs control group, area at risk 
36±3% of the left ventricle). In contrast, the incidence of ventricular fibrillation during the 
60 min TCO in the group preconditioned with either 30 or 90 min of 30% FR (area at risk 
3S±3% of the left ventricle) was not different from the control group. Thus, while the 
protective effect of 90 min of 70% FR could not be explained by differences in area at risk, 
Ole fmdings indicate that severity and duration of the partial flow reduction critically determine 
its protection against ventricular fibrillation duration a sustained ischemic episode. Upon 
reperfusion ventricular fibrillation was absent or rare, which is in agreement with studies 
Table 1 Ventricular fibrillation in all pigs 
Preconditioning 
Groups Stimulus 60 min TCO Reperfusion 
(1) Control 7(18)' 2(17)' 
(2) 10 min TCO + 15 min Rep + 60 min TCO 2(11)+.x 5(11)' 3(10)"+ 
(3) 30 min 70% FR + 60minTCO 0(9) 3(9) 0(9) 
(4) 90 min 70% FR + 6OminTCO 1(9) 0(8) 0(7) 
(5) 90 min 70 % FR 1(8) 0(7) 
(6) 30 min 30% FR + 60minTCO 2(4)X 1(4), 0(3) 
(7) 90 min 30% FR + 60minTCO 0(8) 6(8) 0(7) 
(8) 90 min 30% FR 0(3) 0(3) 
Between parentheses are the total numbers of animals per group at that moment still in the study. TCO = Total coronary artery occlusion, 
Rep = Reperfusion, FR = Coronary Flow Reduction, , one pig fibrillated during both 60 min TCO and Reperfusion, + one pig 
fibrillated during both the preconditioning stimulus and Reperfusion, x one pig fibrillated during both the preconditioning stimulus and 
60minTCO 
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showing that ventricular fibrillation occurs predominantly after TCO's with a duration between 
10 min and 30 min."·" 
Infarct Area - Area at Risk Relation in COlllrol Pigs and Pigs Preconditioned with a Single 10 
min TCO 
In the control group there was a highly lineal' relation (1'=0.98, P<O.OOI) between 
IA,,,,jLV,,,,,and AR,,,,jLV,,,,, which could be described by the equation IA,,,,jLV,,,,, (0100%) 
= 1.01 oAR,,,,,jLV,,,,,,, (0100%) - 4.6 (Fig 2). In the epicardial half of the left ventricle we also 
observed a linear relationship (r=0.97, P<O.ool) which could be described by the equation 
IA",ILV"" (0100%) = 0.91oAR"/LV",,(0100%) - 4.1 (Fig 2). ANCOVA (with AR,,,,,jLV,,,,, 
and AR",ILV,pl as covariates) revealed that IA",iLV,,,,,, was larger than IA,pl/LV,pl 
(P<0.05). 
Preconditioning with 10 min TCO and IS min Rep decreased infarct size in bOtll the inner 
and outer half of the left ventricle. The infarct areas in both the endocardium and epicardium 
were again linearly related with tile areas at risk, with a positive intercept on the ARlLV axis 
that was similar to that of the control group. In contrast, slopes of the linear relation in both 
the endocardium and epicardium were less steep compared to tile control group (both 
P<0.05). ANCOVA (Witll AR,,,,,jLV,,,,,, or AR,p;lLV,pl as covariates) also indicated that 
IA,,,,jLV,,,,, and ~,ILV "I were smaller in the 10 min TCO and 15 min Rep group compared 
to the control group (both P<O.OI). The degree of protection afforded by 10 min TCO and 
IS min Rep in the inner and outer halves of the ventricle was of identical magnitude (P=0.60). 
Infarct Area - Area at Risk Relation in Pigs Undergoing 1\vo Stage Coronary Artery Occlusion 
70% Coronary Artery Flow Reduction 
Trausmural1nfarct Size. When the 60 min TCO was preceded by 30 min of 70% coronary 
flow reduction (PR), transmural infarct size was significantly smaller compared to the control 
group (Fig 3). Extending the duration of the 70% FR to 90 min produced similar protection 
against infarction compared to the 30 min 70% FR animals. Thus, even though 90 min of 70% 
FR without the 60 min TCO had already resulted in considerable myocardial necrosis the 
individual transmural data points remained below the regression line of the control group 
(P<O.OI), indicating significant protection against irreversible myocardial damage produced 
by the subsequent 60 min TCO (Fig 3). 
Distribution of Infarct Size. Thirty min of 70% \'R decreased infarct size in both endo- and 
epicardial halves compared to the control group (P<O.OI) (Fig 4). The protection produced 
by the 30 min 70% FR tended to be greater in Ule epicardium than in the endocardium but this 
failed to reach statistical significane (P=0.13). When the duration of 70% FR prior to the 60 
min TCO was extended from 30 min to 90 min, infarct size limitation in the outer half of the 
62 
50 
1ii' 
gj 
E 
0 
"'0 
<: 25 Q) 
~ 
~ ~ 
< 
0 
0 
50 
~ (f) 
!Q 
E 
c. 25 Q) ~ 
"#. 
~
< 
0 
0 
endocardium 
0 
oo,P 
0 
0 ® 
C Ii) 
:> 
11) 
o ~\i) 
25 
AR (%LVendo mass) 
epicardium 
o 
25 
AR (%LVepl mass) 
o 
Chapter 6 
y = 1.01x - 4.6 
r=0.98 p<O.OOl 
y = 0.63x - 3.2 
r=0.79 p<O.Ol 
o Control 
11) 10mlnTCO+15R+ 
60mlnTCO 
50 
y = 0.91x - 4,1 
r=0.97 p<O.OOl 
y = 0.57x - 3.4 
r=0.94 p<O.OOl 
50 
Fjgure 2 Individual data points detemlining the relation between infarcted area and area at risk in the 
endocardium (upper panel) and in the epicardium (lower panel), both expressed as a percentage of left 
ventricular endocardial (Lvendo) or epicardial mass (Lvepi). Shown are the relationships in the control 
group (60 min total coronary occlusion, TeO) (open circles) and in the animals preconditioned with 10 
min Teo and 15 min Rep prior to the 60 min TeO (closed circles), Infarct size limitations afforded by 
the 10 min TeO and 15 min Rep was of similar magnitude in the two myocardial layers. 
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Figure 3 Individual transmural data points determining tlle relations between infarcted area (IA), 
and the area at risk (AR), both expressed as a percent oftlle left ventricular mass (LV ~,). In the 
upper panel are shown the regression line and individual data points for the control group (60 
min total coronary occlusion), TeO) (open circles), and individual data points for animals 
subjected to 30 min of 70% coronary flow reduction (PR) followed by 60 min Teo (open 
triangle pointing downward), 90 min of70% FR followed by 60 min Teo (open squares), and 
90 min of70% FR without the 60 min Teo (closed squares). In the lower panel are shown the 
relations in the control group (60 min TeO) (open circles), 30 min of30% FR followed by 60 
min TeO (open diamonds), and 90 min 000% FR without the 60 min TeO (closed diamonds). 
Ninety min of 30% FR, which itself did not result in infarction, did not limit infarct size 
produced by 60 min TeO. In contrast, 70% which itself resulted in significant infarction after 
90 min, provided protection against the irreversible damage produced by 60 min TeO. 
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Figure 4 Individual data points detennining the relations between infarcted area (IA) in the 
endocardium (upper panel) or epicardium (lower panel), expressed as a percent of the left 
ventricular endocardial mass or epicardial mass (LV,." mass or LV,,. mass), and the endocardial 
or epicardial area at risk (AR), expressed as a percent of the LV "do mass or LV 'pi mass. Shown 
are the regression line and the equation describing the relations in the control group (60 min total 
coronary occlusion, TCO), and the individual data points in animals sUbjected to 30 min of70% 
FR followed by 60 min TCO (open triangles), 90 min of 70% FR followed by 60 min TCO (open 
squares), and 90 min of 70% FR without the 60 min TCO (closed squares). Ninety min of 70% 
FR, which itself produced some infarction after 90 min, provided protection against irreversible 
damage caused by 60 min TCO. TillS protective effect was sinlliar in endo- and epicardium when 
animals were exposed to 70% FR for 30 min, but was sigruficantly greater in the epicardium 
when the flow reduction was present for 90 min prior to the 60 min TCO. 
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Figure 5 Individual data points detennining the relations between infarct area (IA) in the 
endocardium (upper panel) or epicardium (lower panel), expressed as a percent of the left 
ventricular endocardial mass or epicardial mass (LV,,,,. mass or LV <pi mass), and the endocardial 
or epicardial area at risk (AR), expressed as a percent of the LV endo mass or LV epi mass. 
Shown are the regression line and the equation describing the relationship in the control group 
(60 min total coronary occlusion, TeO), and the individual data points in animals subjected to 
30 min of 30% flow reduction (FR) followed by 60 min TeO (open triangles), in animals 
subjected to 90 min of30% FR wiUlOut the 60 min TeO (closed diamonds). Ninety min of 30% 
FR, which itself did not result in infarction, failed to limit infarct size in either endo- or 
epicardimn produced by 60 min TeO. 
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left ventricle was similar to that observed with the 30 min 70% FR. Infarct size limitation was 
also present in the endocardium (P<0.05 vs control group), but the degree of protection 
produced by 90 min of 70% FR was greater in the epicardium than in the endocardium 
(P<O.OI). Ninety min of70% FR alone resulted in infarction in both endo- and epicardium, 
with the greatest infarct size in the endocardium (P<O.OI endocardium vs epicardium). The 
addition of 60 min of TCO increased infarct size slightly further in both endocardium 
(P<0.05) and epicardium (P<O.OI), so that the magnitude of additional necrosis produced 
by 1110 60 min TCO was not different'between endocardium and epicardium (P> 0.20). Thus, 
the observation IIlat 90 min of70% FR resulted in less infarct size reduction (compared to the 
control group) in the endocardium than in the epicardium was likely due to a greater degree 
of irreversible damage in the endocardium already produced by this duration of severe flow 
reduction. 
30% Coronary Artery Flow Reduction 
Transmural Infarct Size. Transmural infarct size in animals subjected to 30 min of30% FR 
prior to the 60 min TCO was identical to lhat of the control group (Fig 3). Extending the 
period of flow reduction to 90 min did also not alter infarct size produced by 60 min of TCO, 
indicating that exposure to such mild flow reductions fails to limit irreversible ischemic 
damage during a subsequent 60 min TCO. Ninety min of 30% FR without the 60 min TCO 
did not produce myocardial necrosis (Fig 3). 
Distribution of Infarct Size. Endocardial and epicardial infarct size in animals subjected to 
30 or 90 min of 30% FR prior to the 60 min TCO were identical to those of the control group 
(Fig 5). Ninety min of 30% FR without the 60 min TCO did not produce myocardial necrosis 
in either the outer or iI1I1er half of the left ventricle. 
Systemic Hemodynamic Variables 
Baseline values of heart rate (109±3 beats/rnin), mean arterial blood pressure (88±1 
mmHg), cardiac output (2.8±0.1 Limin), or the product of heart rate and systolic arterial 
pressure (11890±340 beats"nunHg/min) were not different between the eight experimental 
groups (n=63). Tn the control group and the 10 min TCO + 15 min Rep group, mean arterial 
pressure and heart rate did not change significantly in response to the 60 min TCO, but cardiac 
output decreased to 2.4±0.1 Limin (P<O.OI). At the end of 120 min of Rep none of the 
hemodynamic variables showed significant recovery towards baseline levels. 
In the groups in which the animals were subjected to 70% FR heart rate and mean aortic 
pressure did not change from baseline, but cardiac output and LVdP/dt"" decreased to 
2.4±0.2 Limin and 151O±110 mmHg/s, respectively (both P<0.05), at 30 min. During the 
remainder of the 90 min 70% FR and during the subsequent 60 min TCO no further changes 
in any of the systemic hemodynamic variables occurred. At the end of 120 min of Rep, cardiac 
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output and LVdP/dt"" remained depressed while heart rate increased to 138±6 heats/min 
(P<O.OI vs baseline). 
In the groups in which pigs were subjected to 30% flow reduction, significant hemodynamic 
changes did not occur in response to either 30 min or 90 min of 30% flow reduction. The 
subsequent 60 min TCO did not alter mean arterial pressure, but increased heart rate to 132±9 
beats/min and decreased cardiac output to 1.9±0.1 Llmin and LVdP/dt"" to 1820±140 
mmHg/s (all variables P<0.05 vs baseline). At the end of 120 min Rep, cardiac output and 
LVdP/dt"" remained depressed; heart rate had increased further to 145±1O beatslmin 
(P<0.05 vs 60 min TCO). 
Relation to ltifarct Size. Analysis of covariance with the infarct area as dependent factor, 
the experimental groups as independent factor, and the area at risk and rate pressure-product 
(either at baseline or at the onset of 60 min TCO) as covariates did not reveal a significant 
correlation between the rate-pressure product (P> 0.09) and infarcted area. Regression 
analysis did also not reveal a significant correlation between IN AR and the rate-pressure 
product at baseline (r=0.12) or at the onset of the 60 min TCO (r=0.29). Similar results were 
obtained when heart rate or systolic pressure were entered as covariates into the ANCOV A, 
or into the regression analysis. 
Myocardial Contractile Function 
At baseline systolic segment shortening in the myocardial regions perfused by the left 
anterior descending and the left circumflex coronary artery were 17±1% and 16±1%, 
respectively. Post-systolic segment shortening was minimal in all experimental groups 
(1 ±0.2%) under baseline conditions. In the control group segment shortening in the area 
perfused by the LADCA decreased to 1 ± I % during the 60 min TCO and did not recover 
during 120 min Rep (2±1 %). The decrease in systolic shortening was accompanied by the 
appearance of post-systolic segment shortening (5 ± I % at the end 60 min TCO, P<O.OI), 
which was not further altered during 120 min of Rep (4±1 %). After 10 min ofTCO and 15 
min Rep, segment shortening had decreased to 11 ±2% (P<O.OI), with a further depression 
to 2± I % (P<O.OI) during the subsequent 60 min TCO and no recovery at the end of 120 min 
Rep. At 30 min of70% FR systolic shortening was 2±1 % (P<O.OI), which did not change 
during the remainder of the 90 min period of FR (2 ± I %). No significant further deterioration 
of systolic function occurred during the subsequent 60 min TCO (0 ± 1 %) or 120 min Rep (-
1 ± I %). Post-systolic shortening had increased to 11 ± I % at 30 min of 70% FR with no 
additonal changes during the remainder of the 90 min FR period (9± 1 %). At 30 min and 90 
min of30% FR systolic shortening had decreased to 12±2% and 13±2%, respectively (both 
P<O.OI vs baseline), while systolic shortening in the control region was not altered. During 
Ole subsequent 60 min TCO systolic shortening was further reduced to 0 ± 1 % and to -I ± 1% 
at 120 min Rep. Post-systolic shortening increased to 4±2% (P<0.05) at 30 min but was no 
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longer significant at 90 min of 30 % flow reduction (2 ± I %). 
Relation to Infarct Size. There was no correlation between the loss of systolic wall 
thickening produced by the precondtioning stimuli and the infarct size. Similarly, we did not 
observe a correlation between systolic segment shortening at the end of 120 min Rep and the 
IN AR, indicating that ischemic preconditioning did not lead to improved functional recovery 
during the first 120 min of reperfusion. In contrast, an inverse relation was observed between 
the magnitude of post-systolic thickening (a marker of myocardial tissue viability) of the 
anterior wall at the end of reperfusion and transmural INAR (r=0.54, P<O.OOI) (Fig 6). 
Analysis of animals with an area at risk ,20% of the left ventricle showed a slight 
improvement in the correlation (r=0.62). 
DISCUSSION 
The present study has yielded several new findings. 1) Infarct size limitation afforded by 
a single 10 min total coronary artery occlusion and 15 min reperfusion preceding a 60 min 
total coronary artery occlusion is distributed homogeneously across the left ventricular wall 
in pigs. 2) Infarct size was also limited by a 70% coronary blood flow reduction for 30 or 90 
min prior to a 60 min total coronary artery occlusion without the need of intermittent 
reperfusion. The transmural distribution of this protective effect depended critically on the 
duration of flow reduction. Thus, whereas 30 min of 70% flow reduction produced similar 
decreases in infarct size in the inner- and outer half of the left ventricle, 90 min of 70% flow 
reduction preferentially limited infarct size in the epicardium. 3) In contrast, protection against 
myocardial infarction or ventricular fibrillation was not afforded by either 30 or 90 min of 
30% flow reduction. 4) The incidence of ventricular fibrillation during the 60 min total 
coronary artery occlusion was not altered by the classical preconditioning stimulus, but was 
significantly reduced when 90 min of 70% flow reduction preceded the sustained ischemic 
period. The implications of these findings will be discussed in detail. 
Ischemic preconditioning and short-term recovery of contractile function 
In the present study we did not observe a correlation between systolic segment shortening 
at the end of 120 min Rep and IN AR, indicating that ischemic preconditioning did not 
improve recovery of systolic function recovery during the first 120 min of reperfusion. In the 
present study we observed an inverse relation between the magnitude of post-systolic 
thickening of the anterior wall at the end of 120 min reperfusion and transmural IAI AR. This 
agrees well with previous observations that post-systolic segment shortening is a marker of 
myocardial viability" 
Ischemic preconditioning and ventricular fibril/ation during subsequent sustailled ischemia 
Studies in rats reported that single or multiple brief total coronary artery occlusions decrease 
the incidence of ventricular fibrillation during a subsequent sustained period of ischemia.23•24 
Figure 6 Relations between post-systolic segment shortening (PSS) measured at the end ofreperfusion 
and transmural infarct area expressed as a percent of the area at risk (IAlAR). Shown are data from the 
six experimental groups that underwent 60 min of total coronary artery occlusion (TCO) and the animals 
ihat were subjected to 90 min of70% flow reduction (FR) without 60 min TCO. In closed circles are 
shown the animals with AR greater or equal to 20% and in open circles are shown animals with 
AR<20%. Regression analysis of all animals showed a moderate but statistically significant correlation 
(FO.54, p<O.OOOl); analysis of the animals with AR greater or equal to 20% improved the correlation 
slightly further (c=O.63, p<O.OOO I). 
Also, a preliminary study in pigs reported that a single 5 min total coronary artery occlusion 
followed by 30 min of reperfusion reduced the incidence of ventricular fibrillation during a 
30 min occlusion." In contrast, we previously observed that a 10 min coronary artery 
occlusion and 15 min reperfusion was ineffective against ventricular fibrillation during the 60 
min coronary occlusion." An explanation for the different results in our study and that of 
Parratt and Vegh" is not readily found but could be due to a number of factors such as 
different durations of tile preconditioning stimulus and the intennittent reperfusion perinds and 
the areas at risk. In the present study a partial coronary artery occlusion immediately preceding 
the sutained period of ischemia (analogous to Harris' two-stage coronary artery occlusion)" 
significantly suppressed the occurrence of ventricular fibrillation provided that the duration 
and severity of flow reduction were sufficient. These fmdings are in agreement with earlier 
studies from our laboratory in partial flow reductions can decrease the incidence of ventricular 
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fibrillation during a sustained coronay artery occlusion." 
To study the effects of preconditioning on infarct size, a 60 min total coronary artery 
occlusion was used that resulted in significant myocardial necrosis. Since ventricular 
fibrillation during reperfusion in pigs occurs predominantly after occlusions of 10-30 min"'" 
these arrhythmias were rare in the present study. Consequently, the efficacy of preconditioning 
on fibrillation during reperfusion could not be assessed. 
Trallsmural Distributioll of Myocardialillfarct Size 
Relatioll Betweellinfarct Area alld Area at Risk ill COII/roi Allimals alld Allimals Subjected to 
Classical Precollditiollillg. 
In anesthetized and awake dogs, IA and AR (both expressed as percent of left ventricular 
mass) are linearly related with a positive intercept on the AR-axis. 21.28 In the present study we 
found a highly linear relation with a positive intercept on the AR-axis in both the endocardial 
and epicardial half of the left ventricle in pigs subjected to 60 min of total coronary artery 
occlusion. The reason for the positive intercept is incompletely understood, but it is possible 
that infarct size development in small areas at risk progresses less rapidly than in larger areas 
at risk. The intercept in dogs has been explained on the basis of progressive increases in 
collateral flow as the area at risk becomes smaller.21•28 This is an unlikely explanation in 
rabbits" and pigs" since these species lack significant coronary collateral circulation. 
Interestingly, the AR intercept in dogs is considerably higher in the epicardium than in the 
endocardium likely because collateral flow is highest in the outer layer." In contrast, we found 
similar intercepts in the inner and outer halves of the left ventricle, which correlates well with 
the transmurally homogeneous blood flow reductions distal to a total coronary artery occlusion 
in pigs.3l ,n 
In dogs myocardial infarction occurs preferentially in the subendocardial layers, due to the 
transmural gradient of collateral blood flow. But also in pigs, in which total coronary artery 
occlusions result in transmurally homogeneous blood flow reductions, infarction progresses 
from inner to outer layer"·33 possibly due to higher energy demands in the inner layers. In 
agreement with these fmdings we observed that for a given area at risk endocardial infarct area 
produced by 60 min total coronary artery occlusion was slightly larger than infarct area in the 
epicardial half of the left ventricle. 
In pigs that were preconditioned by a 10 min total coronary artery occlusion and by 15 min 
of reperfusion the relation between infarct area and area at risk was linear, with a similar AR-
intercept but with a lower slope of the relation than the animals in the control group. The 
decrease in slope was similar in the endo- and epicardium indicating that the protection 
afforded by the 10 min occlusion was identical in the inner and outer half of the left ventricle. 
Preconditioning with partial coronary artery occlusion 71 
Partial Coronary Artery Occlusion: Imparlance of SeverilY and Duralion of Flow Reduclion 
for Ihe Dislribution of Infarcl Size Limilalion. 
Recently, Ovize el al lO reported that moderate myocardial ischaemia in dogs caused by a 
50% reduction in myocardial blood flow lasting for 15 or 25 min failed to reduce infarct size 
during a subsequent 60 min TeO unless intermittent reperfusion was allowed. In contrast, 
infarct size could be limited by 30 min of 70% coronary flow reduction without intermittent 
reperfusion in pigs." The present study extends these ftndings and indicates that a paliial 
coronary artery occlusion can be as effective as the classical model in which preconditioning 
is elicited by a brief total occlusion separated from the sustained occlusion by a period of 
complete reperfusion. 
The magnitude of protection was not different between 30 min or 90 min exposure to the 
coronary flow reductions, but critically depended on the severity of the flow reduction. Thus, 
a 70% reduction of coronary flow preceding the 60 min of TeO reduced infarct size, whereas 
infarct size linlitation was not observed when the myocardium was ftrst subjected to 30% 
reduction in coronary aliery flow. The protection produced by the 30 min 70% flow reduction 
was not different between endo- and epicardium. However, when the duration of 70% flow 
reduction prior to the 60 min Teo was extended from 30 min to 90 min, infarct size limitation 
in the endocardial half was signiftcantly smaller than that in the epicardial half of the left 
ventricle. 90 min of 70% flow without the 60 min Teo produced larger infarct size in the 
endocardium than in the epicardium, which is likely associated with more severe flow 
reductions in the endo- than in the epicardium distal to a coronary artery stenosis. The 
magnitude of additional necrosis produced by the 60 min Teo was not different between 
endocardium and epicardium. Thus, the observation that 90 min of 70% flow reduction 
resulted in less infarct size reduction (compared to the control group) in the endocardium than 
in the epicardium was due to a greater degree of irreversible damage in the endocardium 
already produced by this duration of severe flow reduction. 
Ninety min of 30% flow reduction alone did not result in necrosis in either epi- or 
endocardium, whereas 90 min of 70% flow reduction produced necrosis in the endocardium 
but also in the epicardium. This suggests that the decrease in epicardial flow during 70% 
coronary artery flow reduction was more severe than the decrease in endocardial flow during 
30% coronary artery flow reduction. In the present study we did not measure the transmural 
distribution of myocardial blood flow. Previous studies, including from our laboratory, 
reported that a 70% coronary flow reduction in pigs is associated with approximately 80% 
reduction in blood flow to the inner half and approximately 60% reduction in blood flow to 
the outer half of the left ventricle. I..., In contrast, a 25-30% reduction in total myocardial flow 
resulted in approximately 20% flow reduction to the epicardial half and approximately 40% 
flow reduction to the endocardial half."·I3·I7·38 Thus, the epicardial flow deftcit during 70% 
coronary artery flow reduction was likely to be more severe than the endocardial flow deftcit 
associated with 30% flow reduction. 
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While ischemia was not severe enough to produce myocardial necrosis after 90 min, a 30% 
reduction coronary blood flow did result in ischemia as indicated by a 25 % decrease in systolic 
segment shortening. It is well established that metabolism of an ischemic segment changes 
continuously during a fixed reduction in coronary blood flow, while contractile function 
remains depressed. Studies from several laboratories, including our own, have shown that 
myocardial lactate production and effiux of potassium ions increase during the early period of 
a fixed flow reduction, but that there is a normalization of ischemia-induced metabolic changes 
as the hypoperfusion is prolonged.'4-" Specifically, a 30-40% coronary blood flow reduction 
in pigs produces metabolic abnormalities (increase in myocardial lactate content and production 
and a decrease in myocardial phosphocreatine levels) that reach a nadir at approximately 15 
min after the onset of flow reduction followed by significant recovery towards baseline within 
60 min."·"·" Thus, lack of necrosis after 90 min of 30% FR despite continuing myocardial 
hypoperfusion and hypofunction could be due to metabolic adaptations. The metabolic 
recovery also suggests that a period of 30% flow reduction in pigs lasting longer than 90 min 
is not likely to produce myocardial necrosis. 
The fmdings of the present study are compatible with the hypothesis that an ischemic 
stimulus can produce myocardial preconditioning only when the degree of ischemia per se is 
severe enough so that if the myocardium would be exposed long enough to the stimulus it 
would produce myocardial necrosis. Thus, a total coronary occlusion (requiring intermittent 
reperfusion) and a 70% coronary flow reduction protected the myocardium against a 
subsequent sustained ischemic insult. In contrast, when the degree of ischemia was too mild 
to produce myocardial necrosis, protection against myocardial infarction was absent. In view 
of the metabolic adaptations that have been described in response to prolonged periods of 30% 
flow reductions, the present study suggests that myocardial preconditioning and the metabolic 
adaptations to mild ischemia ("hibernation") have separate mechanisms as hibernation itself 
does not lead to infarct size limitation when the artery becomes subsequently totally occluded. 
An alternative explanation could be that preconditioning requires a threshold stimulus such as 
activation of protein kinase C which is thought to be the intracellular target for several 
mechanisms that can precondition the myocardium. 39•40 Thus, while the flow reduction itself 
may not reach the threshold level of stimulation, addition of another subthreshold stimulus 
(e.g. a low dose of a K+ ATr channel opener) could result in protection as the threshold stimulus 
for preconditoning is reached by the simultaneous presence of two stimuli. This hypothesis is 
supported by findings that both a 90 s coronary artery occlusion and a low dose of aprikalim 
failed to precondition the myocardium, but simultaneous exposure of the myocardium to the 
two stimuli resulted in a synergistic myocardial protection during a period of sustained 
ischemia." A threshold phenomenon would also explain why we previously observed that 
ischemic preconditioning in pigs is an all or nothing phenomenon.42 Thus, protection did not 
appear to be lost gradually as the duration of reperfusion between the preconditioning stimulus 
and the sustained occlusion was extended from 1 to 4 hours at one hour intervals. Ratller, 
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when the duration between the previous 10 min occlusion and the sustained occlusion in an 
individual animal was sufficient the animal was as effectively protecled as al 15 min after the 
10 min occlusion. However, when too much time had elapsed and the degree of stimulation 
decreased below the threshold level for that animal protection was abruptly and completely 
lost. 
Clinical Relevance 
Until recently, myocardial precondiloning was studied using brief total coronary artery 
occlusions followed by complete reperfusion. These abrupt total occlusion and reperfusion 
sequences are useful for the study of basic mechanisms of myocardial precondtioning bul do 
not reflect the clinical situation where patients with myocardial infarction often have significant 
coronary artery lesions associated wilh (transient) reductions in coronary blood flow. Study 
of the infarct size limiting effects of partial coronary artery occlusions may help to determine 
whether patients can benefil from preconditioning. The present study shows that a partial flow 
reduction can be a preconditioning stimulus that is as effective as the classical brief lotal 
occlusion and reperfusion sequence, provided thaI the severity of flow reduction is sufficient. 
Our data also suggest that mild flow reductions, even when sustained for a long perind of time, 
may not produce sufficient stimulation to precondition the myocardium. However, it is 
possible that the addition of another subUlfeshold stimulus, e.g. a low dose of a K+ ATP channel 
opener, could result in protection. Our findings may also have implications for interpretation 
of studies in which the effects of reperfusion therapy on infarct size are evaluated, as the 
myocardial perfusion status immediately preceding the coronary artery occlusion may be an 
important source of infarct size variability. 
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ABSTRACT 
Background. Rapid ventricular pacing reduces ventricular arrhytlmlias during a subsequent 
sustained perind of ischemia and reperfusion. We investigated whether rapid ventricular pacing 
also linlits myocardial infarction and determined tile role of myocardial ischemia and activation 
of K+ AT' channels in the protection afforded by ventricular pacing. 
Methods and Results. Myocardial infarction was produced by a 60 min coronary artery 
occlusion in open-chest pigs. Infarct size of pigs subjected to 10 min of ventricular pacing at 
200 beats per min followed by 15 min of normal sinus rhythm prior to the occlusion (83±2% 
of the area at risk, mean±SEM) was not different from control infarct size (85±2%). Thirty 
nlin pacing followed by 15 min sinus rhythm resulted in marginal albeit significant reductions 
in infarct size (72 ±2 %, p < 0.05 versus control). In contrast, 30 min pacing immediately 
preceding the occlusion without intervening sinus rhytlnn resulted in considerable linlitation 
of infarct size (62±4%, P< 0.05). The K+ AT' chanoel blocker glibenclamide abolished the 
protection by pacing (78 ± 5 %, P= NS). K+ AT' channel activation did not appear to involve 
ischenlia: (i) myocardial endolepi blood flow ratio was 1.07 ±0.08, (ii) phosphocreatine and 
ATP levels and arterial-coronary venous differences in pH and Peo, were unchanged, (iit) end-
systolic segment length did not increase and post-systolic shortening was not observed during 
pacing, and (iv) systolic shortening recovered immediately to baseline levels and coronary 
reactive hyperemia was absent following cessation of pacing. 
Conclusions. Ventricular pacing preconditioned myocardium via non~ischemic activation 
of K+ ATPchannels. 
INTRODUCTION 
Myocardial preconditiOlling can be induced by a variety of ischemic stimuli. Thus, one or 
more brief totall or partial" 3 coronary altery occlusions can limit infarct size produced by a 
sustained ischemic period. Moreover, infarct size can be limited by transient ischemia in 
adjacent myocardium' or even different organs.5•6 In all these studies a temporary interruption 
of oxygen supply either within or outside the myocardial region of interest was required to 
produce preconditioning. Recent studies suggest that non-ischemic stimuli may also 
precondition the myocardium. Thus, Ovize et aF reported that an increase in left ventricular 
wall stretch prnduced by acute volume overload protected the myocardium against infarction 
during a subsequent 60 min coronary artery occlusion. Also two consecutive 2 min periods of 
rapid ventricular pacing in open-chest dogs reduced the incidence of ventricular arrhythmias 
during and immediately following a subsequent 25 nlin coronary artery occlusion'. In contrast, 
Marber et ai' failed to show a protective effect of a single five min period of rapid atrial pacing 
against myocardial infarction in tile rabbit heart. To date no study has addressed the effect of 
rapid ventricular pacing on infarct size development produced by a sustained coronary artery 
occlusion. 
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In the present study we therefore investigated whether rapid ventricular pacing preceding 
a 60 min total coronary artery occlusion (60min TCO) altered infarct size development in 
open-chest pigs. In two groups of animals we studied the effects of either 10 min or 30 min 
of rapid ventricular pacing followed by 15 min of normal sinus rhythm on infarct size 
produced by 60min TCO, analogous to the classical preconditiouing model of a brief ischemic 
stimulus followed by reperfusion. In view of our earlier findings that ischemia produced by 
a partial coronary artery occlusion can precondition the myocardium without the need for 
intemlittent reperfusion', we also studied a third group of animals in which the 30 min rapid 
ventricular pacing period preceded the 60min TCO without normal sinus rhythm. If rapid 
ventricular pacing produces protection by inducing ischemia,s,1O protection is likely to be 
distributed heterogeneously across the left ventricular wall because ischemia would occur 
predominantly in the inner layers. Consequently, infarct size was also determined for the outer 
and hmer halves of the left ventricle. To explore the mechanism of preconditioning produced 
by rapid ventricular pacing, we investigated if ischemia occurred in animals subjected to 30 
min of rapid ventricular pacing followed by 180 min of normal sinus rhythm wirhour 60min 
TCO. Also, in view of evidence that ventricular pacing can activate ventricular K+ channels,'" 
, 12 and that activation of K+ ATPchanneis is cardioprotective in pigs, 13,14 we also studied the role 
of K+ AT' channels in preconditioning induced by rapid ventricular pacing. 
Methods 
All experiments were performed in accordance Witll the "Guiding principles in tlle care and 
use of animals" as approved by the Council of the American Physiological Society and under 
the regulations of the Animal Care Conunittee of the Erasmus University Rotterdam. 
Experimental Groups 
Studies were performed in a total of 46 pigs assigned to six experimental groups (Fig 1). 
In five groups, animals underwent a 60 luin total coronary artery occlusion (60min TCO) 
followed by 120 min of reperfusion. Eleven animals served as control and underwent only a 
single 60min TCO. Two groups of animals underwent a 60min TCO preceded by either 10 
min (n=4) or 30 ruin (n=6) of rapid left ventricular pacing (RVP) at 200 bpm and 15 min of 
normal sinus rhythm, In 18 animals the 60min TCO was preceded by 30min RVP at 200 bpm 
without an intermittent period of normal sinus rhythm; 7 of tllese animals were pretreated with 
glihenclamide (1 mglkg, iv) 10 min before the start of RVP. This dose of glibenclamide was 
chosen as it was previously shown to block preconditioning by a single 10 min coronary 
occlusion in pigs." In the latter two groups ventricular pacing was terminated immediately 
( < 10 s) following the start of the 60 min left anterior descending coronary artery (LADCA) 
ligation. To evaluate wether RVP produced myocardial ischemia, wall function in the 
distribution area of the LADCA, high energy phosphates, oxygen consumption and regional 
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Figure 1 Experimental groups in which the effect of rapid ventricular pacing on infarct size after a 
60 min total coronary artery occlusion was detennined. Filled bar = 60 min total coronary artery 
occlusion (60min TeO), hatched bar = rapid ventricular pacing (RVP). NSR = normal sinus rhythm, 
Rep = reperfusion, Glib = glibenelamid. (1 mglk, iv). 
myocardial blood flow were obtained in seven animals throughout a 30 min period of left 
ventricular pacing at 200 bpm followed by 180 min of normal sinus rhythm. 
Surgical procedure 
Domestic Yorkshire-Landrace pigs (25-35 kg, HVC, Hedel, The Netherlands) were sedated 
with ketamine (20 mg/kg, im), anesthetized with pentobarbital (25 mg/kg, iv) and instrumented 
for measurement of arterial and left ventricular pressure and control of arterial blood gases. 16 
Following administration ofpancuronium bromide (4 mg Lv., Organon Tekllika B.V., Boxtel, 
The Netherlands) and a midline thoracotomy, an electromagnetic flow probe (Skalar, Delft, 
The Netherlands) was placed around the ascending aorta to measure cardiac output (Fig 2). 
The left anterior descending coronary artery (LADCA) was dissected free from the 
surrounding tissue to allow placement of a microvascular clamp (groups 1-5) and a Doppler 
flow probe (Crystal Biotech Inc., Hopkinton, MD, U.S.A.) (groups 2-6). In the animals that 
underwent RVP an electrode was attached to the anteriolateral left ventricular wall close in the 
vicinity of the apex for stimulation of the myocardium by electrical monophasic stimuli with 
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Figure 2 Schematic presentation of the experimental model. The pacing electrode was inserted into 
the superficial layers of the anteriolateral wall of the left ventricle. Pairs of ultrasonic crystals were 
inserted into the mesocardiallayers of the left anterior descending coronary a rlery (LADCA) area and 
the left circumflex coronary artery (LCXCA) area. The LADCA was occluded at Ihe site of Ihe clamp 
causing the shaded area to become ischemic. The site of the clamp was varied in the control animals 
to create a range of areas at risk. LV = left ventricle, EM = electromagnetic, SL = segment length. 
an amplitude of 2 mA and a frequency of 3.33 Hz. A small cannula was inserted into the vein 
accompanying the LADCA for the withdrawal of local venous blood for the determination of 
blood gases. 
Regional Myocardial Function 
In all six groups, pairs of ultrasonic crystals (Sonotek Corporation, Del Mar, CA, USA) 
were positioned into the rnidmyocardiallayers of the left ventricle in the distribution areas of 
the LADCA and the left circumflex coronary artery (LCXCA) for the measurement of regional 
segment shorteniog by sonomicrometryl4·16 (friton Technology Inc., San Diego, CA, 
USA)(Fig 2). From the segment length tracings systolic segment length at the end of diastole 
(EDL, onset of positive ascending aortic flow) and the length at the end of systole (ESL, end 
of positive aortic flow) were determined and regional systolic segment shorteniog (SS) was 
computed as: 
SS(%) = 100' (EDL - ESL)/EDL, 
and post-systolic segment shortening (PSS) was calculated as: 
PSS(%) = 100 • (ESL - minimum segment length)/EDL. 
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Regional Myocardial Blood Flows 
In the animals of group 6 (Fig 1) we also investigated the effects of rapid ventricular pacing 
on the distribution of transmural myocardial blood flow. For this purpose, the left atrial 
appendage was cannulated for injection of 1-2 olO'microspheres, 15 ± 1 (SD) I'm in diameter 
(NEN Company, Dreieich, Germany), labelled with either "NB, lOlRu, lIlSn, "Sc or 141Ce. 
Processing of myocardial tissue samples and computation of blood flow data have been 
described earlier.t' 
IDgh Energy Phosphate Metabolism 
High energy phosphates were measured in transmural myocardial biopsies, taken with a 
Tm-Cut needle (Travenol Laboratories Inc., Deerfield, IL, USA) from the area perfused by 
the left circumflex coronary artery (LCXCA) at baseline and umnediately before the 60min 
TCO. This procedure allowed assessment of the effects of ventricular pacing on high energy 
phosphate metabolism without interfering with the infarct size determination in the area 
perfilsed by the LADCA. Biopsies were innnediately dipped into 0.9% NaCI at O'C to remove 
adherant blood, frozen in liquid nitrogen (within 10 s) and stored until analysis at -80'C. 
Adenine nucleotides (ATP, ADP, AMP), creatine (Cr) and creatine phosphate (CrP) were 
measured by isocratic ion-pairing high performance liquid chromatography as previously 
described. 13 From these measurements CrP/Cr and CrPI ATP ratios were calculated to estimate 
changes in oxidative phophorylation potential. Energy charge was calculated as ([ATP + 0.5 
ADP])/[ATP + ADP + AMPlY 
Experimental protocols 
After completion of the instmmentation, 5,000 I. U. of heparin were administered 
intravenously and a stabilization period of at least 30 min was allowed before baseline data 
were obtained of systemic hemodynamic variables, coronary blood flow and regional segment 
length changes. The animals were then subjected to one of the six study groups (Fig 1). In case 
of ventricular fibrillation defibrillation using DC countershocks (15-30 Watt) was started 
within 10 s. If defibrillation could not be accomplished within 2 min, animals were excluded 
from further study. Throughout the experunental protocol body core temperature was 
rigorously controlled with a heating pad to maintain temperature within a narrow range (37-
38'C) to minimize temperature-induced hrfarct size variability. 18.19 
In the anilnals of groups 3 and 6 arterial and coronary venous blood samples for the 
determination of oxygen content and pH were withdrawn at baseline, at 10 min and 30min 
RVP and at 2, 5 and 15 min of normal sinus rhytlun. In the animals of group 6 measurements 
were also made at 60, 120 and 180 min of normal sinus rhytlun. Myocardial biopsies for the 
measurement of high energy phosphate levels in the LCXCA perfused area were obtained at 
baseline and at 30min RVP. The effects of RVP on the distribution of myocardial blood flow 
were determuled in group 6 with radioactive microspheres at baseline and at 30min RVP. 
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Area at risk and infarct size 
Validation of the methods to determine the area at risk and infarct size has been described 
extensively. ".'0 Briefly, following reocclusion of the LADCA the area at risk was identified 
by an intra-artrial injection of 30 m1 of a 5 % (w/w) solution of fluorescein sodium (Sigma 
Chemical Co, St. Louis, USA). Ventricular fibrillation was then induced with a 9V battery and 
the heart was excised. Both atria, the right ventricular free wall and the left ventricular 
epicardial fat were removed. The left ventricle was filled with alginate impression material 
(BayerDental, Leverkusen, Germany), cooled in crushed ice and sliced parallel to the 
atrioventricular groove into 5 segments. The cut surface(s) of each segment and the demarcated 
areas at risk (AR) was (were) then traced on an acetate sheet under UV light. The viable 
myocardium was then stained deeply blue by incubating the segments for 20 min in 0.125 g 
para-nitrobluetetrazolium (Sigma Chemicals Co., St. Louis, USA) per liter of phosphate buffer 
(PH 7.1) at 37'C. The non-stained pale infarcted tissue was traced onto the acetate sheet. The 
surface of each ring was subdivided into an endocardial (inner) half and an epicardial (outer) 
half by drawing a line which divided the myocardial wall into only two layers of equal 
thickness. Division into two layers was done as it provides information on the transmural 
distribution of infarct size, yet preserving sufficient accuracy of infarct size determination in 
the two halves. Surface areas of the subendocardial and subepicardial halves, and of the 
subendocardial and subepicardial areas at risk and infarct areas (IA) were determined and 
averaged for the apical and basal side of each individual ring. The fraction of the ring that was 
infarcted and at risk were then multiplied by the weight of the ring to yield the weight of the 
area at risk and infarct area for that ring. Subsequently, the weights of the subendocardial and 
subepicardial halves and the total weight of each ring were summed to yield the LV'"d" LV,p' 
and total LV mass. The weights of the endocardial, epicardial and total areas at risk of each 
ring were summed to yield AR,""" AR,p' and total AR mass; the weights of the endocardial, 
epicardial and total infarct areas of each ring were added to yield IA,""" IA,pl and total IA 
mass. Endocardial, epicardial and total AR and IA data were expressed as a percentage of 
LV,""" LV,p' and total LV mass, respectively. 
Data analysis 
Infarct size data have been presented by plotting the IA against AR for the endocardial and 
epicardial half and for the whole left ventricular wall. Linear regression analysis was 
performed to determine the relation between endocardial and epicardial IA and AR in the 
control group. For all experimental groups individual infarct size data points are presented. 
Intergroup differences between lA,,,,,, IA"" or total IA were analyzed by analysis of covariance 
(ANCOVA), with AR,,,,,, AR,p' or total AR as covariate. When a significant effect was 
observed comparisons between individnal groups were made with ANCOV A followed by 
modified Bonferroni procedure to correct for multiple comparisons. Intragroup differences 
between lA,,,,, and IA,p' were analyzed using ANCOVA for repeated measurements, with 
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AR""" and AR"pl as covariates. The effect of rapid ventricular pacing on the incidence of 
ventricular fibrillation during 60min TCO was analyzed by Fisher's exact test. 
Hemodynamic and regional myocardial function data were analyzed by two-way ANOV A 
followed by either paired t-test (intragroup) or unpaired t-test (intergroup) with modified 
Bonferroni procedure to correct for multiple comparisons. A P value less than 0.05 was 
considered statistically significant (two-tailed). Data are presented as Mean ± SEM. 
Results 
Ventricular Fibrillation and Mortality 
In tile control group one animal was excluded because of unsuccessful defibrillation during 
the 60min TCO. All other animals that fibrillated were defibrillated successfully. Table 1 
shows that ventricular fibrillation occurred in 7 of the 11 control animals during the 60min 
TCO. The incidence of ventricular fibrillation in all groups that were subjected to rapid 
ventricular pacing before the 60min TCO (groups 2-5) was not significantly different from the 
control group indicating tlmt in this model RVP did not protect against ventricular fibrillation 
during the subsequent coronary artery occlusion. Ventricular fibrillation was rare when 
reperfusion was reinstated which is in agreement with previous observations that in pigs 
ventricular fibrillation during reperfusion occurs predominantly following 1O-30.Din coronary 
artery occlusions. 21 
Table 1. Ventricular fibrillation 
Experimental groups 60 min TCO Reperfusion 
Control 7(11 )' 1(10)' 
10 min RVP + 15 NSR + 60 min TCO 1(4) 0(4) 
30 min RVP + 15 NSR + 60 min TCO 4(6) 0(6) 
30 min RVP + 60 min TCO 6(11) 0(11) 
Glib + 30 min RVP +60minTCO 2(7) 0(7) 
In parentheses the total number of animals per group at the onset of each intervention is indicated. Teo 
"'" Total coronalY artery occlusion; RVP = rapid ventricular pacing at 200 beats per minute; NSR = 
normal sinus rhythm; Glib = Glibenclamide I rug/kg Lv. as a bolus 10 min prior to the onset of RVP; 0 
one pig fibrillated during both 60 min Teo and Reperfusion 
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Figure 3 Effects of rapid ventricular pacing on the transmural, endocardial and epicardial relations 
between infarct area (IA) and area at risk (AR). Shown are the relations in the control group (60 min 
of total coronary artery occlusion, 600lin TeO) and animals subjected to either 10 or 30 min of rapid 
ventricular pacing (RVP) separated from the 60min TeO by IS min of normal sinus rhythm (15min 
NSR). Note that while lOmin RVP had no effect on transmural infarct size (F~0.6, P~NS), 30min 
RVP produced a small, but statistically significant decreases in transmural infarct size (F= 13.3, 
P<0.005). This was due to a selective reduction in epicardial infarct size (F~11.4, P<O.OI), as 
endocardial infarct size was not significantly altered (F~3.4, P~NS). NS~not significant. 
Infarct Area - Area at Risk Relation 
Mean areas at risk (expressed as percentage of left ventricular mass) for the five 
experimental groups of animals which underwent the 60min TeO were not different from each 
other (34±2%, 34±2%, 37±2%, 31±2% and 31±3% for groups 1,2,3,4 and 5, 
respectively; F~ 1.0, P~0.41). 
In the 10 control animals transmural infarct area was linearly related with the area at risk 
(r=O.92, P<O.OOI; Fig 3). Separation of the left ventricular wall into two layers of equal 
thickness revealed a highly linear relation' in both endocardial half (r=0.91, P<O.OOI) and 
epicardial half (r=0.88, P<O.OOI) of the left ventricle. Ten min of RVP, separated from the 
60min TeO by a IS min period of normal sinus rhythm, failed to reduce transmural, epicardial 
and endocardial infarct size compared to the control group (Fig 3). When the 
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Figure 4 Bffects of rapid ventricular pacing on the transmural, endocardial and epicardial relations 
between infarct area (IA) and area at risk (AR). In lhe top panels are shown lhe control animals (60 
min of total coronary artery occlusion, 60min TeO) and the animals subjected to 30 min of rapid 
ventricular pacing (RVP) immedialely preceding the 60min TeO. 30min RVP produced significant 
reductions in transmural (F= 19.1, P<O.OOI), epicardial (F= 15.7, P<0.OO5) and endocardial 
(F= 13.8, P<0.005) Infarct size. The lower panels illustrate that pretreatment with glibenclamide 
(Glib, 1 mg/kg, intravenous) prevented the protective effects of rapid ventricular pacing. NS=not 
significant. 
period of rapid venticular pacing was extended to 30 min, infarct size in the endocardial half 
was again not significantly different from tilat in the control group (F=3.4, P=0.09), but now 
small albeit statistically significant reductions in epicardial (F= 11.4, P< 0.01) and transmural 
(F= 13.3, P<0.005) infarct size were observed (Fig 3). In this group of animals the 
transmural IAIAR ratio was also significantly lower than that in the control group (72±2% 
versus 85±2%, P<O.OI). 
The transmural IA in eight of the eleven animals that underwent 30min RVP immediately 
followed by 60min TCO was located well below the regression line describing the relation 
between IA and AR in the control group (Fig 4). The IAI AR of this group of animals was 
62±4% (P<O.Ol versus control group). ANCOVA showed that 30min RVP immediately 
followed by 60min TCO significantly reduced infarcted area for a given area at risk compared 
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to the control group (F=19.1, P<0.OOO5). Further analysis indicated that the infarct size 
reduction was not different hetween suhepicardium and subendocardium (Fig 4). Pretreatment 
with glihenclamide abolished the protective effect of 30min RVP in both the endocardial and 
epicardial halves (Figs 4). This is further illustrated by the IAJAR ratio which was 78±5% 
(P=NS versus control group and P<0.05 versus 30min RVP + 60min TCO). 
Hemodynamic Responses to Rapid Ventricnlar Pacing and Total Coronary Artery 
Occlusion (Groups 1-5) 
In the five groups that underwent 60min TCO (groups 1-5), there were no significant 
differences between heart rate (108±3 bpm, n=38), mean aortic pressure (85±1 mmHg), 
cardiac output (2.8±0.1 Llmin), LVdP/dtmu (191O±100 mmHg/s) or LV end-diastolic 
pressure (9± 1 mmHg) at baseline. Rapid ventricular pacing in groups 2,3 and 4 was 
associated with innnediate decreases in mean arterial blood pressure (38±3 %), cardiac output 
(41 ±2 %) and stroke volume (69 ±2 %), while systemic vascular resistance, left ventricular end 
diastolic pressure and LVdP/dt=, remained unchanged. This hemodynamic profile was 
maintained during the remainder of the ventricular pacing period and was not different hetween 
the three groups. In the animals of groups 2 and 3, in which pacing was terminated without 
an inunediate occlusion of the LADCA, all variables returned to baseline within 1 min of 
normal sinus rhythm except for heart rate which remained slightly (-15 bpm) elevated during 
the 15 min following cessation of ventricular pacing. In groups 1-4 (n=31), total coronary 
artery occlusion resulted in decreases in cardiac output (15±3%) and increments in heart rate 
(15±4%) and LV end-diastolic pressure (37±8%) compared to baseline values (all P<0.05), 
with no significant decrease in mean aortic pressure (4±3%); these responses were not 
different between the four groups. None of the hemodynamic variables recovered significantly 
toward baseline levels during 120 min of reperfusion. 
Glihenclamide produced modest increments in left ventricular end-diastolic pressure from 
9±1 to 11±3 mmHg (P<0.05) and mean aortic pressure from 84±3 to 95±4 nmlHg 
(P=0.055). The latter was due to systemic vasoconstriction as cardiac output was not altered 
by the K+ ATPchannel blocker. Glibenclamide had no effect on LADCA blood flow, LADCA 
vascular resistance or systolic segment shortening in the LADCA perfused segment. 
Pretreatment with glibenclamide enhanced the pacing-induced decreases in mean aortic 
pressure (56±4%), cardiac output (62±3%), and coronary blood flow (40±6%) but had no 
effect on hemodynamic changes produced by 60min TCO. 
Effect of Rapid Ventricular Paciug on Myocardial Performance (Groups 3 and 6) 
Rapid ventricular pacing in groups 3 and 6 was associated with inullediate decreases in 
mean arterial blood pressure and cardiac output and hence myocardial work, wlrile LVdP/dt"." 
systemic vascular resistance, and left ventricular end diastolic pressure were 
TABLE 2. Systemic hemodynamics at baseline, during 30 minutes of rapid ventricular pacing and during subsequent 15 min of nonnal sinus rhytinn. 
Variable 
HR. 
CO 
SV 
MAP 
SVR 
LVdP/dt,,~ 
LVEDP 
MW 
Baseline 
108±4 
2.8± 02 
26±2 
83±2 
31 ± 1 
1780±130 
9±1 
231± 12 
Rapid Ventricular Pacing 
(min) 
10 30 0.5 
200± O' 200± 0" 137 ± 4* 
1.8±0.1" 1.9±0.1* 3.1 ±02 
9± I' 9± 1* 23 ± 1 
55±3* 61 ±2* 94±4' 
31 ±2 33±2 32±3 
1980 ± 220 2010 ± 160 1770± 150 
7±1 8±1 8±1 
102±9* 116 ± 9' 294±2S* 
Normal Sinns Rhythm (min) 
1 2 5 15 
133 ±3* 132±3* 126±3* 119 ± 3" 
3.2 ± 0.3 3.1 ± 0.1 2.9 ± 0.1 2.6±O.1 
24±2 23±1 23 ± I' 22± 1* 
97±4" 97±3* 93±2* 84±2 
32±4 31 ± 1 33 ± I 33 ± 1 
1820 ± 130 1840 ± 100 1910 ± 160 1600 ± 140 
8±1 8±1 8±1 8±1 
312±30" 302 ± 14* 271 ± 12" 218 ± 10 
HR ~ heart rate (bpm); CO ~ cardiac output (L/min); SV = stroke volume (ml); MAP = mean arterial pressure (mmHg); SVR = systemic vascular resistance 
(mmHglI./min); LVdP/dt",.. = maximum rise in left ventricular pressure (mmHgts); L VEDP = left ventricular end diastolic blood pressure (mmHg); MW = myocardial 
work, MAP-CO (mmHg-Umin). 
Data are mean±SEM, n=13; * P<O.05 vs baseline. 
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maintained (Table 2). Thirty min of rapid ventricular pacing decreased coronary blood flow 
by 20±5% (n= 13) accompanied by a small increase in myocardial oxygen extraction from 
72±2 % to 76±2 % (P<0.05, Table 3). Oxygen consumption per gram of myocardium 
tended to decrease during RVP, but this failed to reach levels of statistical significances. 
Microsphere data revealed that the subendocardial to subepicardial blood flow ratio at 30min 
RVP was maintained well above unity (1.07±0.08, n=6) although absolute levels were 
slightly lower than at baseline (1.23±0.07) (P<0.05). Coronary vascular resistance 
(calculated as mean arterial pressure divided by coronary blood flow per g of myocardium) was 
also maintained during pacing. Fractional systolic shortening decreased markedly in both the 
LADCA and the LCXCA perfused segments. However, this was due to a marked decrease in 
end-diastolic length of both the LADCA (17±1%) and the LCXCA (15±2%) perfused 
segments as end-systolic length of both LADCA (4 ± I %) and LCXCA (5 ± 1%) segments 
decreased slightly (Table 3). Furthennore the decrease in systolic shortening during RVP was 
not accompanied by the appearance of post-systolic shortening. Throughout the pacing protocol 
the arterial-coronary venous differences in pH (0.04±0.01 and 0.04±0.01 at baseline and 
30min RVP, respectively) and in pCO,(11.4±0.5 mmHg and 10.2±0.9 mmHg at baseline and 
30min RVP, respectively) were maintained. In further support of aerobic metabolism we also 
did not observe decreases in ATP levels (36.3±1.4I'mol/g protein at baseline vs 36.5±1.4 
I'mollg protein at 30min RVP), CrP/Cr ratio (1.24±0.12 vs 1.36±0.12), CrP/ATP ratio 
(1.52±0.26 vs 1.65±0.29) or energy charge (0.922±0.OO3 vs 0.924 ±0.OO3), at 30min RVP 
versus baseline, respectively. 
iJrunediately after RVP was stopped systemic hemodynamic variables recovered to baseline 
values except for heart rate which remained slightly elevated following restoration to normal 
sinus rhythm. Mean aortic pressure increased to levels slightly higher than baseline during the 
first minute but had recovered to baseline levels at 15 min after cessation of rapid ventricular 
pacing. During the first lninute of post-pacing systolic shortening in both the LADCA and 
LCXCA perfused segments recovered to baseline values, although this was followed by a slight 
decrease in systolic thickening in the LCXCA area during the remainder of the protocol. 
Because reactive hyperemia was also absent these findings indicate that 30min RVP was not 
associated with myocardial ischemia. 
Discussion 
The present study has yielded several important findings: I) infarct size after 60 min 
coronary artery occlusion is limited when the occlusion is immediately preceded by a period 
of rapid ventricular pacing. 2) In contrast, when the period of rapid ventricular pacing was 
separated from the 60 min total coronary artery occlusion period by 15 min of normal sinus 
TABLE 3. Regional myocardial performance at baseline, during and following 30 minutes of rapid ventricular pacing and during subsequent 15 min of normal 
sinus rhythm. 
Variable Rapid VentricWar Pacing Normal Sinns Rhythm (min) 
Baseline (min) 
10 30 0.5 1 2 5 15 
LADCA 
CBF 1.73 ± 0.18 1.47± 0.16 1.38 ± 0.18* 1.93 ± 0.21 1.91 ± 0.21 1.77 ± 0.20 1.70± 0.20 1.58 ± 0.21 
CVR O.SS ± 0.06 0.47 ± 0.08 0.52 ± 0.06 0.54 ± O.OS 0.56 ± 0.06 0.61 ± 0.06 0.62± 0.06 0.62 ± 0.06 
cvP02 23.8±0.8 22.2±0.9 23.1±I.S 26.7±1.6* 24.8±L1 23.5±0.8 
O2 extraction 72±2 76±2* 76±2* 68±4 71±2 73±1 
MVO, 6.84 ± 0.78 6.16 ± 0.73 6.01 ± 0.87 6.47±0.90 6.93 ± 0.87 6.62± 1.02 
EDL 9.50±0.23 7.88±O.18* 7.89±O.21* 9.86±0.26 9.87±0.24 9.71±0.21 9.59±0.20 934±O.22 
ESL 7.96±0.20 7.72±O.17* 7.70±0.19* 833±0.24 8.22±0.21 8.19±0.17* 8.07±O.16 7.96±O.17 
SS(%) 16.2 ± 0.9 2.8± 1.2* 2.5 ± 104* 14.8 ± 0.8 IS.8 ± 0.9 IS.6± 0.7 IS.8 ± 0.5 14.8± 0.8 
PSS(%) 1.3±0.6 0.6 ± 004 0.8 ± 0.5 33 ± 0.9 2A± 0.6 2.1 ± O.S 2.3 ± 0.7* L4± 0.5 
LCXCA 
EDL IO.87±03S 9.19±0.41* 9.16±0.39* 10.86±O.44 10.8S±O.49 10.79±038 10.73±0.36 10.58±O36* 
ESL 931±0.32 8.70±0.38* 8.71±0.31* 9.43±0.46 9.61±OA8 9.54±033* 9.43±0.32* 937±O31 
SS (%) 14.8 ± 1.5 9.7 ± 204* 9.8±23* 12.7± 1.6 12.9± 1.5 10.8±1.3* 12.1 ± 1.3' 1I.6± 1.2* 
PSS (%) 0.7 ± 004 0.2 ± 0.2 0.1 ± 0.1 0.4 ± 0.2 0.6 ± OJ 0.6 ± 0.2 0.4± 0.2 0.4 ± 0.2 
LADCA = left anterior descending coronary artery; LCXCA = left circumflex coronary artery; CSF = coronary blood flow (ml_min·1_g-1); CVR = coronary vascular 
resistance (lllIllHg-ml·'·min·g); ""PO, ~ cororuuy venous partial 0, pressure (mmHg); 0, extraction ~ 0, extraction of the LADCA area (% of arterial O2 content); MV02 
~ O,·consumption of the LADCA area (!'I·min·'·g·'); EDL~ end diastolic segment length (mm); ESL~ end systolic segment length (mm); SS ~ segment shortening; 
PSS = post-systolic segment shortening. 
Data are mean±SEM, n=13; * P<O.05 vs baseline. 
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rhytlun the protective effect of rapid ventricular pacing was nearly completely lost. 3) 
pretreatment wilh glibenclamide abolished the protective effect of rapid ventricular pacing 
suggesting the involvement of activation ofK+ATPchannels in the preconditioning and 4) the 
pacing-induced activation of K+ ATPchanneis was not due to myocardial ischemia. 
The protection afforded by rapid ventricular pacing against irreversible myocardial damage 
produced by a sustained period of ischemia was reversed by glibenclamide indicating that 
K+ ATPchanneis mediate, at least in part, the protective mechanism of rapid ventricular pacing. 
Since K+ ATPchannel blockade inhibits ischemic preconditioning in several species including 
rabbits," dogs" and swine, IS.24 it could be hypothesized that ventricular pacing produced 
preconditioning via induction of myocardial ischemia. In support of this hypothesis Vegh et 
ai' and Szilvassy et apo reported that ventricular pacing produced myocardial ischemia as 
judged from myocardial ST-segment elevation. In contrast, in the open-chest pig model used 
in the present study we failed to observe evidence of myocardial ischemia during rapid 
ventricular pacing at 200 bpm: (I) transmural myocardial blood flow during rapid ventricular 
pacing remained equally distributed across the inner and outer layers of the left ventricular 
wall, (i/) the decrease in systolic shortening was entirely due to a decrease in end-diastolic 
length, not an increase in end-systolic length, (iiI) development of post systolic shortening was 
not observed," and (iv) no changes were observed in myocardial ATP and phosphocreatine 
levels, energy charge and arterial or coronary venous pH levels." Furthermore, following 
restoration to normal sinus rhytlun evidence for myocardial ischemia during the preceding 
period of rapid ventricular pacing was also absent because (v) reactive hyperemia did not 
occur, (vi) coronary venous oxygen tension was minimally affected following restoration to 
normal sinus rhytlun, (vii) systolic segment shortening recovered instantaneously to baseline 
levels at which it was maintained tlu'oughout the subsequent 180 min normal sinus rhytlun 
period and (viiI) there was no sustained post-systolic shortening during normal sinus rhytlun 
suggesting that post-ischemic myocardial stunning did not occur. These fmdings fail to support 
the occurrence of significant myocardial ischemia in the present study. Although we cannot 
entirely exclude the occurrence of subtle subendocardial ischemia, this certainly would have 
been insufficient to induce ischemic preconditioning as Ovize et al. 2 have shown that a 25 min 
50% flow reduction immediately preceding a 60 min total coronary artery occlusion (resulting 
in total loss of contractile function in the area perfilSed by the partially occluded coronary 
artery) failed to limit infarct size. In addition, we recently observed that 30 or 90 min periods 
of 30% coronary blood flow reduction, associated wilh a 25% decrease in systolic segment 
shortening (due to an increase in end-systolic length), did not protect the myocardium against 
infarction produced by 60 min of total coronary artery occlusion inunediately following the 
30% flow reduction (unpublished data from our laboratory). Therefore if some endocardial 
might have gone undetected it is highly unlikely that this was responsible for the protective 
effect produced by rapid ventricular pacing. 
AltllOUgh the exact mechanism ofK+ ATPchannel activation by ventricular pacing cannot be 
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determined from the present study, there is ample evidence that ventricular pacing is capable 
of activating transient outward K+ currents. Thus, Geller and Rosen12 observed that an increase 
in electric activation rate of canine ventricular slabs from 90 to 130 pulses per min shortened 
the action potential. The action potential shortening persisted for several min after the 
activation rate was lowered to 90 pulses per min, indicative of myocardial "memory" for the 
activation stimulus. The persistent shortening of the action potential could be antagonized by 
blockade of the transient outward K+ current. Although tile specific role of K+ ATPchannels was 
not investigated in that sn.dy, our findings that after 15 min after cessation of 30 min of rapid 
ventricular pacing a small but statistically significant reduction in infarct size occurred, suggest 
that K+ ATP channel activation by ventricular pacing may also display memory. Interestingly, 
Geller and Rosen" reported that cardiac memory in isolated slabs of canine ventricular 
myocardium was only produced when tile activation sequence was abnormal (stimulation from 
the lateral side of the preparation, i.e. perpendicular to the fiber axis, mimicking ventricular 
pacing ") but not when the activation sequence was normal (stimulation from the basal end of 
the preparation in the direction of the fibers, mimicking atrial pacing). This could explain why 
Marber et aI' failed to observe a protective effect of 5 min of atrial pacing followed by 10 min 
of normal sinus rhythm on myocardial infarci size in rabbit hearts. 
Ventricular pacing afforded myocardial protection which was slightly greater in the 
epicardial half than in the endocardial half when pacing was followed immediately by the 60 
min coronary artery occlusion. In addition, protection was marginal in the subepicardium but 
absent in the subendocardium when a 15 min period of normal sinus rhythm was allowed 
between tile pacing period and the sustained occlusion. There is evidence that the K+ channels 
are heterogeneously distributed across the left ventricular wall. Geller and Rosen" reported 
that transient outward repolarizing K + currents in the epicardium increased more than in the 
endocardium during altered myocardial activation sequence. Also, Litovsky and Antzelevitch27 
reported that acetylcholine sensitive K+ channels are present in the epicardium but not in the 
endocardium. The distribution of K+ ATPchannels is presently unknown, but our findings that 
30 min of rapid ventricular pacing followed immediately by a sustained period of ischemia 
limited infarct size in both endo- and epicardium indicate that ventricular pacing can stinrulate 
both endocardial and epicardial K + ATPchannels. Following cessation of pacing the protective 
effect appeared to be lost more rapidly in the endocardium than in the epicardium. There is 
evidence that exposure of the myocardium to repeated periods of ventricular pacing 
progressively prolongs cardiac memory. II It is thus possible that repeated bouts of rapid 
ventricular pacing in pigs could have resulted in greater infarct size limitation compared to a 
single episode when pacing was separated by 15 min from the sustained coronary artery 
occlusion. 
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Conclusions 
Thirty min of rapid ventricular pacing decreased myocardial infarct size produced by a 60 
min total coronary artery occlusion in open-chest pigs. The magnitude of protection was 
greatest when the period of ventrieular pacing iImnediately preceded the sustained period of 
ischemia, as the protection was nearly completely lost when 15 min of normal sinus rhythm 
separated the rapid ventricular pacing period from Ole sustained occlusion. The protective 
effect of pacing was abolished by K+ ATP channel blockade iIldieating that K+ ATP channel 
activation is involved in the mechanism of protection. Since we failed to observe significant 
myocardial ischemia during rapid ventricular pacing, it appears that K + ATP channel activation 
was produced via a non-ischemic mechanism, possibly an alteration in ventricular activation 
sequence. 
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Introduction 
Some fifteen years ago several groups of investigators paid considerable attention to the 
reproducibility of metabolic and functional changes in animal models of repeated reversible 
ischemia. If reproducible, these models could then be used for the evaluation of 
pharmacological interventions with the animals serving as their own control. The results were 
raO,er disappointing, however. For instance, we found Omt myocardial lactate production and 
ATP breakdown were much less during the second of two periods of ischemia produced by 
identical coronary flow reductions, which were separated by 40 min of complete reperfusion 
[1]. Also in patients undergoing a cardiac caOleterization for suspected coronary artery disease, 
myocardial lactate production and inosine release was less during the second of two identical 
atrial pacing stress tests [2,3]. In addition to these functional and metabolic parameters the 
incidence of ventricular arrhythmias during occlusion and early reperfusion also proved to be 
less during the later occlusion-reperfusion sequences. From these and many oOler observations 
it has become clear that adaptive processes occur in models of repeated reversible ischemia, 
but the mechanism(s) leading to these adaptations were not further investigated at that time 
[4,5]. 
Less than a decade ago Murry el al reported Olat infarct size was 29% in dogs subjected to 
a 40 min coronary artery occlusion but only 7% when the 40 min occlusion was preceded by 
4 cycles of 5 min coronary artery occlusion and 5 min of reperfusion [6]. The protective effect 
of these brief periods of myocardial ischemia on development of infarct size during a sustained 
coronary artery occlusion was tenned "ischemic preconditioning" and has now been confirmed 
in a large number of other laboratory animals [7] including pigs [8], rabbits [9] and rats [10]. 
Protection by preconditioning has not only been connected with infarct size lintitation but 
also with enhanced recovery of regional cardiac contractile function and anti-arrhythmic 
activity. For instance, Cave and Hearse have shown that in globally ischemic isolated rat 
hearts recovery of contractile function is enhanced when these hearts are preconditioned by 
brief episodes of global ischemia [11]. Furthermore, the number of ventricular arrhytlnnias, 
and more importantly Ole incidence of ventricular fibrillation, is reduced in preconditioned rats 
during a sustained coronary artery occlusion and reperfusion [12-14]. Because the incidence 
of reperfusion arrhythnlias is highest after coronary artery occlusions lasting between 10 and 
30 min, which are too short to lead to infarction, the effect of ischemic preconditioning on 
infarct size versus its effect on reperfusion arrhythmias and recovery of contractile function 
is usually studied in separate models. In contrast to the effect on infarct size, the anti-
arrhythnlic component of preconditiOlting has been demonstrated primarily in the rat. 
However, in other animal species this aspect of ischemic preconditiOlting appears to be less 
effective [4,6]. 
In this overview we will restrict the experimental evidence of the protective effect of 
preconditioning to infarct size lintitation and outline the problems that exist in obtaining 
clinical evidence for tills phenomenon. However, clinical studies, exclusively dealing with 
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aspects of preconditioning in models of reversible ischelnia will be discussed. The limitations 
in applying the results of these studies as evidence for protection against irreversible damage 
will be emphasized. Finally, we will address the possibilities that preconditioning can be 
exploited in man. 
Features of experimental studies on ischemic preconditioning with infarct size as endpoint 
There are four distinct phases in ischemic preconditioning experiments (Fig. I), which can 
be characterized as (i) the preconditioning stimulus, (ii) the intervening reperfusion period, (iii) 
the sustained coronary artery occlusion, which is followed by (iv) a sustained reperfusion 
period at the end of which the anatomical area at risk and infarcted area are determined. 
Important features of each of these phases have been summarized in Table I and will be 
discussed briefly below [6-9, IS-55). 
Scheme for preconditioning experiments 
Preconditioning Sustained Infarot size 
stimulus coronary artery determination 
I Intervening occlusion I (reperfuslon) j Sustained period reperfuslon 1 1 
r0/;%I /;/ // ~/ 
Figure 1 Scheme depicting the five different phases in experimental preconditioning protocols. In 
table 1 several of the characteristics of these phases have been tabulated. 
171e precollditiollillg stimulus 
Single or mUltiple brief total coronary artery occlusions varying from 2 to 10 min in 
duration have been used to precondition the myocardium. The minimum stimulus to elicit 
preconditioning is not sharply defined and may depend on the species. Ovize et al reported 
that a 2.5 min left circumflex coronary artery occlusion was already sufficient to precondition 
the myocardium [IS). Li et al have shown that in dogs a single 5 min coronary artery 
occlusion followed by 10 min of reperfusion was as effective as 12 sequences of 5 min 
occlusion and 10 min of reperfusion [16).However, two different subthreshold stimuli can 
produce preconditioning. Thus, Yao and Gmss reported that while a brief coronary artery 
occlusion and low dose of the K+ ATP channel activator Bimakalinl (see mechanisms) had no 
effect on infarct size when given separately, combined administration of these stimuli in dogs 
resulted in significant infarct size limitation [40). Not only total coronary artery occlusions, 
but clinically even more relevant, also partial coronary artery occlusions can precondition the 
Table 1. Features of preconditioning experiments with infarct size as endpoint. 
Preconditioning stimulus 
Ischemic 
single or multiple total coronary artery occlusions lasting from 2 to 10 min (supply 
ischemia) [6-9, 15-18] 
severe partial coronary artery occlusions (supply ischemia) [19-21] 
moderate partial coronary artery occlusions + adrenergic stimulation (demand 
ischemia) [22] 
moderate fIXed stenosis + endothelial injury [23] 
NOIl~ischemic 
heat stress (heat shock proteins) [24, 25] 
brief total occlusion of coronary artery supplying adjacent myocardium (remote 
preconditioning) [26] 
left ventricular volume loading [27] 
rapid ventricular pacing [28] 
trausient hypoxia [29] 
transient occlusion of renal artery? (remote preconditioning) [30, 31] 
Pharmacological substances 
K+ AT' channel openers [32-34], adenosine [35, 36], Protein kinase C activators [37-
39] 
decreased threshold for ischemic preconditioning by subthreshold K+ ATPchannel 
activation [40] 
Illtervelllllg (reperjusioll) period 
mandatory following total occlusion (self evident) 
1 min - 2 hours first window of protection [6, 17,41-44] 
24 hours - ? second window of protection [45, 46] 
not necessary following severe partial occlusions [20, 21] 
not necessary following rapid ventricular pacing [28] 
Sustained coronary artery occlusion 
- duration limited from 30 min to 90 min (species specific) [6, 47] 
Sustained reperfusion 
- mandatory following the sustained coronary artery occlusion (self evident) 
Infarct size detennination 
area at risk determination (ifl~V/VO by negative staining fluoresceine, Evans blue etc.) 
infarct area determination ex vivo with histochemistry Tetrazolium staining after 
reperfusion of at least 90 min [48] 
infarct size expressed as percentage of the area at risk is a reliable index only for 
areas at risk larger than 20% of the left ventricular mass [28, 49-51] 
Other aspects of precollditlolllllg 
controversy about the loss of the protective effect of preconditioning during first 
window (gradual decrease or "all or nothing" phenomenon) [43, 44, 52] 
different endo~ and epicardial distribution of the protective effect due to the different 
time course of the development of infarction in the endo~ and epicardial regions [21] 
preconditioning can he reinstated after the protection is lost [42, 53] 
tolerance develops with chronically applied preconditioning stimuli [54] 
preconditioning has been demonstrated in hypertrophic hearts [55] 
preconditioning has been shown in awake as well as anaesthetized animals [54] 
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myocardium [19-21]. It appears, however, that the flow reduction must be sufficiently large 
(approximately 50%) to produce preconditioning. 
While most investigators have used an impaired blood supply to induce preconditioning, 
Iwamoto et al reported that preconditioning can also be obtained without a reduction in 
absolute supply [22]. This group of investigators showed that when myocardial oxygen demand 
was augmented by stimulation of the left stellate cardiac nerve, the myocardium became 
preconditioned when the accompanying increase in coronary blood flow was prevented. When 
the flow was allowed to increase, thereby leaving the myocardial oxygen supply demand 
balance intact, the increase in adrenergic activity did not trigger cardioprotection. These data 
are consistent witll the observations by Marber et al who failed to observe limitation of infarct 
size when rabbits hearts were subjected to 5 min of rapid atrial pacing [56]. 
In the "classical" ischemic preconditioning studies the myocardium is subjected to a brief 
period of ischemia before the infarct is produced. However, there is evidence that the 
myocardium can also be preconditioned by ischemia in a remote region of the left ventricle or 
forms of stress that do not cause ischemia. Thus, Przyklenk et al reported that a brief total 
coronary artery occlusion preconditions not only the myocardium within its perfusion territory 
but also protects the myocardium outside its territory representing an example of remote 
ischemic preconditioning [26]. Another example of remote ischemic preconditioning is the 
reduction in myocardial infarct size, which is observed when a renal artery is transiently 
occluded prior to the coronary artery occlusion [30, 31]. Ovize et al [27] described that 
stretching the myocardium by volume loading reduces infarct size during a subsequent 
coronary artery occlusion via a mechanism not involving ischemia. Their observations could 
provide an explanation for the remote ischemic preconditioning as severe regional ischemic 
contractile dysfunction leads to stretching of the adjacent non-ischemic myocardium [26]. In 
our laboratory we have shown that 30 min of rapid ventricular pacing at 200 beats min' I 
lunited infarct size during a subsequent 60 min coronary artery occlusion [28]. The effect was 
most pronounced when no intervening period of normal sinus rhythm was used between the 
ventricular pacing period and the sustained coronary artery occlusion. The protection by 
ventricular pacing did not involve ischelnia as in a separate series of experiments it was shown 
that high energy phosphates were not depleted during the ventricular pacing period, while 
systolic segment shortening recovered immediately (no stunning) and reactive hyperemia was 
absent after ventricular pacing was terminated. The mechanism by which ventricular pacing 
protected the myocardium likely involved activation of K+ AT' channels as pretreatment with 
the K+ ATP channel inhibitor glibenclarnide prevented the protection by ventricular pacing. That 
not all forms of stress are capable of preconditioning the myocardium is suggested by the 
studies employing left stellate cardiac nerve stimulation or atrial pacing as preconditioning 
stimuli [22,56]. Interestingly, Zhu et af even reported an increase in infarct size when rats had 
been chronically exposed to cigarette smoke [57]. 
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The intervefling reperfusion period 
When myocardium is preconditioned with a total coronary artery occlusion, it is self evident 
that an intervening reperfusion period is mandatory as otherwise the period of sustained 
ischemia would merely be increased. It is still unclear what minimal duration of reperfusion 
is required, but 1 to 2 minutes of complete reperfusion between the preconditioning stimulus 
and the sustained coronary artery occlusion may well be sufficient to trigger myocardial 
preconditioning [41]. With respect to the maximum length of the intervening reperfusion 
period, it is now clear that ischemic preconditioning is a transient phenomenon. Thus, with 
reperfusion periods exceeding two hours preconditioned animals develop infarcts which are 
not different from that of control animals. However, some investigators reported that when the 
duration of the intervening reperfusion period is increased to 24 hours the myocardium may 
again become preconditioned [45,46]. This reappearance of protection has been called the 
second window of protection (SWOP) to discriminate it from the first window of protection 
(FWOP) or classical preconditioning which exists during the first two hours after a 
preconditioning stimulus has been applied. However, the experimental evidence for thls second 
window of protection is not as convincing as that for the first window of protection and is 
therefore still a point of debate [58]. 
The necessitity of an intervening reperfusion period has been a point of discussion when 
myocardium is preconditioned by a partial coronary artery occlusion. Ovize et al could not 
trigger preconditioning without a period of complete reperfusion when they used a 50% flow 
reduction which lasted 15 min. The auUlOrs concluded that complete reperfusion is mandatory 
for preconditioning to occur [19]. In contrast to their findings in dogs [19], we found that in 
pigs a 70% flow reduction which was maintained for 30 min without an intervening 
reperfusion period did reduce infarct size produced by a 60 min total coronary artery 
occlusion [20]. This two-stage coronary artery occlusion model is very similar to the model 
which was initially employed by Harris to reduce the high incidence of ventricular fibrillation 
during the first 30 min of a total coronary artery occlusion [59]. 
In pigs, which lack a significant innate coronary collateral circulation we observed that 
preconditioning by a 10 min total coronary artery occlusion caused almost identical reductions 
in the inner (endocardial) and outer (epicardial) half of the myocardium. Conversely, after 
preconditioning with a 70% flow reduction protection was greater in the epicardial than in the 
endocardial half [21]. Consistent with the observation by Ovize et al [19] we found that infarct 
size after the 60 min total coronary artery occlusion was not reduced when only a 30% flow 
reduction was used to precondition the myocardium, even when the duration of the flow 
reduction was increased to 90 min [21]. No studies have yet investigated whether myocardium 
is also preconditioned when reperfusion during the intervening period after a brief total 
coronary artery occlusion is incomplete. These data would be of significant clinical imp0l1ance 
as they are likely to mimic the clinical situation (e.g. residual coronary stenosis following 
thrombolysis) more closely than the ablUpt occlusion-reperfusion protocols. 
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The sustained total coronary artery occlusion 
Studies in dogs suggest that with sustained coronary artery occlusions lasting longer than 
90 min the protective effect of the preconditioning stimulus is lost [6]. The protective effect 
of preconditioning should therefore he considered to he a shift ill the time course of infarct size 
development (Fig. 2), and will not likely reduce infarct size when the duration of the sustained 
occlusion exceeds a certain limit [6,47]. 
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Figure 2 Schematic presentation of the effect ischemic preconditioning by a brief total coronary 
artery occlusion on myocardial infarct size produced by a sustained coronary artery occlusion. 
Preconditioning results in a rightward shift of the time infarct size relation indicating a delay in cell 
death (time window of protection is ~20 min), Depending on the duration of the sustained coronary 
occlusion the amount of protection can be close to 100% (40 min), 40% (60 min) or neglibible 
(> 90 min), The shape and steepness of the curve are species dependent. It is currently unclear 
whether different preconditioning stimuli (duration of brief occlusion, rapid ventricular pacing, 
stretch) produce different time windows of protection. 
17le sustained repeljusiofl period 
The histochemical staining tecimiques for the determination of infarct size require a 
prolonged period of complete reperfusion (minimal duration of 90 min) to obtain accurate 
measurements [48]. It has been suggested that a decrease in infarct size determined during the 
early phase of reperfusion ( < 6 hours) produced by using pharmacological interventions may 
be lost when the duration of reperfusion is prolonged to 3 days [60]. Analogous to the 
observation with pharmacological interventions it could be hypothesized Ulat ischemic 
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preconditioning merely postpones myocardial cell death during the reperfusion period. in 
particular since most studies of myocardial preconditioning use brief periods of reperfusion 
( < 4 hours).That the protective effect of preconditioning persists and is not only a delay of cell 
death during the reperfusion period follows from studies in dogs [6] and rabbits [65] that 
allowed 3-4 days of reperfusion prior to infarct size determination. 
Assessment of infarct size 
In experimental studies the ratio of the infarcted area and the area at risk is routinely used 
to assess Ule efficacy of ischentic preconditioning. In such studies the anatontical area at risk 
is defIned as Ule myocardium supplied by the coronary artery which has been occluded for a 
sustained period of time to produce a myocardial infarction. The area at risk is usually 
delineated from the remaining myocardium by reoccluding the coronary artery and infusion 
of fluoresceine- or Evans blue dye into the left atrium at the end of the experiment. The 
infarcted area is then deterntined by excising the he311 and staining Ule vital myocardium with 
tetrazolium salts (NAD-dependent dehydrogenase staining). Several groups of investigators 
have shown that in animals both with and without an extensive coronary collateral circulation 
the relation between infarcted area (lA) and anatomic area at risk (AR) is highly linear. but 
not proportional [20,49-51]. In other words the equation relating these two variables can be 
described as IA = a AR + b. This implies Umt the IAI AR ratio is not a constant but depends 
on AR (lAI AR = a + bl AR). Only when the area at risk exceeds 20% of the left ventricular 
mass the tenn blAR is negligible compared to a [49]. Comparisons between studies which 
have used different areas at risk must therefore be performed cautiously to avoid erroneous 
conclusions. 
Other aspects of precondItioning 
Natural decay of protective effect of preconditioning. 
Because the protection by ischelnic preconditioning is lost after a two hour intervening 
reperfusion period the question arises wheUler a gradual decrease in the amount of protection 
occurs as the duration of the intervening reperfusion period increases. Some studies [43.44] 
indeed suggest a gradual decrease already during the fIrst hour of U,e intervening reperfusion 
period. Our studies in pigs do not support such a hypothesis as we observed that after a single 
10 min total coronary artery occlusion the amount of protection was the same for intervening 
reperfusion periods of 15 min and 60 lnin [52]. Following a two hour reperfusion period most 
animals developed infarcts of a similar size as in the control animals. but a few animals had 
infarct sizes which were not different from the preconditioned animals with 15 or 60 min of 
intervening reperfusion. These observations are more consistent with nan all or nothing ti 
phenomenon in the individual aninlal. The available evidence suggests that averaging data for 
a group of animals may give the impression Umt the protective effect of preconditioning wanes 
gradually. at a time when individual data points suggest an all or nothing type of response. 
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Development of tolerance to continuously applied preconditioning stimuli and reinstatement 
of preconditioning after it has been lost. 
It appears that a stimulus given immediately after preconditioning is lost will reinstate the 
cardioprotective action [42,43,531, but that a stimulus given while the myocardium is still 
protected does not prolong the protective effect beyond that produced by the initial stimulus 
[611. This observation could have significant clinical importance as most patients are likely to 
have several periods of ischemia prior to developing myocardial infarction. 
Numerous examples can be found in the literature about the development of tolerance upon 
continuous infusion of drugs (tachyphylaxis), with the tolerance to nitrates being the most 
widely described. Since patients may have multiple episodes of ischemia each day for a 
prolonged period of time, the question arises whether the protective action of ischemic 
preconditioning persists when multiple sequences of brief occlusions and reperfusions are 
continued for a period of hours to days. Cohen et al addressed this issue in conscious rabbits 
which were preconditioned using 5 min occlusions at 30 min intervals for 8 hours every day 
[541. In this model infarct size was reduced from 38% to 6% when a 30 min coronary artery 
occlusion was preceded by a preconditioning stimulus consisting of a single 5 min coronary 
artery occlusion separated from the sustained occlusion by an intervening reperfusion period 
of30 min. After 3 to 4 days of these repetitive occlusions, myocardial infarct size produced 
by the 30 min occlusion was not different (27%) from that of the control group. These authors 
also showed that a couple of days after these repetitive occlusions, preconditioning could be 
recaptured with a single 5 min occlusion. It is yet unknown how relevant the model used by 
Cohen et 01 is for the clinical situation as such a large array of multiple occlusions is unlikely 
to occur in' patients with ischemic heart disease. It is, however, quite feasible that 
preconditioning may already be lost after a much lower number of these ischemic episodes 
which would enhance the clinical relevance of these observations. An equally important 
observation is that preconditioning could be reinstated after an ischemic free period. Another 
important feature of this study is that it was the first preconditioning study performed in 
conscious animals, thereby eliminsting possible interference from the effects of acute surgical 
trauma and anaesthesia on reflex pathways and the autonomic nervous system. 
Ischemic preconditioning in hypertrophic hearts. 
Classical ischemic preconditioning studies have mostly employed animals with a normal 
heart. However, many patients suffering from a myocardial infarction are older than 50 years 
and are likely to have hearts which are quite different from those in which ischemic 
preconditioning has been demonstrated. For instance, the Framingham study revealed that left 
ventricular hypertrophy occurs in 12-40% of subjects aged 50 years and older [621. Hence, 
in order to increase its potential clinical relevance, ischemic preconditioning should also be 
demonstrated in animal models of left ventricular hypertrophy. Thus, Speechly-Dick et 01 
studied ischemic preconditioning in rats with left ventricular hypertrophy induced by 
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concurrent administration of deoxycorticosterone acetate (DOCA) and saline for 4 weeks [55]. 
The infarct to risk area volume ratio was considerably lower in the hypertrophied animals 
which had been preconditioned by a 5 min coronary artery occlusion separated from the 30 
min sustained occlusion by 10 min of reperfusion (19% vs 67% in the control group). 
Possible mecbanisms of preconditioning 
Ischemic preconditioniog has been demonstrated in several species whicl/lack a significant 
coronary collateral circulation, and thus recruitment of collateral blood flow by the brief 
ischemic periods can be excluded as a potential mechanism for ischemic preconditioniog [8, 
32]. The original investigators [6] as well as others [63] reported reduced rates of glycolysis 
and high energy phosphate depletion as well as better preservation of pH and myocardial 
ultrastructure during the sustained coronary artery occlusion when preceded by brief periods 
of reversible ischemia. The reduced rate of energy utilization was initially believed to result 
from a decrease in myocardial energy requirements secondary to the depressed contractile 
function produced by the brief period of reversible ischemia (Le. myocardial stunning). 
However, Matsuda ef at demonstrated that the myocardium remained protected when systolic 
segment shortening (a marker for regional cardiac function) in stunned myocardium was 
recruited by infusion of dobutamine within the allocated 2 hours interval between the shOit and 
the longlasting coronary artery occlusions [64]. In agreement with their findings Miura ef at 
failed to observe a correlation between the degree of stunning and infarct size limitation 
produced by preconditioning [65]. These studies indicate that myocardial stunning is not a 
prerequisite for triggering cardioprotection. 
It was not until Downey and co-workers proposed a role for adenosine in preconditioning, 
that a large number of studies began to focus on the (sub)cellular mechanisms [35,37,66]. 
Inhibition of mitochondrial ATPase, free radicals, and the endothelium derived substances 
prostacyclin and nitric oxide are examples of mechanisms that have at some point been 
suggested to playa role, but which may now be considered as lninor when infarct size is taken 
as the endpoint [7,67,68]. Mechanisms that are currently ascribed a pivotal role in ischemic 
preconditioning are adenosine [4,6,35,36], K+ AT' channel activation [32-34,69], and G-
protein/protein kinase C activation [37-39]. Most of the evidence has been obtained by using 
substances which eiUler mimic or inhibit the effect of preconditioning. It is beyond the scope 
of this review to discuss the possible mechanisms of preconditioning in detail and Fig. 3 
therefore only provides a scheme for some of the proposed mechanisms. For a more detailed 
description of the mechanisms of preconditioning the reader is referred to one of the many 
extensive reviews recently published [5,7,37,67,68]. 
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Evidence for the existence of ischemic preconditioning in patients 
It is self evident that no clinlcal study meets the strict conditions outlined for the 
experimental studies in Table 1. Consequently, direct evidence for the occurrence of ischemic 
preconditioning with infarct size as endpoint in man is not available. Table 2 lists the potential 
pitfalls in obtaining indirect evidence for the occurrence of preconditioning in man. 
Table 2. Problems with obtaining evidence for preconditioning in man using infarct size as 
endpoint. 
Preconditioning stimulus 
unknown jf the duration and severity of anginal attacks are sufficient to precondition the 
myocardium 
unknown if silent ischemia Can precondition the myocardium 
medication and other forms of stress may interfere with the potential protective effect of 
the brief ischemic periods [treatment with K+ ATP channel openers for hypertension or 
treatment with K+ mehannel blockers (Glibenelamide) for diabetes mellitus type II] 
Intervening repeljusioll period 
reperfusion following anginal attacks may be incomplete and variable in duration 
Sustained coronary arlery occlusion 
occlusion that produces infarction may be incomplete and variable in severity 
collateral blood flow to the area at risk is unknown 
onset and duration of occlusion caMot be accurately defined 
Reperfusioll following tlte sustailled corollary artery occlusioll 
onset of reperfusion caMot be accurately defUled 
reperfusion may be incomplete due to pre-existent coronary artery stenosis 
Determitlanon of infarct size 
llinfarct size" should be related to the anatomical area at risk; area at risk is usually not 
determined 
enzyme leakage, preservation of left ventricular function or survival are often used as 
endpoints; these may not accurately reflect the extent of the infarcted area 
A main source of error lies in the inability to accurately define the onset, duration and the 
completeness of the different occlusion and reperfusion phases as outlined in Fig 1. Thus, a 
confounding factor is that both the onset of occlusion and the beginning of reperfusion (and 
also whether these are complete) are not precisely known as tllis does not necessarily coincide 
with the onset or relief of anginal pain or changes in the electrocardiogram. The extent of 
coronary collateralization is another important detenninant of infarct size, which cannot be 
quantified with sufficient degree of accuracy. Also a shortcoming of clinical studies is the 
inability to accurately determine infarct size, for which often indirect measures (enzyme 
leakage, survival or left ventricular function) have to be relied on. Although the area at risk 
can be determined, most often it is not and consequently it is impossible to relate the amount 
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of necrosis to the area at risk. Thus, because of methodological limitations comparison of 
infarct size between different groups of patients remains lImited to comparing such variables 
as total enzyme leakage without taking into account the area at risk and the duration of the 
occlusion. Finally, patients may be on medication (e.g. aminophylline, K+ ATP channel 
modulators) that are capable of mhnicking or inhibiting ischemic preconditoning. 
In view of these lImitations of human studies on myocardial infarction we will in the 
following paragraphs not only review infarction studies, but also studies in which multiple 
periods of ischemia have been investigated usually as part of a diagnostic or therapeutic 
intervention. A number of these repeated ischemia studies have attempted to unravel the 
mechanisms underlying Ole myocardial adaptation triggered by the first period of ischemia. If 
it could be shown that the mechanisms responsible for ischemic preconditioning (infarct size 
limitation) are the same as the mechanisms responsible for myocardial adaptation (lesser signs 
of ischemia during the second of two periods of reversible ischemia) this would provide 
strong, though indirect, evidence tllat ischemic preconditioning may occur in the human heart. 
Lawson [70] and Kloner and Yellon [71] have identified several patient categories in which 
the phenomenon of ischemic adaptation can be demonstrated. These groups are: (l) patients 
which suffer an acute myocardial infarction preceded by periods of angina pectoris [71-83] 
(Table 3). Because reperfusion following the sustained period of ischemia is mandatory if 
preconditioning is to be able to lImit infarct size. These authors have differentiated between 
studies performed during the pre- and thrombolytic eras, (it) patients who have undergone two 
or more episodes of reversible ischemia as part of diagnostic or therapeutic interventions. 
These interventions include repeated exercise stress tests [85-84] and atrial pacing stress tests 
[2,3,88-89] and percutaneous transluminal coronary angioplasty (PTCA) [91-99], (iii) patients 
undergoing arterial cross-clamping as part of cardiac surgery [100], and (iv) in-vitro studies 
in samples obtained from human hearts [101,102] (Table 4). 
Angina prior to an acute myocardial infarction 
The clinically most relevant situation for studying ischemic preconditioning is that of the 
patients who experience anginal attacks shortly before they suffer an acute myocardial 
infarction. These anginal episodes may be caused by exercise-induced oxygen supply-demand 
mismatch or by cyclic flow variations reSUlting from repeated platelet formation and 
dispersion, situations by which ischClniC preconditioning can be induced in the laboratory [22, 
23]. 
Because the protective effect of ischemic preconditioning is not seen after permanent 
occlusions, studies must be stratified according to whether they have been performed before 
or after the introduction of thrombolytic therapy and emergency coronary angioplasty. Table 
3 shows that positive as well as negative results have been reported which cannot be explained 
by the absence or presence of reperfusion by tlll'ombolysis or acute percutaneous transluminal 
coronary angioplasty. importantly, none of the studies reported positive results on long 
Table 4. Myocardial adaptation to repealed episodes of reversible ischemia in man. 
Adaptation 10 Ischemia 
Exercise stress lest C'Wanllllp" and "Walk ,hrollgh ll phellomelloll) 
decreased intensity of pain 
increased time to onset of pain 
less ST segment changes 
decreased anaerobic myocardial metabolism 
decreased myocardial Ordemand (systemic hemodynamics) 
decreased myocardial 02-consumption 
increased coronary bloodtlow 
Alrial pacillg slress lesl 
Positive results 
decreased intensity of pain 
increased time to onset of pain 
less ST segment changes 
decreased anaerobic myocardial metabolism 
decreased myocardial 02-consumplion 
decreased myocardial Ordemand (systemic hemodynamics) 
Negative results 
similar intensity of pain 
similar time to onset of pain 
similar ST segment changes 
similar anaerobic myocardial metabolism 
similar myocardial 02-collSumption 
similar myocardial 02-demand (systemic hemodynamics) 
Angioplasly procedures 
Positive resu/ls 
decreased intensity of pain 
less ST segment changes 
decreased anaerobic myocardial melbolislll 
improved global hemodynamics 
Negative results 
similar ST segment changes 
similar global hemodynamics 
similar anaerobic myocardial metabolism 
Aortic cross clamp during cardiac surgery 
slowing of high energy phosphates degradation 
III vilro studies 
Isolaled IIumall right a/rial Irobeculae 
less deterioration of contractile function 
Human ventricular myocy/es 
decreased cell death, decreased H+, 
preserved aerobic myocardial metabolism 
References 
[84) 
[85,86) 
[85,86) 
[86) 
[84,85) 
[86) 
[85) 
[87, 88) 
[87) 
[3, 88, 89) 
[3, 88, 89) 
[88) 
[3, 89) 
[2) 
[2) 
[87) 
[2) 
[2) 
[87) 
[90-94) 
[90-92,94-96) 
[91) 
[91,92) 
[97-99) 
[93) 
[99) 
[100) 
[101) 
[102) 
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teml survival. This may be attributed to a greater prevalence of severe coronary artery disease 
and other risk factors such as age, smoking and presence of hypertension. Furthermore, it 
cannot be excluded that in a number of patients, because of the frequency of ischemic episodes 
prior to the occurrence of myocardial infarction tolerance to ischemic preconditioning might 
have developed [54). Based on the currently available evidence it is premature to conclude that 
angina prior to myocardial infarction limits infarct size. Until more sensitive measures of 
infarct size and area at risk become available, and the incidence and duration and severity of 
occlusions can be more accurately determined, this question will likely remain unanswered. 
Repeated episodes of ischemia 
Acute tolerance to angina pectoris: the 'warm up' and 'walk through' phenomellon. 
In a large number of patients the first anginal attack in the morning is more severe than 
those occurring during the later hours of the day ('warm up' phenomenon). A circadian 
variation in the autonomic tone is a generally accepted mechanism to explain this observation 
[103,104). In view of the concept of myocardial adaptation an alternative explanation could 
. be Omt Ole less severe signs of ischemia during these later episodes are the result of adaptation' 
triggered by the first episode. It has also been shown that exercise-induced ischemia is less \ 
severe during the second of two identical exercise tests when these are separated by a short 
recovery period [84-86). In one of these studies, myocardial oxygen consumption at a given 
workload was less, suggesting a role for metabolic adaptation [83). 
At the present time it is unclear if exercise when stopped at the earliest signs of myocardial 
ischemia (as is often the case) is sufficient to protect the myocardium against irreversible 
damage during the development of myocardial infarction [19,20,22,28). 
Atrial pacing stress test. 
During atrial pacing stress tests the myocardial oxygen balance can become disturbed by the 
increase in heart rate. The ensuing ischemia results from bOOI a decrease in diastolic duration, 
with myocardial blood flow being distributed away from the subendocardium, and a modest 
increase in myocardial oxygen demand. Early on it was recognized that the metabolic, 
electrocardiographic and functiOlml responses to two pacing stress tests were not always 
reproducible when repeated at a short time interval. Thus in several studies, though not all, 
it was shown that during the second test time to onset of angina was prolonged, while ST-
segment changes and metabolic and functional changes were less compared at comparable heart 
rates (Table 4). These findings are compatible with the hypothesis that the myocardium can 
adapt to ischemia. However, since pacing-induced ischemia may be too brief in duration and 
not severe enough to elicit ischemic preconditioning these studies of atrial pacing stess tests 
must be viewed with caution. 
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Angioplasty procedures. 
During angioplasty the myocardium is exposed to brief multiple periods of ischemia of 
which the duration can be well controlled. A serious disadvantage is that the occlusion periods 
are rather short and that differences in myocardial perfusion during balloon deflation may be 
caused by a reduction in the severity of the lesion and during subsequent balloon inflations by 
recruitment of collateral flow. Moreover, the balloon inflations do not cause irreversible 
damage and tlle endpoint of these studies, such as intensity of pain, ST segment depression and 
lactate production, are therefore markers of reversible forms of ischemia. 
Several studies have reported tllat the changes occurring during the second and third balloon 
inflations indicate less severe signs of ischemia than during the first inflation. This is in itself 
not a surprising finding as it has also been shown for atrial pacing stress tests in patients 
undergoing a diagnostic catheterisation for suspected coronary artery disease. Not all studies 
have, however, demonstrated that an adaptative mechanism becomes operative after the first 
inflation, which can be explained by the fact that tlle myocardium of these patients may already 
have been adapted because of previous ischemic episodes [61] or had become resistant [54]. 
In addition, the duration of inflation in the studies of De Bruyne et al [93] and Oldroyd et al 
[99] might have been too short (60 sec) [15] to produce adaptation. In a preliminary study 
Kerensky et al [96] reported that after pretreatment with intracoronary adenosine, the 
magnitude of ST-segment changes was no longer different between the first and second 
inflation. Their findings could suggest that adenosine pretreatment adapted the myocardium 
analogous to its role in ischemic preconditioning (infarct size limitation). Of interest is that 
pretreatment of patients with glibenclamide completely abolished the attenuation of 
intracoronary electrographic chagnes during the second balloon inflation [94], suggesting that 
activation of K+ ATP channels which are involved in ischemic preconditioning also modulate the 
myocardial adaptation process to these brief periods of reversible ischemia. 
Studies in human myocardial samples 
Left ventricular biopsies collected during cardiac surgery. 
Yellon et al [100] recently demonstrated metabolic adaptative processes during aortic-cross 
clamping in patients undergoing cardiac surgery. The advantage of this last model is that in 
dealing with global rather than regional ischemia, the importance of the coronary collateral 
circulation as a confounding factor is eliminated. In tlleir study the authors assigned 14 patients 
randomly to a sustained period of global ischemia consisting of 10 min cross-clamping either 
without (control) or with two preceding sequences of 3 min cross-clamping and two min of 
reperfusion (preconditioning). As expected, adenosine triphosphate levels were decreased (by 
approximately 30%) after the preconditioning protocol and thus lower than in the control 
group when the 10 min cross-clamping period was started. At the end of this 10 min period 
of global ischemia, the adenosine triphosphate levels in the preconditioned group were higher 
than in the control group. This was due to the absence of further decreases in adenosine 
Ischemic preconditioning: modalities and clinical relevance 113 
triphosphate in the preconditioned group, while the adenosine triphosphate levels decreased 
by 60-70% in the control group. These observations are in agreement with the original 
observations in dogs by Murry el al who showed Utat ischemic preconditioning slows energy 
metabolism during a sustained coronary artery occlusion [4, 6]. The study by Yellon el al 
[100] shows metabolic features of myocardial preconditioning in man that are consistent with 
those found in the preconditioning experiments in the animal laboratory, providing direct 
evidence that in man the myocardium can adapt to ischemic stress. However, there is no proof 
that slowing of the energy metabolism is the critical factor in limiting necrosis when the 
duration of the ischemic episode is prolonged. Whether the metabolic adaptations will 
ultimately lead to /imilalion of ilifarci size (Hue preconditioning) still remains to be answered. 
Righi alrial Irabeculae. 
Walker el al [101] suspended human right atrial trabeculae in an organ bath and 
preconditioned one group with 3 min of pacing (180 pulses/min) while superfusing the 
trabeculae with a hypoxic and substrate-free buffer. As an intervening reperfusion period the 
trabeculae were paced at 60 pulses/min for 10 min in a reoxygenated buffer with substrate. 
Tllis preconditioned group and a control group which did not receive prior treatIuent were then 
subjected to pacing (180 pulses/min) for 90 min during superfusion with a hypoxic and 
substrate-free buffer (comparable to "the sustained coronary artery occlusion" period). This 
was followed by 120 min of reoxygenation and pacing at 60 pulses/min. At the end of this 
reoxygenation period recovery of developed tension was twice as large in the preconditioned 
group. It may be argued that pacing in a hypoxic substrate-free medium is not the same as in 
vivo ischemia produced by total coronary artery occlusions. We have shown, however, that 
it is also possible to precondition myocardium by partial coronary artery occlusions during 
which there is also a (limited) wash-out of metabolites [20,21]. 
Isolaled hUfl101I cardlomyocyles. 
In cultured myocytes grown from ventricular myocytes obtained during cardiac surgery have 
been preconditioned with 20 min of anoxia followed by 20 min of normoxia before they were 
subjected to 90 min of anoxia [102]. After 30 min of normoxia, these preconditioned cells had 
a higher survival rate and less uptake of trypan blue than a group of cells which underwent 
only the test procedure. The supernatant of the preconditioned cells had also lower 
concentrations of hydrogen, lactate and lactic dehydrogenase. Models of isolated cultured cells 
are attractive as potential mechanism(s) of preconditioning can be studied under rigorously 
controlled conditions without any interference of other cells. The latter may also be a 
disadvantage as events in adjacent myocardial cells and even other organs could lead to 
cardioprotection. 
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Summary and Conclusion 
The protective effect of a brief period of reversible ischemia against the development of 
irreversible damage has now convincingly been demonstrated in a large number of animal 
species. The protective state is temporary but may have a biphasic paUern as some studies 
suggest Omt the protective state of a preconditioning stimulus disappears after a few hours, but 
reappears after 24-36 hours. There is evidence that myocardium can also be preconditioned 
by a partial coronary artery stenosis, even without the need of an intervening reperfusion 
period. The severity of the flow reduction during the partial occlusion appears to be important 
and the transmural distribution of protection may not be homogeneous. In the animal 
laboratory myocardial preconditioning can also be obtained by transient ischemia in other 
organs as well as by non-ischemic stimuli such as stretch and rapid ventricular pacing. These 
models may help to bridge Ole gap between the classical abrupt occlusion-reperfusion models 
which have limited clinical applicability and the clinical situation. 
There is evidence to suggest that the protection afforded by ischemic preconditioning could 
extend into the coronary circulation, in particular the endothelium of which the function can 
become inlpaired following longer periods of myocardial ischemia and reperfusion. Deftly and 
Chilian [105] reported that endothelium-dependent vasodilation was depressed in isolated 
coronary microvessels from dogs subjected to 60 min of coronary artery occlusion and 
reperfused for 90 min. A 10 min coronary artery occlusion preceding the 60 min occlusion 
preserved endothelium-dependent vasodilation. In contrast, Bauer ef at [106] failed to observe 
a protective effect of four episodes of 5 min occlusions on the loss of endothelium-dependent 
vasodilation produced by a 60 min coronary artery occlusion in dogs. Thus, at the present time 
the question whether preconditioning protects against coronary vascular damage remains 
unanswered. 
Direct clinical evidence for the classical preconditioning phenomenon with infarct size 
limitation as endpoint cannot be obtained but a number of patient groups have been identified 
in which adaptation to ischemia has been demonstrated by enhanced recovery of function or 
preservation of high energy phosphates in models of repeated ischemia such as angioplasty and 
aortic cross-clamping during cardiac surgery. Evidence is accumulating that mechanisms which 
are operative in experimental ischemic preconditioning (infarct size limitation) are also 
operative in the clinical models of repeated reversible ischemia. Insight into the mechanisms 
responsible for ischemic preconditioning could potentially help to develop pharmacological 
agents which mimic preconditioning. This is especially aUractive as several of the ischemic 
episodes may be too short or not severe enough to trigger preconditioning. By a synergistic 
or additive action combination of such a stimulus and low dose of pharmacological agent might 
result in a protective action [40]. If these agents were also to be used for treating 
cardiovascular conditions, such as the K+ ATPchannel activator nicorandil for the treatment of 
angina pectoris, the cardioprotective effect could be a beneficial side effect. The currently 
available protein kinase C activators are oncogenic, it may be envisioned that, in the future 
Ischemic preconditioning: modalities and clinical relevance 115 
with file recognition and better understanding of the different subtypes new Protein kinase C 
activators may become available which can be applied for cardioprotection without negative 
side-effects. The hearts of patients who regularly experience episodes of ischemia may be in 
a more or less permanent state of preconditioning afforded by one of these stimuli. 
Alternatively, resistance may have developed. In this situation it is quite feasible that additional 
protection by a pharmacological agent cannot be accomplished at that time. It is reassuring, 
however, that preconditioning can be reinstated immediately after the cardioprotection is lost 
and that it can also be demonstrated in hearts with pathologic conditions such as hypertrophy. 
In view of the observations that cardioprotection may also be produced by transient ischemia 
in other organs and even some forms of stress which do not lead to myocardial ischemia, it 
could be envisioned fllat ischemic preconditioning is only one component of a general form of 
cardioprotection. 
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Chapter 9 
General Discussion and Summary 
[A more detailed version of this chapter will be published as '''Novel approaches to 
myocardial preconditioning in pigs" in Myocardial Preconditioning, Wainwright C.L. and 
Parratt J. (eds), Austin, Texas, RG Landes Co.] 
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In tills tllesis are presented tile results of our studies on ischaemic preconditioning in domestic 
pigs. A number of earlier observations have guided these studies. First, it has been well 
established that in dogs the relation between infarct size (IS) and the anatomical area at risk (AR) 
is linear but not proportional, i.e. the regression line describing the relation between IS and AR 
is linear but has a positive intercept on the AR-axis.' Such a relation implies that the IS/AR ratio, 
which is the index commonly used to express infarct size, is not a constant but depends on AR. 
As was shown in this thesis, a positive intercept is also present in swine which can severely limit 
the use of IS/AR in assessing infarct size and myocardial protection. Secondly, it is well 
established that most of the protective effect of a brief period of ischaemia is lost when the 
intervening reperfusion period separating the brief and sustained coronary al1ery occlusions 
exceeds two hours.' The relation between the extent of protection by ischaemic preconditioning 
and the duration of the intervening reperfusion period is not well established, although some data 
suggest that tile preconditioning stimulus starts to lose some of its efficacy already very early in 
the intervening reperfusion period.' Thirdly, the necessity of a period ofreperfusion between the 
brief and sustained total coronary artery occlusions to elicit ischaemic preconditioning is self-
evident; otherwise the duration of the sustained coronary artery occlusion will be merely 
increased. It is less obvious, however, whether a partial coronary ru1ery occlusion can lead to 
ischaemic preconditioning without the need for an intervening reperfusion period. Finally, Ovize 
et aI' have shown that stretch can precondition the myocardium without the need for ischaemia. 
We have extended tills observation and investigated whether other non-ischaemic stimuli are also 
capable to precondition myocardium. 
Relation between infarct size and area at risk in pigs (Chapter 4 and 5) 
The effect of ischaemic preconditioning is usually evaluated by the ratio of infarct size (IS) 
and the anatomical area at risk (AR). This index (IS/AR) can be used without restriction only 
when infarct size development occurs independent of the size of the area at risk. For 
anaesthetized as well as conscious dogs, it has been shown that the linear relation between infarct 
size and area at risk has a positive intercept on the AR-axis.2 Because dogs can have an extensive 
coronary collateral circulation, the positive intercept can be easily ascribed to collateral blood 
flow. Consequently, in tills species infarct size correlates well with the amOlmt of collateral blood 
flow to the area at risk. If collateral blood flow is indeed the cause of this positive intercept the 
relation between infarct size and area at risk should be proportional in pigs, a species with a 
negligible native coronary collateral circulation. In open-chest anaesthetized pigs we have 
occluded the left anterior descending coronary artery or its branches at different locations, 
thereby intentionally creating a wide range in the size of the area at risk.'" In 17 animals that 
underwent a 60 min coronary artery occlusion we found that the relation between infarct size and 
area at risk was highly linear (1""'0.99, P<O.OOI) and could be described by IS=0.97AR - 4.5, in 
which IS and AR are both expressed as percent ofleft ventricular mass (Fig. I, upper panel). 
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Figure 1 Relation between infarct size (IS) detemlined 2 hours after a 60 min total coronary artery 
occlusion (60 min TCO). and the area at risk (AR) for a group of control animals and a group of animals 
preconditioned by a 10 min total coronary artery occlusion which was separated from the 60 min TCO 
by 15 min of complete reperfusion (upper panel). Due to the positive intercept on the AR~ax1s the lSI AR 
ofthese two groups (upper panel) of the relation between IS and AR of animals strongly depends on AR 
for AR less than 20% of the left ventricular mass (LVmass) (lower panel). (adapted from Koning et 
alM.II). 
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Figure 2 Regression lines for the control (con) and preconditioned (precond) pigs, as depicted in figure 
I, are shown in the upper panel. The lower panel shows the infarct size limitation (lSL) afforded by the 
10 min TeO + 15 min REP preconditioning stimulus. ISL (%) was computed as (18'011 - ISpr~~(lnJ)IISWlJ 
where IS(.(lo and ISLpre,:(lnd are the infarct size (IS) of the control group and the preconditioned group, 
respectively. 
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TIlliS, similar to the findings in dogs, we also observed a positive AR-intercept in a species with 
minimal coronary collaterals. In support of our fllldings, Ytrehus et aF recently showed that also 
in rabbits, tlle relation between infarct size and area at risk can be described by a linear regression 
equation with a positive intercept on the AR-axis. 
In a subsequent series of experiments we investigated how the relation between infarct size 
and area at risk is modified by ischaemic preconditioning. For this purpose animals were 
preconditioned with a 10 min total coronary m1ery occlusion which was separated from the 60 
min occlusion by 15 min ofr.perfusion.'·' In these preconditioned animals the linear relation 
between infarct size mld area at risk was rotated downward WiOl a lower slope but with a similar 
positive intercept on the AR-axis as in the control animals (IS~0.64AR-4.4: Fig. I, upper panel). 
The implication of these findings is that in both control and preconditioned animals IS/AR 
depends on AR (Fig. I, lower panel). From this figure it can be easily deducted that in pariicular 
for areas at risk less than 20% of the left ventricular mass IS/AR is highly sensitive to the size 
of the area at risk. Figure 2 illustrates the infarct size limitation, defined as the difference in 
infarct sizes (predicted from the regression lines) of the control and the preconditioned animals 
expressed as a percent ofthe infarct size of the control animals [(ISc.ofltrol M ISpre.:onditioned)IIScontwl]' 
. This figure clearly demonstrates that an interstudy comparison of the protective effect of 
ischaemic preconditioning can easily lead to erroneous conclusions when in these studies 
different areas at risk have been used. This may be especially true for the pig in which (in order 
to reduce the incidence of ventricular fibrillation) smaller areas at risk are quite often preferred. 
Transmural distribution of infarct size in pigs (Chapter 6 and 7) 
In order to assess whether the endocardial and tlle epicardial halves benefit equally from 
ischaemic preconditioning, we divided the myocardium in two layers of equal thickness and 
related these infarcts to the corresponding areas at risk. The results revealed linear relations with 
similar positive intercepts on the AR-axis, for the endocardial and epicardial half of the left 
ventricle in control pigs SUbjected to a 60 min total coronary ariery occlusion (Fig. 3). In dogs, 
IS and AR are also linearly related, but in contrast to pigs, the AR-intercept in dogs is 
considerable higher in the epicardium than in the endocardium.' The consequent heterogeneity 
of transmural infarct size distribution in dogs is likely in pari due to the transmural gradient of 
collateral blood flow in the dog heari. In pigs, in which total coronary ariery occlusions result in 
transmurally homogeneous myocardial blood flow reductions, infarction also progresses from 
inner to outer layer"IO, possibly due to higher energy demands in the inner layers. In agreement 
with these fllldings we observed that for a given area at risk the infarct size produced by the 60 
min total coronary ariery occlusion was slightly (but significant by ANCOV A) larger in the 
endocardial than in the epicardial half ofthe left ventricle." 
In the pigs preconditioned by the 10 min total coronary occlusion and 15 min reperfusion the 
relation between infarct area and area at risk of the endocardial and the epicardial halves were 
also linear. The AR-intercepts were the same as in the control animals but with lower slopes. The 
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Figure 3 Transmural distribution of infarct size (IS) for control pigs (0, 60 min TCO only) and for pigs 
preconditioned by 10 min TCO + IS min REP prior to the 60minTCO ( ), Note that the infarct size 
reduction was similar in the epi M and endocardial halves of the left ventricular wall, but that the scatter 
of the data points around the regression line was considerably less in the epicardial than in the 
endocardial half of the preconditioned animals. (Adapted from Koning et aIS,6,1I). 
decrease in slope was the same for the endo- and epicardium indicating that the protection was 
similar in the hmer and outer half of the left ventricle, 11 
The duration of protection afforded by ischaemic preconditioning (Chapter 4) 
To detennine the time course of protection we prolonged the intervening reperfusion period 
between the brief and sustained coronary artery occlusions from 15 min to 60 min, We 
hypothesized that if the preconditioning stimulus already starts to lose its efficacy early in the 
intervening reperfusion period, the regression line relating infarct size and area at risk would 
gradually rotate upwards towards the control line when the duration of the intervening 
reperfusion period is extended, With the 60 min reperfusion period the relation between infarct 
size and the area at risk remained virtually unchanged compared to the 15 min reperfusion period, 
indicating that in pigs a 10 min preconditioning stimulus does not start to lose its efficacy during 
the first hour of rep em lSi on,' A further prolongation of the intervening reperfusion period up to 
2 hours revealed that the infarct size of most animals was no longer different from the control 
animals, However, the infarct size of a few animals remained well below the regression line of 
the control animals,' Because in the control animals all 18-AR data points are very close to the 
regression line it appears that the preconditioned animals with the 18-AR data points well below 
the regression line ofthe control group were still preconditioned, Infarct size determinations for 
animals with even longer intervening reperfusion periods showed that a few animals, although 
a progressively smaller percentage, remained preconditioned up to 5 hours after the brief period 
of ischaemia, It thus appears that in contrast to the earlier observations in rabbits,' (i) the efficacy 
of preconditioning in pigs remains virtually unchanged dnring the first hour, (ii) most pigs have 
lost protection by ischaemic preconditioning at two hours and (iii) a few pigs may remain 
protected up to five hours, 
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[schaemic preconditioning with a partial coronary artery oce/usion without intervening 
reperfilsion (Chapter 5 and 6) 
In allllclassical" preconditioning experiments \U1impeded coronary blood flow was restored 
after a brief total occlusion before the coronary artery was occluded for a sustained period of 
time. This period of reperfusion is obviously necessary because otherwise the duration of 
sustained ischaemia will merely be increased. A different situation may arise if myocardiwn 
could be preconditioned by a prulial coronary artery occlusion. Harris was the first who applied 
a partial occlusion for 30 min (without measuring residual coronary artery blood flow) prior to 
a complete occlusion which lasted several hours (two-stage coronary artery occlusion) and 
observed a decrease in the high incidence of ventricular fibrillation usually occurring during the 
first 30 min after the onset of a total coronary artery occlusion." This reduction in the incidence 
of ventricular fibrillation has been explained by the lesser severity ofischaemia during the partial 
occlusion period. The onset of the subsequent total occlusion (at 30 min) was considered beyond 
the time-point when most lethal arrhythmias occur. It was never considered why these lethal 
arrhythmias would not occur ~fter the artery was occluded completely. Current insight into the 
effects of ischaemic preconditioning" offers an alternative hypothesis: the partial occlusion 
preconditions the myocardium thereby attenuating the incidence of ventricular fibrillation during 
the subsequent total occlusion. The first attempt to induce myocardial preconditioning by a two-
stage coronary artery occlusion was by Ovize et ai, who reduced coronary blood flow by 50% 
for 15 min before occluding the coronary artery completely without an intervening reperfusion 
period between the flow reduction and the complete coronary artery occlusion." Infarct size in 
these animals was not different from that of a group of control animals which underwent only 
the sustained total coronary artery occlusion. Increasing the duration of the flow reduction to 25 
min did not affect the results. Infarct size was markedly reduced, however, when these 
investigators allowed 10 min of complete reperfusion between the 15 min 50% coronary flow 
reduction and the sustained artery occlusion. The authors therefore concluded that myocardium 
could be preconditioned by a partial coronary artery occlusion but that an intervening period of 
reperfusion was mandatory to elicit the protective action. 
We hypothesized that in the study ofOvize et al" the flow reduction may not have been severe 
enough or the duration too short for preconditioning to occur and therefore first reduced blood 
flow in the left anterior descending coronary by 70% for 30 min before occluding the artery for 
60 min without an intervening reperfusion period. Figure 4 shows that all animals which 
underwent this two-stage coronary artery occlusion had transmural infarct sizes smaller than in 
the control group. When the duration of the 70% flow reduction period was extended from 30 
min to 90 min before the coronary artery was occluded completely, transmural infarct sizes were 
still smaller than in the control groups, even though the 90 min 70% flow reduction per se had 
already caused some irreversible danlage. In contrast a 30 min 30% flow reduction preceding the 
60 min total coronary artery occlusion without an intervening period ofreperfusion did not limit 
infarct size." Findings were also negative when the duration of the 30% flow reduction was 
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Figure 4 Effect of ischaemic preconditioning with a 70% coronary flow reduction (70%FR) without 
an intervening period of reperfusioll on myocardial infarct size produced by a 60 min total coronary 
artery occlusion (60minTCO). Shown are the regression line and individual data points for the control 
group (60minTCO) and individual data points for animals subjected to a 30min70%FR followed by 
60minTCO, a 90min70%FR followed by 60minTCO and a 90min70%FR without the 60minTCO. Note 
that although the 90min70%FR itself resulted in significant infarction after 90 min, it still provided 
protection against the irreversible damage produced by the subsequent 60minTCO (adapted from Koning 
et al. l1) 
increased to 90 min. It therefore appears that myocardium can be preconditioned by a flow 
reduction without the need for an intervening reperfusion period, but that the severity of flow 
reduction is critical. 
We also hypothesized that the protection by ischaemic preconditioning would most likely not 
be homogeneously distributed when a partial coronary artery occlusion was used as a stimulus. 
Because the flow deficit in the endocardial layers would be greater, it is there that ischaemia 
would be more severe than in the epicardial layers. If, as has been proposed, there is a threshold 
for ischaemia before preconditioning can occur it can be envisioned that with moderate flow 
reductions the endocardium could be preconditioned while the epicardium was exposed to a 
subthreshold stimulus. On the other hand, the subendocardium may already start to develop 
irreversible damage because ofthe larger flow deficit" as was observed when the coronary artery 
flow was reduced by 70% for 90 min. When we analyzed the endocardial (inner 50%) and the 
epicardial (outer 50%) infarct size we found that in the animals in which the induction of 
preconditioning was attempted by a 30% flow reduction, neither the endocardial nor the 
epicardial half were protected." In the animals subjected to the 30 min 70% flow reduction 
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Figure 5 Effect of ischaemic preconditioning with a 70% coronary flow reduction (70%FR) without 
an intervening period ofreperfusion on the transmural distribution of myocardial infarct size produced 
by a 60 min total coronary artery occlusion (60minTCO). Shown are the regression line and individual 
data points for the control group (60minTCO) and individual data points for animals subjected to a 
30min70%FR followed by 60minTCO, a 90min70%FR followed by 60minTCO and a 90min70%FR 
without the 60minTCO. For details or the legends see Fig. 4. (adapted from Koning et al.") 
infarcts were smaller in the epicardial than in the endocardial half, but both were less than the 
infarcts in the corresponding halves of the control animals (Fig. 5). TIle 90 min 70% flow 
reduction caused some ilTeversible damage, but tltis occurred predominantly in the endocardial 
half. Nevertheless, the endocardial infarcts after the subsequent 60 min total coronary artery 
occlusion were still smaller than in the control group, although the difference was less prominent 
than in the epicardial half. Thus, in contrast to classical preconditioning with a total coronary 
artery occlusion (wltich in our hands affords transmurally homogeneous protection) partial 
occlusions produced preferential epicardial protection. These findings may be of clinical 
relevance, since a large group of patients suffering from myocardial infarction will have pre-
existing coronary artery lesions which may provide variably flow reductions prior to the 
occlusion by a thrombus. 
Myocardial protect/on by a period of rapid ventricular pacing (Chapter 7) 
Przyklenk et al have shown that myocardium can be preconditioned by a brief coronary artery 
occlusion supplying the adjacent myocardium demonstrating that myocardium does not have to 
become ischaemic itself to increase its tolerance to irreversible ischaemic damage, IS This 
protection could be due to stretch of this virgin myocardium in response to the ischaemic 
dysfunction in the adjacent area. Further support for this hypothesis came from the same group 
ofinvestigators when they showed that stretching the myocardium, obtained by volume loading, 
also attenuated infarct size during a sustained coronary artery occlusion without the prerequisite 
of ischaemia.' The protection by "stretch" could be blocked by pretreatment with gadolinium, 
an inhibitor of stretch-activated cation channels. In search of preconditioning myocardium by 
other types of stress we have used rapid ventricular pacing. TIle rationale for this approach is the 
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Figure 6 Effect 0[30 min of rapid ventricular pacing at 200 bpm (30minRVP) on myocardial infarct 
size produced by a 60 min total corollary artery occlusion. Ventricular pacing was stopped after the onset 
of the coronary occlusion (left panel). The panel on the right shows that the protective effect of 
30minRVP could be blocked by pretreatment with the K'ATP channel inhibitor glibenclamide (Glib, I 
mg/kg, iv). (adapted from Koning et al,") 
observation by Vegh et aI, that rapid ventricular pacing reduced the incidence of ventricular 
fibrillation during and after subsequent coronary artery occlusion." 
In foul' animals we found that 10 min of rapid ventricular pacing at 200 bpm separated from 
a 60 min total coronary artery occlusion by 15 min of normal sinus rhytlun did not limit infarct 
size. When in six other animals the duration of rapid ventricular pacing was increased to 30 min 
there was a small but significant limitation of infarct size in the epicardial half but not in the 
endocardial half." A much more striking effect was observed when the intervening period of 
normal sinus rhytlun was abolished. Thus, when at the end of a 30 min period of rapid ventricular 
pacing, the left anterior descending coronary artery was occluded and the pacemaker was 
switched off immediately thereafter, infarct size in both the epicardial and the endocardial half 
were significantly reduced compared to that of the control group (Fig. 6 and Fig. 7). Pretreatment 
with glibenclarnide abolished the protection by ventricular pacing in all but one ofthe animals, 
suggesting a role for K'ATP charmel activation analogous to the preconditioning by a brief total 
coronary artery occlusion in pigs,l8-20 It would seem reasonable to assmne that ventricular pacing-
induced ischaemia played a major role in eliciting the protection, since several groups of 
investigators have shown that ventricular pacing produces changes in the electrocardiogram 
similar to those observed with ischaemia."·21 We therefore evaluated the effects of 30 min of 
ventricular pacing on global and regional cardiac performance." In a separate group of pigs we 
established that ventricular pacing (i) did not affect transmural blood flow and its distribution of 
the transmural layers, (ii) did not widen the arterial coronary venous differences in pH and pCO" 
(iii) left high energy phosphate levels and energy charge unchanged, (iv) did not cause coronary 
vasodilation during pacing, (v) did not result in reactive hyperaemia after pacing was stopped and 
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Figure 7 Effect of 30 min of rapid ventricular pacing at 200 bpm (30minRVP) on the transmural 
distribution of myocardial infarct size produced by a 60 min total CorODroy artery occlusion. Ventricular 
pacing was stopped after the onset of the coronary occlusion. Note that the protective effect on the 
epicardial half{lefi panel) was more pronounced than on the endocardial half(right panel). (adapted from 
Koning et al.") 
(vi) did not prevent the immediate return of regional cardiac function after pacing was stopped. 
We feel that these fmdings fail to indicate the presence of myocardial ischaemia. Even, if some 
subendocardial ischaemia would have gone undetected, it would not have been severe enough 
to precondition myocardium via a pathway involving ischaemia. This conclusion is based on our 
fmdings that a 30% reduction in coronary blood flow does not lead to myocardial protection," 
but produces significant metabolic and functional signs of ischaemia. 
Evidence jor the existence oj ischemic preconditioning in humans (Chapter 8) 
Direct clinical evidence for the classical preconditioning phenomenon with infarct size 
limitation as endpoint carmot be obtained. However, a number of patient groups have been 
identified in which adaptation to ischemia has been demonstrated by enhanced recovery of 
function or preservation of high energy phosphates in models of repeated ischemia such as 
angioplasty and aortic cross-clamping during cardiac surgery. Evidence is accumulating that 
mechanisms which are operative in experimental ischemic preconditioning (infarct size 
limitation) are also operative in the clinical models of repeated reversible ischemia. Insight into 
the mechanisms responsible for ischemic preconditioning could potentially help to develop 
pharmacological agents which mimic preconditioning. This is especially attractive as several of 
the ischemic episodes may be too short or not severe enough to trigger preconditioning. By a 
synergistic or additive action combination of such a stimulus arId low dose of pharmacological 
agent might result in a protective action." If these agents were also to be used for treating 
cardiovascular conditions, such as the K' AlP charmel activator nicorandil for the treatment of 
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angina pectoris, the cardioprotective effect could be a beneficial side effect. The currently 
available protein kinase C activators are oncogenic. However, it may be envisioned that in the 
future, with the recognition and better understanding of the different subtypes, new Protein 
kinase C activators may become available which can be applied for cardioprotection without 
negative side-effects. The hearts of patients who regularly experience episodes of ischemia may 
be in a more or less permanent state of preconditioning afforded by one of these stimuli. 
Conversely, resistance may develop in such patients. In these situations it is quite feasible that 
additional protection by a pharmacological agent cannot be accomplished at that time. It is 
reassuring, however, that preconditioning can be reinstated inuuediately after the 
cardioprotection is lost and that it can also be demonstrated in hearts with pathologic conditions 
such as hypertrophy. 
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Het vermogen van myocard (hartspierweefsel) om zich aan te passen aan ischemische 
(zuurstof tekort) stress is 15 jaar geleden al aangetoond in zowel experimentele als ktinische 
studies. Hierin maakte men gebmik van herhaalde perioden van myocard ischemie, die werden 
opgewekt door de coronaire doorbloeding te reduceren. Zo is in varkens aangetoond dat het 
vrijkomen van metabole producten (markers van ischemie) tijdens de tweede van twee 
opeenvolgende perioden van ischemie veel geringer is. Ook bij patienten werd dit fenomeen 
waargenomen. Destijds zijn cchter geen pogingen ondernomen de gewijzigde reactie op de 
tweede ischemische periode te verklaren. Het doel van die studies was nametijk modellen te 
ontwikkelen waarbij reproduceerbare veranderingen in de verschiHende tlmarkersll van ischemie 
zouden optreden. In dergetijke modellen zou de patient of het proefdier als zijn eigen controle 
kunnen dienen in het evalueren van de effecten van farmacologische interventies. Daarap 
volgende studies naar de metabole en ftmctionele gevolgen van meervoudige korte perioden van 
ischemie, zaals oak beschreven staat in hoofdstuk 2, toonden eveneens aan dat er geen 
cumulatieve verliezen waren van energierijke fosfaten en regionale -contractiele functie in het 
myocardweefsel. Kennelijk vindt er na een periode van myocard ischemie een adaptatie in het 
myocard plaats, die tot doel heeft de integriteit van het myocard te bewaren. 
Myocardiale adaptatie begon pas meer aandacht te krijgen toen Murry et al. in 1986 in honden 
aantoonden dat de infarctgrootte van het ischemische risicogebied afnam van 29% naar 7% 
wanneer een kransslagader afsluiting van 40 minuten werd vooraf gegaan door 4 cycti van 5 
minuten occlusie en 5 minuten reperfusie. Imniddels is ook voor een groot aantal andere 
diersoorten, zoals varkens, konijnen en ratten, aangetoond dat het mogelijk is om het myocard 
door middel van korte periodes van ischemie te beschennen tegen het ontwikkelen van 
onherstelbare schade ten gevolge van een langdurige afsluiting van een kransslagader 
(tlischemische preconditionering"), De bescherming die geboden wordt door ischemische 
preconditionering is cchter aan een aantal beperkingen onderhevig. Zo kan het beschermende 
effect van ischemische preconditionering niet meer worden aangetoond als de langdurige 
kransslagader afsluiting langer duurt dan 90 minuten. Tevens hceft de bescherming een beperkte 
duur en verdwijnt watmeer tussen de preconditioneringsstimulus en de lattgdurige occlusie meer 
dan 2 uur verstrijkt. 
In dit proefschrift zijn de resultaten van een aantal studies naar ischemische preconditionering 
bij varkens beschreven. In honden is reeds duidetijk vast komen te staan dat de relatie tussen 
infarctgrootte (infarct-size, IS) en het anatomische risicogebied (AR) wei tineair, maar !liet 
proportioneel is, d.w.z. de regressietijn die de relatie beschrijft tussen IS en AR is tineair maar 
heeft een positief intercept op de AR-as ofwel bij een klein risicogebied treedt er geen infarct op. 
Dit houdt in dat de IS/AR ratio, de gebmiketijke index om infarctgrootte uit te dmkken, niet 
constant is, maar afhanketijk is van AR. Zoals beschreven is in hoofdstuk 3 kan dit in ernstige 
mate het gebmik van de lSI AR ratio beperken bij het vaststellen van infarctgrootte en 
myocardiale bescherming. In hoofdstuk vier wordt beschreven hoe het beschermende effect van 
een kOlie periode van ischemie grotendeels verloren gaat wanneer de reperfusicperiode (herstelde 
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doorbloeding) die de korte en de langdurige ocelusie periode scheidt langer duurt dan 2 uur. De 
relatie tussen de duur van de bescherming door ischemische preconditionering en de duur van 
de tussenliggende reperfusie periode is nag niet voHedig duidelijk. Er zijn studies die sllggereren 
dat het beschennende effect van de preconditioneringsstimulus al heel snel in de tussenliggende 
reperfusieperiode begint te verdwijnen. De noodzaak van een reperfusie peri ode tussen de korte 
en de langdurige voHedige kransslagader afsluiting om ischemische preconditionering op te 
wekken is vanzelfsprekend, aangezien de dum van de langdurige kransslagader afsluiting aurlers 
simpelweg verlengd zou worden. Het is eelller minder duidelijk of een gedeeltelijke afsluiting 
van een kransslagader ook kan leiden tot ischemische preconditionering (zonder een 
tussenliggende reperfusie periode). Indien dit mogelijk blijkt is het vervolgens de vraag of deze 
beschenning gelijk is voor de buitenste (epicard) en binnenste (eudocard) helft van het myocard, 
omdat de doorbloeding van de endocardiale laag van de linker ventrikelwand het meest 
vennindert. Teneinde een antwoord op die vraag te geven bepaalden we de transmuraie 
distributie van de infarctgrootte veroorzaakt door een 60 minuten durende voHedige 
kransslagader afsluiting direct voorafgegaan door gedeeltelijke kransslagader afsluitingen 
(hoofdstuk 5 en 6). 
Relalie IliSSen injarclgroolle en rlsicogebied in varkens 
Het effect van ischemische preconditionering wordt gewoonlijk ge~valueerd aan de hand van 
de ratio van infarctgrootte (IS) en het anatomische risicogebied (AR) dat verstoken is van 
perfusie. Deze index (lS/AR) mag aHeen zonder restricties worden gebruikt als de ontwikkeling 
van de infarctgrootte onafhankelijk is van de groolte van het risicogebied. Voor zowe! 
genarcotiseerde ais wakkere honden is eehter aangetoond dat de lineaire relatie tussell 
infarctgroolte en risicogebied een positiefintercept heeft op de AR -as. Honden kIllIllen echter een 
uitgebreide coronair collateraal circulatie hebben. Dit kan het positieve intercept gemakkelijk 
verklaren, omdat het risicogebied via deze collateralen van bloed kan worden voorzien. Indien 
de collaterale bloedtoevoer inderdaad de oorzaak is van het positieve intercept moet de relatie 
tussen infarctgrootte en risicogebied in varkens, een diersoort met eell verwaarloosbal'e 
coilateraal circulatie in het hart, proportioneei zijn. Daartoe werd in hoofdstuk 4 en 5 de groolte 
van het risicogebied gevarieerd door op verschillende plaatsen de arteria coronaria anterior 
descendens zelf of eon ofmeer van zijn zijtakken afte sluiten. Wij vonden dat na een 60 minuten 
durende kransslagader afsluiling de relatie tussen infarctgrootte en risicogebied zeer lineair was 
(r=0.99, P<O.OOI; waarbij IS~0.97AR-4.5), en dat deze wederom een positief AR-intercept 
vertoonde. 
In hoofdstuk 3 en 4 werd o.a. gekeken naar hoe de relatie tussen infarctgrootte en 
risicogebied wordt gewijzigd door ischemische preconditionering. Hiertoe werden de varkens 
gepreconditioneerd middels een 10 minuten durende volledige kransslagader afsluiting, die van 
een 60 minuten durende volledige afsluiting was gescheiden door 15minuten reperfusie. In 
de gepreconditioneerde varkens bleek de linea ire relatie tussen infarctgrootte en risicogebied 
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een lagere richtingscoefficient te bezitten dan bij de controle dieren (IS = O.64AR-4.4), maar 
met een vrijwel identiek positief intercept op de AR-as. Dus zowel in de controle als in de 
gepreconditioneerde dieren is de lSI AR ratio afhankelijk van AR. De lSI AR ratio bleek met 
name zeer gevoelig te zijn voor de grootte van het risicogebied tot 20% van de linker 
ventrike!. Ben directe vergelijking van resultaten uit verschillende studies kan dus gemakkelijk 
leiden tot verkeerde conc1usies indien verschillende risicogebieden zijn bestudeerd. Oit geldt 
in hoge mate voor het varken, waarbij vaak bewust de voorkeur wordt gegeven aan kleinere 
risicogebieden teneinde de kans op het optreden van fatale ventrikel ritmestoornissen te 
verminderen. 
TranslIlurale distributie van injarclgrootte in varkens 
In hoofdstuk 6 werd de transmurale distributie (Le. de verdeling over endocardiale en 
epicardiale lagen) van het beschermende effect van preconditionering in de linker 
ventrikelwand bestudeerd. Lineaire relaties met een positief AR-intercept werden in zowel de 
endocardiale als de epicardiale helften van de linker ventrikelwand gevonden in controle 
varkens die een 60 minuten durende volledige kransslagader afsluiting hadden ondergaan. In 
honden zijn de infarctgrootte en het anatomisch risicogebied ook lineair gerelateerd, maar in 
tegenstelling tot varkens is het AR-intercept bij honden beduidend groter in het epicard dan 
in het endocard. Oit is waarschijnlijk gedeeltelijk een gevolg van de transmurale gradient in 
collaterale bloedtoevoer in het hondehart, die het grootst is in het epicard. In varkens, waar 
een volledige kransslagader afsluiting resulteert in een transmuraal homogene afname van de 
myocardiale bloedtoevoer, ontwikkelt het infarct zich ook van de binnenste naar de buitenste 
laag, mogelijk ten gevolge van een groter energieverbruik en daarom een snellere reductie van 
de energievoorraad in de binnenste lagen. In overeenstemming hiermee vonden wij dat voor 
een gegeven anatomisch risicogebied de infarctgrootte veroorzaakt door de 60 minuten durende 
volledige kransslagader afsluiting, iets groter was in de endocardiale helft dan in de epicardiale 
helft van de linker ventrike!. 
Ook in varkens gepreconditioneerd middels een 10 minuten durende kransslagader afsluiting 
en gevolgd door 15 minuten reperfusie, bleek de relatie tussen infarctgrootte en risicogebied 
van de endocardiale en de epicardiale helften lineair. Terwijl de AR-intercepten gelijk waren 
aan de intercepten in de controle dieren, waren de regressie coefficienten van de relaties 
kleiner. De afname van de regressie coefficient was gelijk voor endocard en epicard, wat wijst 
op een vrijwel identieke bescherming van de binnenste en buitenste laag van de linker ventrikel 
door preconditionering. 
De duur van de bescherllling len gevolge van preconditionering 
Om de duur van de bescherming te bestuderen werd in hoofdstuk 4 de tussenliggende 
reperfusieperiode tussen de korte en de langdurige kransslagader afsluiting verlengd van 15 
minuten naar I uur. De hypothese was dat als de preconditioneringsstimulus zijn effect al vroeg 
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in de tussenliggende reperfusie periode begint te verliezen, de regressielijn die de relatie van 
infarctgrootte en het anatomisch risicogebied beschrijft geleidelijk opwaarts zou roteren in de 
richting van de controle lijn wanneer de tussenliggende reperfusieperiode wordt verlengd. Een 
I uur durende reperfusieperiode resulteerde in een vrijwel identieke relatie tussen de 
infarctgrootte en het risicogebied vergeleken met 15 minuten reperfusie, wat erop duidt dat het 
effect van een 10 minuten durende preconditionerillgsstimulus in varkens gedurende het eerste 
uur repernlSie nog niet verloren is gegaan. Wanneer de duur van de tussenliggende 
repernlSieperiode tot 2 uur werd verlengd, bleek de infarctgrootte in de meeste dieren niet langer 
te verschiUen van de infarctgrootte in de controle dieren. In enkele dieren bleef de infarctgrootte 
echter nog steeds ruim onder de regressielijn van de controle dieren. Aangezien de IS-AR pnnten 
van de controle groep weinig variatie vel1oondell, is het zeer waarschijnlijk dat de dieren met IS-
AR punten ruim onder de regressielijn nog steeds gepreconditioneerd waren na 2 uur reperfusie. 
Wanneer de tussenliggellde reperfusieperiode nog verder verlengd werd tot 5 uur, bleek dat 
eukele dieren (hoewel een progressief afnemend percentage) nog steeds beschermd waren tot 
zelfs 5 uur na de korte ischemische periode. Hieruit kan men concluderen dat (i) het effect van 
preconditionering in varkells nagenoeg onveranderd blijft gedurende het eerste uur, (ii) de meeste 
varkens de bescherming door ischemische preconditionering na 2 uur hebben verloren en (iii) 
enkele varkens tot 5 uur na de preconditioneringsstimulus beschermd blijven. Dit suggereert dat 
ischemische preconditionering een "niles of niets" fenomeen is. 
Ischemische preconditionering door een gedeeltelijke kransslagader aJsluifing zander 
tussenliggende periode van reper/usie 
In aile IIklassiekell preconditionerings experimenten wordt de kransslagader doorbloeding 
hersteld voordat de coronaire arterie voor een lallgdurige peri ode volledig wordt afgesloten. 
Voor het preconditioneren van het hartspierweefsel door een gedeeltelijke afsluiting van een 
kransslagader ligt dit mogelijk anders, omdat in dit geval de resterende doorbloeding voldoende 
zau kunnen zijn om het preconditioneren plaats te laten vinden. Harris was de eerste die 
gedurende 30 minuten een gedeeltelijke afsluiting toepaste (zander overigens de resterende 
kransslagader doorbloeding te quantificeren) voorafgaand aan een volledige afsluiting van eukele 
uren. Harris beschreef een afuarne van de hoge incidentie van ventrikel fibriUerell die normaal 
gesproken optreedt gedurende de eerste 30 milluten na het volledig afsluiten van een coronair 
arterie. Deze afuanle in de incidentie van ventrikel fibriUeren werd uitgelegd door de mindere 
ernst van de ischemie gedurende de peri ode van gedeeltelijke afsluiting. De start van de 
daaropvolgende totale occlusie (na 30 minuten) werd beschouwd als komende na de tijdsduur 
waarbinnen de meeste ventrikel arrhytmi~en optreden. Huidige inzichten in de effectell van 
ischemische preconditionering leveren een altematieve hypothese op: de gedeeltelijke afsluiting 
preconditioneert het myocard, waarbij de kans van ventrikel fibriUeren tijdens de daaropvolgende 
volledige afsluiting wordt verminderd. Het beschermende effect van een gedeeltelijke 
kransslagader afsluiting werd voor het eerst bestudeerd door Ovize et al door gedurende 15 
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minuten de kraru;slagader doorbloeding met 50% te reduceren alvorens de kransslagader voHedig 
nfte sluiten. De infarctgrootte in deze dieren verschilde niet van die in een contrale groep, waarin 
de honden aHeen de langdurige kransslagader afsluiting hadden ondergaan. Ook een 25 minuten 
durende 50% kransslagader afsluiting had geen effect op de infarctgrootte. Een afname van de 
infarctgrootte werd aileen waargenomen indien 10 minuten van voHedige reperfusie werd 
toegestaan tussen de 15 minuten 50% reductie van de kransslagader doorbloeding en de 
langdurige kransslagader afsluiting. De auteurs concludeerden dat myocard kon worden 
gepreconditioneerd door eell partiele occlusie, maar dat een tussenliggende reperfusieperiode 
obligaat was om een beschemIend effect te verkrijgen. 
We veronderstelden dat in de studie door Ovize et al de reductie in doorbloeding niet ernstig 
genoeg was of te kort duurde om preconditionering op te wekken. In hoofdstuk 6 reduceerden 
we de bloedtoevoer in de arteria coranaria anterior descendens eerst gedurende 30 minuten met 
70% voordat de kransslagader direct aansluitend (dus wnder tussenliggende reperfusie) voor 60 
minuten werd afgesloten. AIle dieren die aan dit reginIe werden onderworpen hadden beduidend 
kleinere infarcten dan de controle groep. WarnIeer de duur van de peri ode van de 70% 
doorbloedingsreductie van 30 minuten werd verlengd naar 90 minuten, bleken de gevonden 
infarcten nog steeds kleiner dan de infarcten bij de controle dieren ondanks het feit dat de 90 
minuten 70% reductie van de bloedtoevoer op zichzelf al had geresulteerd in enige irreversibele 
schade. In tegenstelling tot de beschemIende effecten van 70% doorbloedingsreducties, beperkte 
een 30 of90 minuten durende 30% reductie van de kransslagader doorbloeding de infarctgrootte 
niet. Deze bevindingen suggereren dat myocard kan worden gepreconditioneerd door een 
reductic in bloedtoevoer zander een tussenliggende peri ode van reperfusie, maar dat een 
voldoende mate van doorbloedingsreductie, waarbij de stimulus eell zekere drempelwaarde 
overschreidt, van cruciaal belang is. 
Tijdens een partiele afsluiting van een kransslagader is de afname VatI bloedtoevoer distaal van 
de afsluiting niet homogeen verdeeld over de wand van de hartspier. In de endocardiale lagen 
neemt de bloedtoevoer meer af dan in de epicardiale lagen, waardoor de ischemie het ernstigst 
is in het endocard. Indien, zoals gesuggereerd is, er een drempei bestaat voor ischemische 
preconditionering die een voldoende sterke prikkel vereist, kan men zich voorstellen dat met een 
30% reductie van de kransslagader doorbloeding het endocard ZOll kunnen worden 
gepreconditioneerd, terwijl het epicard slechts blootgesteld geweest wu zijn aan een stimulus die 
niet boven de drempelwaarde uitkomt. Aan de andere kant kan zich bij een 70% 
doorbloedingsvennindering subendocardiaal al irreversibele schade ontwikkelen, vanwege de 
grotere .fuame in bloedtoevoer, wdat de bescherming gedeeltelijk teniet wordt gedaan. Wanneer 
we de endocardiale (hinnenste 50%) en de epicardiale (buitenste 50%) infarctgrootte 
analyseerden, bleek dat in de dieren die onderworpen waren aan 30 minuten 70% afhame van de 
bloedtoevoer in beide helften de infarcten k1einer waren dan in de corresponderende helften van 
de controle dieren. Echter wij constateren d.t de infarctgroottebeperking in de epicardiale helft 
groter was dan in de endocardiale helft. In tegenstelling tot klassieke preconditionering met een 
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totale occlusie van een coronair arterie (die in onze proeven een transmuraal homogene protectie 
biedt) resulteerde een 70% vennindering in de kransslagader doorbloeding in een voorkeur voor 
epicardiale protectie. 
Myocardiale beschel'lning door een periode van snel ven/rikel pacen 
Przyklenk et al hebben aangetoond dat het hartspierweefsel gepreconditioneerd kan worden 
door een kort durende afsluiting van een kransslagader die een aangrenzend dee! van de hartspier 
van bloed voorziet. Dil duidt erop dat myocard niet zelfter plaatse ischemisch hoeft te worden 
om toch een verhoogde beschenning tegen ischemische schade te verkrijgen. De beschenning 
kan het gevolg zijn van rek van dit niet ischemische hartspierweefsel in respons op een 
verslechtering van contractiefunctie in het aangl'enzende ischemische gebied. Onderstetuling voor 
deze hypothese kwam van dezelfde groep onderzoekers die aantoonden dat het rekken van de 
hartspier verkregen door acute volume belasting, ook Ieidde tol een vermindering van 
infarctgrootte ten gevolge van een Iangdurige kransslagader afsluiting zonder dat hiervoor 
ischemie nodig was. De beschenning door "rek" kon worden geblokkeerd door voorbehandeling 
met gadolinium, een remmer van rek-geactiveerde kation-kanalen. In hoofdstuk 7 is beschreven 
hoe hoogfrequente elektrische ventrikel stimulatie resulterend in een hartfrequentie van 200 
siagen per minuut preconditionering opwekt. De gedachte achter deze benadering is de observalie 
door Vegh et al dat elektrische ventrikel stimulatie de incidentie van ventrikel fibriUeren 
venninderde gedurende en direct volgend op een afsluiting van een kransslagader. Tien minuten 
elektrische ventrikel stimulatie met 200 slagen per minuut, gescheiden van een 60 minuten 
durende coronair arterie occlusie door 15 minuten normaal sinusritme, had geen effect op de 
infarctgrootte. Wal1lleer de ventrikel stimulatie dertig minuten duurde resulteerde dit in een 
geringe, maar significante beperking van de infarctgrootte in de epicardiale, maar niet in de 
endocardiale helft. Een hogere mate van infarctverkleining werd bereikt als de tussenliggende 
periode van nonnaal sinusritme achterwege werd gelaten. Dus warmeer aan het einde van de 30 
mlnuten elektrische ventrikel stimulatie de arteria coronaria anterior descendens werd afgesloten, 
nadat de elektrische stimulator (pacemaker) was afgezet, dan Waren de infarctgroottes in zowel 
de epicardiale ais de endocardiale helft beduidend kleiner in vergelijking met de controle groep. 
Voorbehandeling met de A TP-gevoelige kalililll-kanaal antagonist glibenclamide resulteerde bij 
aile dieren, op een na, in het uitblijven van de beschermende effecten van ventrikel stimulatie. 
De centrale 1'01 van de ATP-gevoelige kalium-kanalen bij ventrikel stimulatie is analoog aan 
diens rol bij preconditionering door een korte totale kransslagader afsluiling bij varkens. Er werd 
vee!al aangenomen dat hoogfrequente ventrikel slimulatie ischemie gaf, welke de beschermende 
werking van ventrikel stimulatie ZOll verklaren. Deze aanname is gebaseerd op de door ventrikel 
stimulatie geinduceerde veranderingen in het electrocardiogranl, welke vergelijkbaar zijn met de 
veranderingen zoals die worden waargenomen tijdens ischemie. Metingen aan het hart gedurende 
en volgend op 30 minuten van venlrikel stimulatie toonden aan dat de ventrikel stimulatie (i) 
geen effect had op de transmurale verdeling van de doorbloeding van de linker ventrikelwand, 
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(ii) de coronair arterio-veneuze pH en pCO, gradi~nten en (iii) de energierijke 
fosfaatverbindingen en de lIenergielading" onveranderd liet. Verdere aanwijzingen dat ischemie 
niet optrad tijdens ventrikel stimulatie zijn (iv) de afwezigheid van een ,eactieve hyperemie en 
(v) het directe herstel van de regionale hartspierfunctie na het uitzetten van de pacemaker. Maar 
zelfs als enige subendocardiale ischemie optrad, welke door de metingen niet we,d geregistreerd, 
dan nog ZOll deze niet ernstig genoeg zijn om de hartspier te preconditioneren. Deze conclusie 
is gebaseerd op onze bevindingen dat een 30% vennindering in kransslagader doorbloeding niet 
leidt tot myocardiale bescherming (hoofdstuk 6), maar wei resulteerde in anaemob metabolisme 
met significante veranderingen van de metabole en functionele tlmarkers" van ischemie. 
In dit proefschrift is aangetoond dat het gebruik van de ratio infarctgrootte over anatomisch 
risicogebied om de mate van bescherming door ischemische preconditionering vast te stellcn niet 
feilloos is, omdat de ratio afhankelijk is van de grootte van het anatomische risicogebied. Ook 
is bewijs aangevoerd dat niet aileen volledige maar ook gedeeltelijke kransslagader afsluitingen 
de hartspier kunnen preconditioneren. In het door ons gehanteerde model bleek ook dat een 
tussenliggende reperfusieperiode niet noodzakelijk is na de gedeeltelijke kransslagaderafsluiting. 
De beschenning welke wordt geleverd door een gedeeltelijke afsluiting is groter in de epicardiale 
dan in de endocardiale helft van de linker ventrikelwand, wat in tegenstelling is met de 
transmuraal homogeen verdeelde bescherming veroorzaakt door een korte volledige afsluiting 
van een kransslagader. Hoog/i'equente eleklrische ventrikel stimulatie is in slaal myocard Ie 
preconditioneren, hoewel het ngeheugentt voor bescherming gCYnduceerd door ventrikel 
stimulatie veel kortcr is dan dat vOOr een korte afsluiting van een kransslagader. Activatie van 
K+ ATP kanalen, via niet-ischemische weg lijkt een centrale rol te spelen in het 
beschermingsmechanisme van ventrikel slirnulatie. Omdal de hartspier ook door andere vormen 
van niet-ischemische belasling kan worden gepreconditioneerd, waaronder rek en mogelijk ook 
ischemie in andere organen, zoals de nier, lijkt het dal lokale ischemie slechls een methode is om 
stress op te wekken in het myocard, welke vervolgens bescherml legen irreversibele schade door 
een langdurige lotale afsluiting van een kransslagader. Echter de vraag blijft welke vormen van 
stress preconditionering van het hru1 zouden kmmen geven, omdat stress door bijvoorbeeld een 
chronische blootstelling aan tabaksrook de infarclgrootte ten gevolge van een kransslagader 
afsluiting juist doet toenemen. 
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